[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 92 of about 92
6. Schwamborn K, Krieg RC, Jirak P, Ott G, Knüchel R, Rosenwald A, Wellmann A: Application of MALDI imaging for the diagnosis of classical Hodgkin lymphoma. J Cancer Res Clin Oncol; 2010 Nov;136(11):1651-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Application of MALDI imaging for the diagnosis of classical Hodgkin lymphoma.
  • Hodgkin lymphoma (HL) is a distinctive lymphoma subtype characterized by rareness of tumor cells [Hodgkin's and Reed-Sternberg (HRS) cells in classical HL and lymphocytic and histiocytic cells in lymphocyte predominant HL] as well as the vast majority of the surrounding inflammatory-like cellular infiltrate.
  • [MeSH-minor] Algorithms. Cell Division. Diagnosis, Differential. Gene Expression Regulation, Neoplastic. Humans. Lymph Node Excision. Lymphadenitis / diagnosis. Lymphadenitis / pathology. Lymphadenitis / surgery. Neoplasm Proteins / analysis. Neoplasm Proteins / genetics. Proteome

  • Genetic Alliance. consumer health - Hodgkin lymphoma.
  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Pathol. 2002 Mar;55(3):162-76 [11896065.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18126-31 [18776051.001]
  • [Cites] Nat Med. 2001 Apr;7(4):493-6 [11283679.001]
  • [Cites] Mol Cell Proteomics. 2005 Apr;4(4):394-401 [15677390.001]
  • [Cites] Am J Pathol. 2004 Oct;165(4):1057-68 [15466373.001]
  • [Cites] Blood. 2005 May 1;105(9):3722-30 [15650054.001]
  • [Cites] Blood. 2000 May 15;95(10):3020-4 [10807764.001]
  • [Cites] CA Cancer J Clin. 2004 Sep-Oct;54(5):260-72 [15371284.001]
  • [Cites] J Exp Ther Oncol. 2007;6(2):137-45 [17407972.001]
  • [Cites] Proteomics. 2005 Nov;5(16):4274-86 [16206328.001]
  • [Cites] Mod Pathol. 2004 Jun;17(6):670-8 [15098007.001]
  • [Cites] Nature. 2003 Mar 13;422(6928):226-32 [12634796.001]
  • [Cites] Int J Mol Med. 2007 Aug;20(2):155-9 [17611632.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10962-6 [7971992.001]
  • [Cites] Ann Oncol. 2002;13 Suppl 4:147-52 [12401681.001]
  • [Cites] Pathologe. 2000 Mar;21(2):113-23 [10840817.001]
  • [Cites] Blood. 2008 Feb 15;111(4):2339-46 [18070985.001]
  • [Cites] Lab Invest. 2007 Nov;87(11):1113-24 [17876297.001]
  • [Cites] Ann Oncol. 2002;13 Suppl 1:11-8 [12078890.001]
  • [Cites] Histol Histopathol. 2007 Aug;22(8):923-35 [17503349.001]
  • [Cites] J Clin Oncol. 2005 Sep 10;23(26):6379-86 [16155023.001]
  • [Cites] Anal Chem. 1999 Dec 1;71(23):5263-70 [10596208.001]
  • [Cites] Pathologe. 2002 May;23(3):207-18 [12089788.001]
  • [Cites] Cancer Cell. 2003 Jan;3(1):9-15 [12559171.001]
  • [Cites] J Biomol Tech. 2005 Dec;16(4):341-6 [16522855.001]
  • (PMID = 20865362.001).
  • [ISSN] 1432-1335
  • [Journal-full-title] Journal of cancer research and clinical oncology
  • [ISO-abbreviation] J. Cancer Res. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Neoplasm Proteins; 0 / Proteome
  •  go-up   go-down


7. Chan JW, Taylor DS, Lane SM, Zwerdling T, Tuscano J, Huser T: Nondestructive identification of individual leukemia cells by laser trapping Raman spectroscopy. Anal Chem; 2008 Mar 15;80(6):2180-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Currently, a combination of technologies is typically required to assess the malignancy of cancer cells.
  • These methods often lack the specificity and sensitivity necessary for early, accurate diagnosis.
  • Here we demonstrate using clinical samples the application of laser trapping Raman spectroscopy as a novel approach that provides intrinsic biochemical markers for the noninvasive detection of individual cancer cells.
  • Populations of normal T and B lymphocytes from four healthy individuals and cells from three leukemia patients were analyzed, and multiple intrinsic Raman markers associated with DNA and protein vibrational modes have been identified that exhibit excellent discriminating power for cancer cell identification.
  • A combination of two multivariate statistical methods, principal component analysis (PCA) and linear discriminant analysis (LDA), was used to confirm the significance of these markers for identifying cancer cells and classifying the data.
  • We also provide evidence that these markers are unique to cancer cells and not purely a function of differences in their cellular activation.

  • MedlinePlus Health Information. consumer health - Leukemia.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18260656.001).
  • [ISSN] 0003-2700
  • [Journal-full-title] Analytical chemistry
  • [ISO-abbreviation] Anal. Chem.
  • [Language] eng
  • [Grant] United States / NCRR NIH HHS / RR / UL1 RR024146
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


8. Schrohl AS, Würtz S, Kohn E, Banks RE, Nielsen HJ, Sweep FC, Brünner N: Banking of biological fluids for studies of disease-associated protein biomarkers. Mol Cell Proteomics; 2008 Oct;7(10):2061-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Clinically validated biomarkers may provide information to be used for diagnosis, screening, evaluation of risk/predisposition, assessment of prognosis, monitoring (recurrence of disease), and prediction of response to treatment and as a surrogate response marker.

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Scand J Clin Lab Invest. 2002;62(3):223-30 [12088341.001]
  • [Cites] Transfusion. 1999 Oct;39(10):1078-83 [10532601.001]
  • [Cites] Int J Oncol. 2003 Dec;23(6):1715-26 [14612946.001]
  • [Cites] Dan Med Bull. 2003 Nov;50(4):368-84 [14694852.001]
  • [Cites] Am J Phys Anthropol. 2008 Jun;136(2):138-46 [18257023.001]
  • [Cites] Br J Cancer. 2002 Feb 1;86(3):417-23 [11875709.001]
  • [Cites] Clin Chem. 2002 May;48(5):691-8 [11978595.001]
  • [Cites] Transfus Med. 2004 Aug;14(4):305-12 [15285727.001]
  • [Cites] Clin Chem. 1997 Aug;43(8 Pt 1):1348-51 [9267312.001]
  • [Cites] Br J Cancer. 1998 Mar;77(6):956-64 [9528841.001]
  • [Cites] Br J Cancer. 1999 May;80(3-4):495-503 [10408859.001]
  • [Cites] Anal Biochem. 2005 Mar 15;338(2):294-8 [15745750.001]
  • [Cites] Clin Chem Lab Med. 2006;44(4):358-65 [16599826.001]
  • [Cites] Clin Chim Acta. 2007 May 1;380(1-2):128-32 [17328880.001]
  • [Cites] Clin Chem. 2007 Jul;53(7):1338-42 [17525103.001]
  • [Cites] Scand J Clin Lab Invest. 2007;67(5):545-52 [17763191.001]
  • [Cites] J Clin Endocrinol Metab. 2007 Sep;92(9):3674-80 [17595257.001]
  • [Cites] Scand J Immunol. 2007 Oct;66(4):458-64 [17850591.001]
  • [Cites] Dis Markers. 2008;24(1):1-10 [18057530.001]
  • [Cites] Scand J Clin Lab Invest. 2007;67(8):821-35 [17852826.001]
  • [Cites] Scand J Gastroenterol. 2008;43(2):186-91 [18224564.001]
  • [Cites] Scand J Gastroenterol. 2008;43(2):242-8 [18224568.001]
  • [Cites] Int J Biol Markers. 2008 Jan-Mar;23(1):42-7 [18409150.001]
  • [Cites] Am J Hematol. 2001 Jul;67(3):157-62 [11391711.001]
  • [Cites] Int J Biol Markers. 2003 Jul-Sep;18(3):170-6 [14535586.001]
  • (PMID = 18676364.001).
  • [ISSN] 1535-9484
  • [Journal-full-title] Molecular & cellular proteomics : MCP
  • [ISO-abbreviation] Mol. Cell Proteomics
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Proteins
  • [Number-of-references] 26
  • [Other-IDs] NLM/ PMC2559931
  •  go-up   go-down


9. Abaffy T, Duncan R, Riemer DD, Tietje O, Elgart G, Milikowski C, DeFazio RA: Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process. PLoS One; 2010 Nov 04;5(11):e13813
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Discovering new melanoma biomarkers would improve early detection and diagnosis.

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Moles.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Anal Chem. 2000 Feb 15;72(4):747-56 [10701259.001]
  • [Cites] J Am Chem Soc. 2010 Mar 24;132(11):3642-3 [20196537.001]
  • [Cites] Philos Trans R Soc Lond B Biol Sci. 2002 Jan 29;357(1417):17-23 [11839178.001]
  • [Cites] Breast J. 2003 May-Jun;9(3):184-91 [12752626.001]
  • [Cites] Trends Biochem Sci. 2003 Jun;28(6):329-35 [12826405.001]
  • [Cites] Cancer Treat Rev. 2003 Dec;29(6):489-99 [14585259.001]
  • [Cites] Lancet. 2004 Feb 28;363(9410):728-30 [15005091.001]
  • [Cites] Prev Med. 2004 Apr;38(4):382-7 [15020171.001]
  • [Cites] Environ Health Perspect. 2004 May;112(7):A396-7 [15159211.001]
  • [Cites] Nat Rev Cancer. 2004 Jul;4(7):551-61 [15229480.001]
  • [Cites] J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Sep 5;808(2):269-77 [15261821.001]
  • [Cites] Nature. 1966 Nov 26;212(5065):933-5 [4306794.001]
  • [Cites] J Biol Chem. 1980 Nov 10;255(21):10493-501 [7430132.001]
  • [Cites] Anticancer Res. 1985 Jan-Feb;5(1):1-30 [3888043.001]
  • [Cites] Mutat Res. 1989 Jan;219(1):71-9 [2911273.001]
  • [Cites] Biochem Pharmacol. 1995 Dec 22;50(12):1955-62 [8849320.001]
  • [Cites] Science. 1996 Jul 5;273(5271):59-63 [8658196.001]
  • [Cites] J Biol Chem. 1997 May 2;272(18):11895-901 [9115250.001]
  • [Cites] Nucleic Acids Res. 1999 Jun 1;27(11):2291-8 [10325416.001]
  • [Cites] Cancer Res. 1999 Aug 15;59(16):3855-60 [10463569.001]
  • [Cites] J Invest Dermatol. 1964 Aug;43:111-3 [14196302.001]
  • [Cites] Biochemistry. 2004 Nov 16;43(45):14332-9 [15533037.001]
  • [Cites] Nature. 2005 Aug 4;436(7051):720-4 [16079850.001]
  • [Cites] J Invest Dermatol. 2006 Dec;126(12):2565-75 [17108903.001]
  • [Cites] Mass Spectrom Rev. 2007 Jan-Feb;26(1):51-78 [16921475.001]
  • [Cites] Nature. 2007 Feb 22;445(7130):843-50 [17314970.001]
  • [Cites] Am J Clin Nutr. 2007 Apr;85(4):946-9 [17413090.001]
  • [Cites] Cancer Biomark. 2007;3(2):95-109 [17522431.001]
  • [Cites] Int J Epidemiol. 2008 Apr;37 Suppl 1:i23-30 [18381390.001]
  • [Cites] Skin Res Technol. 2008 May;14(2):226-36 [18412567.001]
  • [Cites] PLoS Med. 2008 Jun 3;5(6):e120 [18532874.001]
  • [Cites] J Thorac Oncol. 2008 Jul;3(7):774-80 [18594325.001]
  • [Cites] Int J Cancer. 2008 Nov 15;123(10):2446-55 [18729182.001]
  • [Cites] Br J Dermatol. 2008 Sep;159(4):780-91 [18637798.001]
  • [Cites] J Am Chem Soc. 2008 Oct 29;130(43):14111-3 [18831549.001]
  • [Cites] Nature. 2008 Oct 23;455(7216):1054-6 [18948945.001]
  • [Cites] Lung Cancer. 2009 Feb;63(2):164-8 [18599152.001]
  • [Cites] Can Fam Physician. 2009 Jan;55(1):24; autor reply 24 [19155361.001]
  • [Cites] Anal Bioanal Chem. 2009 Feb;393(3):781-95 [18836706.001]
  • [Cites] Nature. 2009 Feb 12;457(7231):910-4 [19212411.001]
  • [Cites] J Am Soc Mass Spectrom. 2009 Mar;20(3):464-8 [19070510.001]
  • [Cites] Am J Pathol. 2009 Apr;174(4):1524-33 [19342374.001]
  • [Cites] Nat Rev Genet. 2009 May;10(5):295-304 [19308066.001]
  • [Cites] Cancer Control. 2009 Jul;16(3):200-18 [19556960.001]
  • [Cites] Eur Respir J. 2009 Jul;34(1):261-75 [19567608.001]
  • [Cites] BMC Cancer. 2009;9:348 [19788722.001]
  • [Cites] Pigment Cell Melanoma Res. 2009 Dec;22(6):750-60 [19735457.001]
  • [Cites] Pigment Cell Melanoma Res. 2010 Feb;23(1):64-71 [19788535.001]
  • [Cites] Rapid Commun Mass Spectrom. 2010 Mar 15;24(5):613-20 [20143319.001]
  • [Cites] J Invest Dermatol. 2001 Apr;116(4):520-4 [11286617.001]
  • (PMID = 21079799.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA132046-02; United States / NCI NIH HHS / CA / R21 CA132046; United States / NCI NIH HHS / CA / R21CA 132046; United States / NCI NIH HHS / CA / R21 CA132046-01A1; United States / NCI NIH HHS / CA / R21 CA132046-02
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Volatile Organic Compounds
  • [Other-IDs] NLM/ PMC2973952
  •  go-up   go-down


10. Franck J, Arafah K, Elayed M, Bonnel D, Vergara D, Jacquet A, Vinatier D, Wisztorski M, Day R, Fournier I, Salzet M: MALDI imaging mass spectrometry: state of the art technology in clinical proteomics. Mol Cell Proteomics; 2009 Sep;8(9):2023-33
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • 1) diagnosis based on profile signatures that complement histopathology, 2) early detection of disease, 3) selection of therapeutic combinations based on the individual patient's entire disease-specific protein network, 4) real time assessment of therapeutic efficacy and toxicity, 5) rational redirection of therapy based on changes in the diseased protein network that are associated with drug resistance, and 6) combinatorial therapy in which the signaling pathway itself is viewed as the target rather than any single "node" in the pathway.

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Chim Acta. 2005 Jul 24;357(2):210-8 [15913587.001]
  • [Cites] J Proteome Res. 2005 Jul-Aug;4(4):1200-12 [16083270.001]
  • [Cites] J Am Soc Mass Spectrom. 2005 Oct;16(10):1654-9 [16095912.001]
  • [Cites] Anal Chem. 2005 Oct 1;77(19):6118-24 [16194068.001]
  • [Cites] Anal Chem. 2005 Oct 15;77(20):6682-6 [16223256.001]
  • [Cites] Rapid Commun Mass Spectrom. 2006;20(2):284-90 [16345125.001]
  • [Cites] Anal Chem. 2006 Feb 1;78(3):734-42 [16448046.001]
  • [Cites] Anal Chem. 2006 Feb 1;78(3):809-19 [16448055.001]
  • [Cites] Anal Chem. 2006 Feb 1;78(3):827-34 [16448057.001]
  • [Cites] J Proteome Res. 2006 Feb;5(2):262-9 [16457591.001]
  • [Cites] Rapid Commun Mass Spectrom. 2006;20(6):965-72 [16470674.001]
  • [Cites] Mol Carcinog. 2006 Aug;45(8):613-26 [16788983.001]
  • [Cites] J Neuropathol Exp Neurol. 2006 Sep;65(9):837-45 [16957577.001]
  • [Cites] Anal Chem. 2006 Sep 15;78(18):6448-56 [16970320.001]
  • [Cites] Brain Res. 2006 Oct 3;1113(1):24-32 [16938284.001]
  • [Cites] Mol Cell Proteomics. 2006 Oct;5(10):1876-86 [16705188.001]
  • [Cites] Anal Chem. 2006 Oct 15;78(20):7145-53 [17037914.001]
  • [Cites] Methods Enzymol. 2006;412:94-106 [17046654.001]
  • [Cites] Angew Chem Int Ed Engl. 2006 Nov 6;45(43):7188-92 [17001721.001]
  • [Cites] J Am Soc Mass Spectrom. 2007 Jan;18(1):145-51 [17055739.001]
  • [Cites] Curr Opin Chem Biol. 2007 Feb;11(1):29-35 [17185024.001]
  • [Cites] J Pharmacol Toxicol Methods. 2007 Mar-Apr;55(2):193-200 [16919485.001]
  • [Cites] J Mass Spectrom. 2007 Feb;42(2):254-62 [17230433.001]
  • [Cites] Rapid Commun Mass Spectrom. 2007;21(7):1271-6 [17340571.001]
  • [Cites] Anal Chem. 2007 Mar 15;79(6):2463-71 [17305311.001]
  • [Cites] J Mass Spectrom. 2007 Apr;42(4):476-89 [17328093.001]
  • [Cites] J Proteome Res. 2007 Apr;6(4):1295-305 [17291023.001]
  • [Cites] Wien Med Wochenschr. 2007;157(5-6):122-9 [17427009.001]
  • [Cites] J Proteome Res. 2007 Jun;6(6):2057-67 [17477556.001]
  • [Cites] Nat Clin Pract Gastroenterol Hepatol. 2007 Jul;4(7):372-85 [17607293.001]
  • [Cites] Int J Mol Med. 2007 Aug;20(2):155-9 [17611632.001]
  • [Cites] J Mass Spectrom. 2007 Aug;42(8):1099-105 [17621390.001]
  • [Cites] J Am Soc Mass Spectrom. 2007 Sep;18(9):1646-52 [17659880.001]
  • [Cites] Nat Methods. 2007 Oct;4(10):828-33 [17901873.001]
  • [Cites] J Proteome Res. 2007 Nov;6(11):4127-34 [17939699.001]
  • [Cites] Pac Symp Biocomput. 2007;:458-69 [17990510.001]
  • [Cites] Curr Pharm Des. 2007;13(32):3317-24 [18045185.001]
  • [Cites] Nat Methods. 2008 Jan;5(1):57-9 [18084298.001]
  • [Cites] Nat Methods. 2008 Jan;5(1):101-8 [18165806.001]
  • [Cites] Mol Cell Proteomics. 2008 Feb;7(2):411-23 [17991918.001]
  • [Cites] J Proteome Res. 2008 Mar;7(3):969-78 [18247558.001]
  • [Cites] Anal Chem. 2008 Apr 15;80(8):2780-8 [18314967.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):237-46 [18337021.001]
  • [Cites] Rapid Commun Mass Spectrom. 2008 May;22(10):1503-9 [18421763.001]
  • [Cites] Rapid Commun Mass Spectrom. 2008 May;22(10):1615-8 [18433085.001]
  • [Cites] Expert Rev Proteomics. 2008 Jun;5(3):413-24 [18532909.001]
  • [Cites] Anal Chem. 2008 Jun 15;80(12):4761-6 [18476721.001]
  • [Cites] J Am Soc Mass Spectrom. 2008 Aug;19(8):1069-77 [18472274.001]
  • [Cites] J Proteomics. 2008 Aug 21;71(3):332-45 [18644473.001]
  • [Cites] Histochem Cell Biol. 2008 Sep;130(3):421-34 [18618129.001]
  • [Cites] Proteomics. 2008 Sep;8(18):3702-14 [18704906.001]
  • [Cites] Proteomics. 2008 Sep;8(18):3715-24 [18712763.001]
  • [Cites] Anal Chem. 2008 Nov 15;80(22):8628-34 [18847214.001]
  • [Cites] Comb Chem High Throughput Screen. 2009 Feb;12(2):156-74 [19199884.001]
  • [Cites] Rapid Commun Mass Spectrom. 2009 Mar;23(6):733-6 [19206086.001]
  • [Cites] Rapid Commun Mass Spectrom. 2009 Apr;23(8):1183-8 [19283784.001]
  • [Cites] J Proteome Res. 2008 Dec;7(12):5230-6 [19367705.001]
  • [Cites] J Exp Biol. 2000 Dec;203(Pt 23):3565-73 [11060217.001]
  • [Cites] Nat Med. 2001 Apr;7(4):493-6 [11283679.001]
  • [Cites] Curr Opin Chem Biol. 2002 Oct;6(5):676-81 [12413553.001]
  • [Cites] Neuro Endocrinol Lett. 2003 Feb-Apr;24(1-2):9-14 [12743525.001]
  • [Cites] J Mass Spectrom. 2003 Oct;38(10):1081-92 [14595858.001]
  • [Cites] Anal Chem. 2004 Feb 15;76(4):1145-55 [14961749.001]
  • [Cites] Am J Pathol. 2004 Oct;165(4):1057-68 [15466373.001]
  • [Cites] J Neurochem. 1994 Jan;62(1):404-7 [8263544.001]
  • [Cites] Endocrinology. 1994 Apr;134(4):1812-9 [8137747.001]
  • [Cites] J Biol Chem. 1994 Dec 2;269(48):30288-92 [7982940.001]
  • [Cites] Brain Res Mol Brain Res. 1994 Sep;25(3-4):355-8 [7808235.001]
  • [Cites] Anal Chem. 1997 Dec 1;69(23):4751-60 [9406525.001]
  • [Cites] Biochemistry. 1998 Feb 17;37(7):2070-6 [9485334.001]
  • [Cites] Anal Chem. 1998 May 1;70(9):1805-11 [9599581.001]
  • [Cites] Exp Nephrol. 1998 Sep-Oct;6(5):421-8 [9730658.001]
  • [Cites] J Neurophysiol. 1999 Mar;81(3):1251-60 [10085352.001]
  • [Cites] Cancer Res. 2004 Dec 15;64(24):9093-100 [15604278.001]
  • [Cites] Mol Cell Proteomics. 2005 Apr;4(4):394-401 [15677390.001]
  • [Cites] Drug Discov Today. 2005 Jun 15;10(12):823-37 [15970265.001]
  • (PMID = 19451175.001).
  • [ISSN] 1535-9484
  • [Journal-full-title] Molecular & cellular proteomics : MCP
  • [ISO-abbreviation] Mol. Cell Proteomics
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Proteins
  • [Number-of-references] 84
  • [Other-IDs] NLM/ PMC2742436
  •  go-up   go-down


11. Wicker CA, Sahu RP, Kulkarni-Datar K, Srivastava SK, Brown TL: BITC Sensitizes Pancreatic Adenocarcinomas to TRAIL-induced Apoptosis. Cancer Growth Metastasis; 2010 Jan 20;2009(2):45-55
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pancreatic adenocarcinoma is an aggressive cancer with a greater than 95% mortality rate and short survival after diagnosis.
  • Codon 12 mutations maintain Ras in a constitutively active state leading to continuous cellular proliferation.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20559452.001).
  • [Journal-full-title] Cancer growth and metastasis
  • [ISO-abbreviation] Cancer Growth Metastasis
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA106953; United States / NCI NIH HHS / CA / CA106953-03; United States / NCI NIH HHS / CA / CA106953-05; United States / NCI NIH HHS / CA / CA106953-06; United States / NCI NIH HHS / CA / R01 CA129038
  • [Publication-type] JOURNAL ARTICLE
  • [Publication-country] United States
  •  go-up   go-down


12. Provenzano PP, Eliceiri KW, Keely PJ: Shining new light on 3D cell motility and the metastatic process. Trends Cell Biol; 2009 Nov;19(11):638-48
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Understanding tissue architecture and physical and chemical reciprocity between cells and their microenvironment provides vital insights into key events in cancer metastasis, such as cell migration through three-dimensional (3D) extracellular matrices.
  • Yet, many mechanistic details associated with metastasis remain elusive due to the difficulty of studying cancer cells in relevant 3D microenvironments.
  • Optical imaging is also providing novel 'optical biomarkers' with diagnostic potential that are linked to cell-motility pathways associated with metastasis, and these can to help guide new approaches to cancer diagnosis and therapy.
  • Here we present recent advances in one subclass of optical imaging of particular promise for cellular imaging - multiphoton microscopy - that can be used to improve the detection of malignant cells as well as advance our understanding of the cell biology of cancer metastasis.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neoplasia. 2000 Jan-Apr;2(1-2):89-117 [10933071.001]
  • [Cites] Nat Rev Mol Cell Biol. 2001 Jun;2(6):444-56 [11389468.001]
  • [Cites] Nat Med. 2001 Jul;7(7):864-8 [11433354.001]
  • [Cites] Biophys J. 2002 Jan;82(1 Pt 1):493-508 [11751336.001]
  • [Cites] Nature. 2002 Jan 31;415(6871):530-6 [11823860.001]
  • [Cites] Cancer Res. 2002 Feb 1;62(3):682-7 [11830520.001]
  • [Cites] Nat Rev Cancer. 2002 Jan;2(1):11-8 [11902581.001]
  • [Cites] Cancer Res. 2002 Apr 1;62(7):2125-30 [11929834.001]
  • [Cites] Biophys J. 2002 May;82(5):2811-25 [11964266.001]
  • [Cites] J Biomed Opt. 2002 Apr;7(2):205-14 [11966305.001]
  • [Cites] J Microsc. 2002 Apr;206(Pt 1):65-71 [12000564.001]
  • [Cites] Nat Rev Cancer. 2002 Apr;2(4):266-76 [12001988.001]
  • [Cites] J Cell Biol. 2003 Jan 20;160(2):267-77 [12527751.001]
  • [Cites] Methods. 2003 Jan;29(1):97-109 [12543075.001]
  • [Cites] J Struct Biol. 2003 Jan;141(1):53-62 [12576020.001]
  • [Cites] Genes Dev. 2003 Mar 1;17(5):545-80 [12629038.001]
  • [Cites] Science. 2003 Apr 4;300(5616):87-91 [12677058.001]
  • [Cites] Gynecol Oncol. 1997 Jul;66(1):122-32 [9234932.001]
  • [Cites] Biophys J. 1998 Oct;75(4):2015-24 [9746543.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 May 25;96(11):6255-60 [10339574.001]
  • [Cites] Nat Biotechnol. 1999 Aug;17(8):763-7 [10429240.001]
  • [Cites] Science. 1962 Aug 17;137(3529):499-508 [13878016.001]
  • [Cites] Nature. 2004 Nov 18;432(7015):332-7 [15549095.001]
  • [Cites] J Cell Biol. 2004 Nov 22;167(4):769-81 [15557125.001]
  • [Cites] Genes Dev. 2004 Dec 15;18(24):2998-3003 [15601818.001]
  • [Cites] FEBS Lett. 2005 Feb 7;579(4):927-32 [15680976.001]
  • [Cites] Nat Rev Mol Cell Biol. 2005 Jan;6(1):56-68 [15688067.001]
  • [Cites] Biophys J. 2005 Feb;88(2):1224-37 [15531633.001]
  • [Cites] Biophys J. 2005 Feb;88(2):1377-86 [15533922.001]
  • [Cites] Trends Cell Biol. 2005 Mar;15(3):138-45 [15752977.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3738-43 [15701700.001]
  • [Cites] Cancer Res. 2005 Jun 15;65(12):5278-83 [15958574.001]
  • [Cites] BMC Biotechnol. 2005;5:14 [15910685.001]
  • [Cites] Cancer Res. 2005 Jul 1;65(13):5674-82 [15994941.001]
  • [Cites] Adv Biochem Eng Biotechnol. 2005;95:17-56 [16080264.001]
  • [Cites] Adv Biochem Eng Biotechnol. 2005;95:57-75 [16080265.001]
  • [Cites] Adv Biochem Eng Biotechnol. 2005;95:143-75 [16080268.001]
  • [Cites] J Biomed Opt. 2005 Sep-Oct;10(5):051601 [16292949.001]
  • [Cites] Nat Methods. 2005 Dec;2(12):905-9 [16299475.001]
  • [Cites] Nat Methods. 2005 Dec;2(12):932-40 [16299478.001]
  • [Cites] Nat Methods. 2005 Dec;2(12):941-50 [16299479.001]
  • [Cites] Biophys J. 2006 Jan 15;90(2):693-703 [16258040.001]
  • [Cites] Cell. 2006 Jan 27;124(2):263-6 [16439202.001]
  • [Cites] Science. 2006 Apr 14;312(5771):217-24 [16614209.001]
  • [Cites] J Biomed Opt. 2006 Mar-Apr;11(2):020502 [16674173.001]
  • [Cites] J Cell Biol. 2006 May 8;173(3):395-404 [16651380.001]
  • [Cites] Nat Biotechnol. 2006 Jul;24(7):848-51 [16823374.001]
  • [Cites] Oncogene. 2006 Jul 27;25(32):4429-40 [16547501.001]
  • [Cites] Curr Biol. 2006 Aug 8;16(15):1515-23 [16890527.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17137-42 [17088565.001]
  • [Cites] Cell. 2006 Nov 17;127(4):679-95 [17110329.001]
  • [Cites] J Cell Biol. 2007 Jan 1;176(1):35-42 [17190792.001]
  • [Cites] BMC Med. 2006;4(1):38 [17190588.001]
  • [Cites] Biophys J. 2007 Mar 15;92(6):2212-22 [17172303.001]
  • [Cites] Neuro Oncol. 2007 Apr;9(2):103-12 [17325340.001]
  • [Cites] Cancer Res. 2007 Apr 15;67(8):3505-11 [17440055.001]
  • [Cites] J Biomed Opt. 2007 Mar-Apr;12(2):024014 [17477729.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11760-5 [17601776.001]
  • [Cites] Dev Cell. 2008 Dec;15(6):813-28 [19081071.001]
  • [Cites] Exp Cell Res. 2009 Feb 1;315(3):396-410 [19041305.001]
  • [Cites] Med Phys. 2008 Dec;35(12):5758-67 [19175133.001]
  • [Cites] J Clin Invest. 2009 Feb;119(2):252-66 [19147981.001]
  • [Cites] Histol Histopathol. 2009 Apr;24(4):503-10 [19224453.001]
  • [Cites] Clin Exp Metastasis. 2009;26(4):357-70 [18766302.001]
  • [Cites] J Biophotonics. 2008 Mar;1(1):13-23 [19343631.001]
  • [Cites] J Cell Biol. 2009 Apr 6;185(1):11-9 [19332889.001]
  • [Cites] Cell Biochem Biophys. 2009;53(3):145-57 [19259625.001]
  • [Cites] Opt Lett. 2003 Jun 1;28(11):902-4 [12816240.001]
  • [Cites] Cell. 2003 Jul 11;114(1):33-45 [12859896.001]
  • [Cites] Nat Cell Biol. 2003 Aug;5(8):711-9 [12844144.001]
  • [Cites] Opt Lett. 2003 Sep 1;28(17):1552-4 [12956376.001]
  • [Cites] Nat Biotechnol. 2003 Nov;21(11):1369-77 [14595365.001]
  • [Cites] Photochem Photobiol. 2003 Nov;78(5):462-9 [14653577.001]
  • [Cites] Microsc Res Tech. 2004 Jan 1;63(1):18-22 [14677129.001]
  • [Cites] Microsc Res Tech. 2004 Jan 1;63(1):58-66 [14677134.001]
  • [Cites] Nat Rev Cancer. 2003 Dec;3(12):921-30 [14737122.001]
  • [Cites] J Neurophysiol. 2004 Apr;91(4):1908-12 [14668300.001]
  • [Cites] Science. 2004 Apr 30;304(5671):743-6 [15118165.001]
  • [Cites] Nat Rev Mol Cell Biol. 2004 Oct;5(10):816-26 [15459662.001]
  • [Cites] Cancer Res. 2004 Oct 1;64(19):7022-9 [15466195.001]
  • [Cites] Biosens Bioelectron. 2004 Oct 15;20(3):643-50 [15494250.001]
  • [Cites] Nature. 1985 Oct 24-30;317(6039):748-9 [4058582.001]
  • [Cites] J Cell Biol. 1987 Jul;105(1):41-8 [3112165.001]
  • [Cites] Science. 1990 Apr 6;248(4951):73-6 [2321027.001]
  • [Cites] Anal Biochem. 1992 May 1;202(2):316-30 [1519759.001]
  • [Cites] J Cell Sci. 1993 Jun;105 ( Pt 2):317-31 [8408268.001]
  • [Cites] Ann Biomed Eng. 1994 Jul-Aug;22(4):342-56 [7998680.001]
  • [Cites] J Cell Biochem. 2007 Aug 15;101(6):1338-54 [17471532.001]
  • [Cites] Nat Cell Biol. 2007 Aug;9(8):893-904 [17618273.001]
  • [Cites] Cell. 2007 Sep 7;130(5):784-95 [17803903.001]
  • [Cites] Nat Rev Cancer. 2007 Oct;7(10):737-49 [17891189.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2048-57 [17932352.001]
  • [Cites] Curr Opin Gastroenterol. 2008 Jan;24(1):64-9 [18043235.001]
  • [Cites] Nat Cell Biol. 2007 Dec;9(12):1392-400 [18037882.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19494-9 [18042710.001]
  • [Cites] Clin Gastroenterol Hepatol. 2008 Jan;6(1):95-101 [18065276.001]
  • [Cites] Cell Metab. 2008 Jan;7(1):11-20 [18177721.001]
  • [Cites] Lasers Surg Med. 2008 Apr;40(4):273-81 [18412229.001]
  • [Cites] Biophys J. 2008 Jun;94(11):4504-14 [18281387.001]
  • [Cites] BMC Med. 2008;6:11 [18442412.001]
  • [Cites] Adv Drug Deliv Rev. 2008 Aug 17;60(11):1226-40 [18495291.001]
  • [Cites] Curr Opin Cell Biol. 2008 Oct;20(5):541-50 [18586481.001]
  • [Cites] Oncogene. 2008 Sep 18;27(41):5497-510 [18794884.001]
  • [Cites] Opt Express. 2008 Oct 13;16(21):16431-41 [18852749.001]
  • [Cites] Am J Pathol. 2008 Nov;173(5):1551-65 [18845837.001]
  • [Cites] Trends Cell Biol. 2008 Nov;18(11):560-74 [18848450.001]
  • [Cites] Phys Med Biol. 2008 Dec 7;53(23):6641-52 [18997272.001]
  • [Cites] Biophys J. 2008 Dec;95(11):5374-84 [18775961.001]
  • [Cites] J Biomed Opt. 2008 Sep-Oct;13(5):054050 [19021430.001]
  • [Cites] Dis Model Mech. 2008 Sep-Oct;1(2-3):155-67; discussion 165 [19048079.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11014-9 [12177437.001]
  • [Cites] Nat Rev Cancer. 2002 Sep;2(9):683-93 [12209157.001]
  • [Cites] Curr Opin Neurobiol. 2002 Oct;12(5):593-601 [12367641.001]
  • [Cites] J Microsc. 2002 Oct;208(Pt 1):35-48 [12366596.001]
  • [Cites] Cancer Res. 2002 Nov 1;62(21):6278-88 [12414658.001]
  • [Cites] N Engl J Med. 2002 Dec 19;347(25):1999-2009 [12490681.001]
  • [Cites] Cancer Res. 2002 Dec 15;62(24):7166-9 [12499251.001]
  • [Cites] Nat Genet. 2003 Jan;33(1):49-54 [12469122.001]
  • [Cites] Nat Med. 2003 Jan;9(1):123-8 [12514725.001]
  • [Cites] Science. 2009 May 22;324(5930):1029-33 [19460998.001]
  • [Cites] J Invest Dermatol. 2009 Jul;129(7):1752-8 [19177136.001]
  • [Cites] Anticancer Res. 2009 Jun;29(6):1909-19 [19528447.001]
  • [Cites] Nat Rev Mol Cell Biol. 2009 Jul;10(7):445-57 [19546857.001]
  • [Cites] Nat Methods. 2009 Jul;6(7):511-2 [19525959.001]
  • [Cites] Mol Cell Biol. 2005 Mar;25(5):1680-95 [15713627.001]
  • [Cites] Nat Rev Cancer. 2003 May;3(5):362-74 [12724734.001]
  • [Cites] Nat Med. 2003 Jun;9(6):796-800 [12754503.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7075-80 [12756303.001]
  • (PMID = 19819146.001).
  • [ISSN] 1879-3088
  • [Journal-full-title] Trends in cell biology
  • [ISO-abbreviation] Trends Cell Biol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA076537; United States / NIBIB NIH HHS / EB / EB000184; United States / NCI NIH HHS / CA / R01 CA114462; United States / NIBIB NIH HHS / EB / R21 EB008811; United States / NCI NIH HHS / CA / R21 CA126635; United States / NCI NIH HHS / CA / R01 CA076537-11; United States / NIBIB NIH HHS / EB / EB008811-01A1; United States / NCI NIH HHS / CA / R01 CA142833; United States / NCI NIH HHS / CA / T32CA009681; United States / NCI NIH HHS / CA / R01 CA076537; United States / NCI NIH HHS / CA / CA076537-11; United States / NCI NIH HHS / CA / CA126635-01A1; United States / NIBIB NIH HHS / EB / R01 EB000184; United States / NIBIB NIH HHS / EB / R21 EB008811-01A1; United States / NCI NIH HHS / CA / R29 CA076537; United States / NCI NIH HHS / CA / R21 CA126635-01A1; United States / NCI NIH HHS / CA / T32 CA009681
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 137
  • [Other-IDs] NLM/ NIHMS142781; NLM/ PMC2783928
  •  go-up   go-down


13. Lu W, Singh AK, Khan SA, Senapati D, Yu H, Ray PC: Gold nano-popcorn-based targeted diagnosis, nanotherapy treatment, and in situ monitoring of photothermal therapy response of prostate cancer cells using surface-enhanced Raman spectroscopy. J Am Chem Soc; 2010 Dec 29;132(51):18103-14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gold nano-popcorn-based targeted diagnosis, nanotherapy treatment, and in situ monitoring of photothermal therapy response of prostate cancer cells using surface-enhanced Raman spectroscopy.
  • Prostate cancer is the second leading cause of cancer-related death among the American male population, and the cost of treating prostate cancer patients is about $10 billion/year in the United States.
  • Current treatments are mostly ineffective against advanced-stage prostate cancer and are often associated with severe side effects.
  • Our experimental data show that, in the presence of LNCaP human prostate cancer cells, multifunctional popcorn-shaped gold nanoparticles form several hot spots and provide a significant enhancement of the Raman signal intensity by several orders of magnitude (2.5 × 10(9)).
  • As a result, it can recognize human prostate cancer cells at the 50-cells level.
  • Our results indicate that the localized heating that occurs during near-infrared irradiation can cause irreparable cellular damage to the prostate cancer cells.
  • Ultimately, this nanotechnology-driven assay could have enormous potential applications in rapid, on-site targeted sensing, nanotherapy treatment, and monitoring of the nanotherapy process, which are critical to providing effective treatment of cancer.

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. GOLD, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Anal Chem. 2008 Feb 1;80(3):567-72 [18166023.001]
  • [Cites] ACS Nano. 2010 Nov 23;4(11):6395-403 [20958080.001]
  • [Cites] Nat Rev Cancer. 2008 Apr;8(4):268-78 [18337732.001]
  • [Cites] J Am Chem Soc. 2008 Apr 23;130(16):5523-9 [18373341.001]
  • [Cites] Bioconjug Chem. 2008 Jun;19(6):1309-12 [18512972.001]
  • [Cites] Nat Nanotechnol. 2007 Dec;2(12):751-60 [18654426.001]
  • [Cites] J Proteome Res. 2008 Aug;7(8):3329-38 [18578523.001]
  • [Cites] J Phys Chem B. 2008 Sep 11;112(36):11198-201 [18702540.001]
  • [Cites] J Am Chem Soc. 2008 Nov 12;130(45):14934-5 [18937463.001]
  • [Cites] Mod Pathol. 2008 Dec;21(12):1421-7 [18839017.001]
  • [Cites] Acc Chem Res. 2008 Dec;41(12):1842-51 [19053240.001]
  • [Cites] J Am Chem Soc. 2008 Dec 24;130(51):17214-5 [19053187.001]
  • [Cites] Chemistry. 2009;15(2):342-51 [19035615.001]
  • [Cites] J Am Chem Soc. 2009 Jan 14;131(1):162-9 [19063599.001]
  • [Cites] ACS Nano. 2007 Oct;1(3):208-14 [19206651.001]
  • [Cites] ACS Nano. 2008 Nov 25;2(11):2306-14 [19206397.001]
  • [Cites] ACS Nano. 2009 Jan 27;3(1):80-6 [19206252.001]
  • [Cites] Acc Chem Res. 2008 Dec;41(12):1578-86 [18447366.001]
  • [Cites] Acc Chem Res. 2008 Dec;41(12):1630-40 [18698851.001]
  • [Cites] Nano Lett. 2009 Mar;9(3):1139-46 [19193041.001]
  • [Cites] J Am Chem Soc. 2009 Apr 29;131(16):5728-9 [19351115.001]
  • [Cites] J Am Chem Soc. 2009 Jun 17;131(23):7937-9 [19507897.001]
  • [Cites] Chem Rev. 2009 Jul;109(7):3200-8 [19522504.001]
  • [Cites] Chem Rev. 2009 Jul;109(7):2859-61 [19583428.001]
  • [Cites] ACS Nano. 2009 Sep 22;3(9):2834-40 [19691350.001]
  • [Cites] J Am Chem Soc. 2009 Sep 30;131(38):13639-45 [19772360.001]
  • [Cites] J Am Chem Soc. 2009 Dec 2;131(47):17328-34 [19929020.001]
  • [Cites] J Am Chem Soc. 2010 Feb 17;132(6):1929-38 [20092330.001]
  • [Cites] ACS Nano. 2010 Mar 23;4(3):1739-49 [20155973.001]
  • [Cites] J Am Chem Soc. 2010 Apr 7;132(13):4678-84 [20225865.001]
  • [Cites] Nat Rev Clin Oncol. 2010 May;7(5):266-76 [20351700.001]
  • [Cites] Chem Rev. 2010 May 12;110(5):3196-211 [20170129.001]
  • [Cites] Chem Rev. 2010 May 12;110(5):3146-95 [20225900.001]
  • [Cites] Angew Chem Int Ed Engl. 2010 May 17;49(22):3777-81 [20391446.001]
  • [Cites] Chemistry. 2010 May 17;16(19):5600-6 [20397252.001]
  • [Cites] Nat Rev Cancer. 2005 Mar;5(3):161-71 [15738981.001]
  • [Cites] J Am Chem Soc. 2005 Mar 9;127(9):3115-9 [15740151.001]
  • [Cites] Nat Rev Cancer. 2006 Jan;6(1):63-74 [16372017.001]
  • [Cites] J Am Chem Soc. 2006 Feb 15;128(6):2115-20 [16464114.001]
  • [Cites] J Am Chem Soc. 2006 Feb 22;128(7):2426-33 [16478198.001]
  • [Cites] J Am Chem Soc. 2006 Jul 5;128(26):8378-9 [16802785.001]
  • [Cites] Cancer Lett. 2006 Jul 28;239(1):36-45 [16202512.001]
  • [Cites] J Am Chem Soc. 2007 Nov 28;129(47):14572-3 [17985912.001]
  • [Cites] Nano Lett. 2008 Jan;8(1):214-20 [18052230.001]
  • [Cites] J Am Chem Soc. 2008 Mar 5;130(9):2780-2 [18257576.001]
  • (PMID = 21128627.001).
  • [ISSN] 1520-5126
  • [Journal-full-title] Journal of the American Chemical Society
  • [ISO-abbreviation] J. Am. Chem. Soc.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / GM008047-35; United States / NIGMS NIH HHS / GM / S06 GM008047; United States / NIGMS NIH HHS / GM / S06 GM008047-35; United States / NIGMS NIH HHS / GM / S06GM008047
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 7440-57-5 / Gold
  • [Other-IDs] NLM/ NIHMS256741; NLM/ PMC3074586
  •  go-up   go-down


1
Advertisement
4. Gromov P, Celis JE, Gromova I, Rank F, Timmermans-Wielenga V, Moreira JM: A single lysis solution for the analysis of tissue samples by different proteomic technologies. Mol Oncol; 2008 Dec;2(4):368-79
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cancer, being a major healthcare concern worldwide, is one of the main targets for the application of emerging proteomic technologies and these tools promise to revolutionize the way cancer will be diagnosed and treated in the near future.
  • This need, compounded by mounting evidence that cellular model systems are unable to fully recapitulate all biological aspects of human dissease, is driving scientists to increasingly use clinically relevant samples for biomarker and target discovery.
  • [MeSH-minor] Electrophoresis, Gel, Two-Dimensional. Humans. Neoplasms / diagnosis. Solutions. Tissue Array Analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] OMICS. 2006 Fall;10(3):411-27 [17069517.001]
  • [Cites] J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 15;849(1-2):1-31 [17113834.001]
  • [Cites] Cancer Cell. 2003 Apr;3(4):317-25 [12726858.001]
  • [Cites] Nat Biotechnol. 2006 Aug;24(8):971-83 [16900146.001]
  • [Cites] Biotechniques. 2008 Apr;44(5):697-8, 700 [18474047.001]
  • [Cites] Cold Spring Harb Symp Quant Biol. 2005;70:517-24 [16869790.001]
  • [Cites] Mol Cell Proteomics. 2008 Oct;7(10):1887-901 [18676365.001]
  • [Cites] Methods Mol Biol. 2008;424:35-42 [18369850.001]
  • [Cites] Proteomics. 2004 Dec;4(12):3665-85 [15543535.001]
  • [Cites] Nature. 2001 May 17;411(6835):355-65 [11357143.001]
  • [Cites] Mol Cell Proteomics. 2004 Nov;3(11):1102-18 [15358805.001]
  • [Cites] Genome Biol. 2001;2(2):RESEARCH0004 [11182887.001]
  • [Cites] Anal Chem. 2007 Aug 1;79(15):5817-25 [17605470.001]
  • [Cites] Electrophoresis. 1999 Feb;20(2):355-61 [10197443.001]
  • [Cites] Curr Opin Chem Biol. 2008 Feb;12(1):72-7 [18295612.001]
  • [Cites] Mol Oncol. 2008 Dec;2(4):368-79 [19383358.001]
  • [Cites] Anal Chem. 1996 Mar 1;68(5):850-8 [8779443.001]
  • [Cites] Proteomics. 2006 Mar;6(5):1427-36 [16440370.001]
  • [Cites] Clin Lab Sci. 2007 Fall;20(4):245-8 [18069451.001]
  • [Cites] Mol Oncol. 2008 Oct;2(3):213-22 [19383342.001]
  • [Cites] Mol Cell Proteomics. 2008 Oct;7(10):1795-809 [18632593.001]
  • [Cites] Adv Clin Chem. 2007;44:103-42 [17682341.001]
  • [Cites] Clin Chem. 2004 Nov;50(11):1994-2002 [15364885.001]
  • [Cites] Nat Protoc. 2006;1(2):812-23 [17406312.001]
  • [Cites] FEBS J. 2005 Jan;272(1):2-15 [15634327.001]
  • [Cites] Nature. 2007 Dec 13;450(7172):991-1000 [18075578.001]
  • [Cites] Cancer. 2007 Jun 25;111(3):173-84 [17487852.001]
  • [Cites] Mol Oncol. 2007 Sep;1(2):172-80 [19383293.001]
  • [Cites] Proteomics. 2003 Nov;3(11):2085-90 [14595806.001]
  • [Cites] Mol Cell Proteomics. 2003 Jun;2(6):369-77 [12832461.001]
  • [Cites] Mol Cell Proteomics. 2008 Oct;7(10):1780-94 [18664563.001]
  • [Cites] Curr Opin Mol Ther. 2003 Jun;5(3):302-9 [12870441.001]
  • [Cites] Curr Opin Biotechnol. 2008 Feb;19(1):30-5 [18187316.001]
  • [Cites] Mol Oncol. 2007 Dec;1(3):321-49 [19383306.001]
  • [Cites] Mol Oncol. 2007 Jun;1(1):97-119 [19383289.001]
  • [Cites] Nature. 2003 Mar 13;422(6928):198-207 [12634793.001]
  • [Cites] Mol Oncol. 2007 Dec;1(3):313-20 [19383305.001]
  • [Cites] Electrophoresis. 2000 Jun;21(11):2235-42 [10892734.001]
  • [Cites] Cancer Cell. 2003 Jan;3(1):9-15 [12559171.001]
  • [Cites] Mol Oncol. 2007 Jun;1(1):42-54 [19383286.001]
  • [Cites] J Biol Chem. 1975 May 25;250(10):4007-21 [236308.001]
  • [Cites] Mol Oncol. 2008 Aug;2(2):153-60 [19383334.001]
  • [Cites] Mol Oncol. 2007 Sep;1(2):216-25 [19305640.001]
  • [Cites] AJR Am J Roentgenol. 1998 Jul;171(1):59-63 [9648764.001]
  • [Cites] Proteomics. 2008 Dec;8(23-24):5038-52 [19003862.001]
  • [Cites] Methods Mol Biol. 2007;355:111-9 [17093307.001]
  • [Cites] Mol Cell Proteomics. 2005 Apr;4(4):492-522 [15695426.001]
  • [Cites] Mol Cell Proteomics. 2004 Apr;3(4):327-44 [14754989.001]
  • [Cites] Mol Oncol. 2007 Sep;1(2):144-59 [18443658.001]
  • [Cites] Proc Natl Acad Sci U S A. 1980 Mar;77(3):1311-5 [6246487.001]
  • [Cites] Mol Oncol. 2007 Jun;1(1):84-96 [18516279.001]
  • (PMID = 19383358.001).
  • [ISSN] 1878-0261
  • [Journal-full-title] Molecular oncology
  • [ISO-abbreviation] Mol Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Buffers; 0 / Solutions
  •  go-up   go-down


15. Skala MC, Riching KM, Bird DK, Gendron-Fitzpatrick A, Eickhoff J, Eliceiri KW, Keely PJ, Ramanujam N: In vivo multiphoton fluorescence lifetime imaging of protein-bound and free nicotinamide adenine dinucleotide in normal and precancerous epithelia. J Biomed Opt; 2007 Mar-Apr;12(2):024014
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Multiphoton fluorescence lifetime imaging microscopy (FLIM) is a noninvasive, cellular resolution, 3-D functional imaging technique.
  • We investigate the potential for in vivo precancer diagnosis with metabolic imaging via multiphoton FLIM of the endogenous metabolic cofactor nicotinamide adenine dinucleotide (NADH).
  • Inhibition of cellular glycolysis and oxidative phosphorylation in cell monolayers produces an increase and decrease, respectively, in the protein-bound NADH lifetime (p<0.05).

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11715-20 [9751731.001]
  • [Cites] Anticancer Res. 1996 Mar-Apr;16(2):741-9 [8687123.001]
  • [Cites] Anal Biochem. 1995 Jul 1;228(2):312-7 [8572312.001]
  • [Cites] J Oral Pathol Med. 1998 Nov;27(10):470-4 [9831958.001]
  • [Cites] Nat Biotechnol. 1999 Aug;17(8):763-7 [10429240.001]
  • [Cites] Photochem Photobiol Sci. 2005 Jan;4(1):13-22 [15616687.001]
  • [Cites] J Fluoresc. 2004 Sep;14(5):649-54 [15617271.001]
  • [Cites] Cancer Res. 2005 Feb 15;65(4):1180-6 [15735001.001]
  • [Cites] Cancer Res. 2005 Jun 15;65(12):5163-71 [15958560.001]
  • [Cites] J Biol Chem. 2005 Jul 1;280(26):25119-26 [15863500.001]
  • [Cites] J Photochem Photobiol B. 2005 Aug 1;80(2):122-9 [15908228.001]
  • [Cites] Cancer Res. 2005 Oct 1;65(19):8766-73 [16204046.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Jun 16;344(4):1086-93 [16643849.001]
  • [Cites] Cell Death Differ. 2006 Nov;13(11):1900-14 [16514418.001]
  • [Cites] Biophys J. 1998 Oct;75(4):2015-24 [9746543.001]
  • [Cites] Int J Exp Pathol. 1996 Feb;77(1):7-14 [8664146.001]
  • [Cites] N Engl J Med. 2001 May 24;344(21):1603-7 [11372013.001]
  • [Cites] Annu Rev Biomed Eng. 2000;2:399-429 [11701518.001]
  • [Cites] Biophys J. 2002 May;82(5):2811-25 [11964266.001]
  • [Cites] Photochem Photobiol. 2003 May;77(5):550-5 [12812299.001]
  • [Cites] J Biomed Opt. 2003 Jul;8(3):432-9 [12880349.001]
  • [Cites] Nat Biotechnol. 2003 Nov;21(11):1356-60 [14595363.001]
  • [Cites] Lasers Surg Med. 2004;34(1):25-38 [14755422.001]
  • [Cites] Appl Opt. 2004 Sep 20;43(27):5173-82 [15473237.001]
  • [Cites] Biochim Biophys Acta. 1976 Sep 28;446(1):192-205 [974111.001]
  • [Cites] J Biol Chem. 1979 Jun 10;254(11):4764-71 [220260.001]
  • [Cites] Diagn Histopathol. 1981 Oct-Dec;4(4):307-33 [6802623.001]
  • [Cites] Biochemistry. 1989 May 16;28(10):4259-62 [2569889.001]
  • [Cites] Indian J Cancer. 1989 Mar;26(1):21-30 [2777329.001]
  • [Cites] Science. 1990 Apr 6;248(4951):73-6 [2321027.001]
  • [Cites] Zhonghua Zhong Liu Za Zhi. 1990 Mar;12(2):92-4 [2401184.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1271-5 [1741380.001]
  • [Cites] J Cell Sci. 1995 Feb;108 ( Pt 2):595-607 [7769004.001]
  • [Cites] Contraception. 1995 Nov;52(5):317-20 [8585890.001]
  • (PMID = 17477729.001).
  • [ISSN] 1083-3668
  • [Journal-full-title] Journal of biomedical optics
  • [ISO-abbreviation] J Biomed Opt
  • [Language] eng
  • [Grant] United States / NIBIB NIH HHS / EB / R01 EB000184; United States / NIBIB NIH HHS / EB / R01 EB000184-03
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0U46U6E8UK / NAD
  • [Other-IDs] NLM/ NIHMS122928; NLM/ PMC2743958
  •  go-up   go-down


16. Chen WT, Thirumalai D, Shih TT, Chen RC, Tu SY, Lin CI, Yang PC: Dynamic contrast-enhanced folate-receptor-targeted MR imaging using a Gd-loaded PEG-dendrimer-folate conjugate in a mouse xenograft tumor model. Mol Imaging Biol; 2010 Apr;12(2):145-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PROCEDURES: KB cells, FR siRNA knockdown KB cells, and FR negative HT-1080 cells, were incubated with fluorescein-labeled dendrimer and their cellular uptake was observed.
  • RESULTS: Green fluorescence was found in the KB cells in the cellular uptake experiment, but was not seen in other settings.
  • A 17% cut-off point for a 30-min washout percentage can be a useful parameter for the diagnosis of FR-positive tumors.

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • Hazardous Substances Data Bank. FOLIC ACID .
  • Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Magn Reson Imaging. 2000 Mar;11(3):233-43 [10739554.001]
  • [Cites] Magn Reson Med. 1991 Dec;22(2):282-7; discussion 300-3 [1725917.001]
  • [Cites] J Cell Mol Med. 2008 Jan-Feb;12(1):174-86 [18194445.001]
  • [Cites] Zhonghua Yi Xue Za Zhi. 2007 Mar 13;87(10):673-8 [17553304.001]
  • [Cites] MAGMA. 2001 May;12(2-3):104-13 [11390265.001]
  • [Cites] Cancer Res. 2003 Jun 1;63(11):2723-7 [12782573.001]
  • [Cites] Anal Biochem. 2005 Mar 15;338(2):284-93 [15745749.001]
  • [Cites] Radiology. 2001 May;219(2):316-33 [11323453.001]
  • [Cites] J Biol Chem. 1979 Nov 25;254(22):11312-8 [500647.001]
  • [Cites] J Cell Mol Med. 2008 Jan-Feb;12(1):187-8 [18208557.001]
  • [Cites] Curr Opin Mol Ther. 2003 Dec;5(6):625-30 [14755889.001]
  • [Cites] J Magn Reson Imaging. 2002 Mar;15(3):308-14 [11891976.001]
  • [Cites] Int J Nanomedicine. 2008;3(2):201-10 [18686779.001]
  • [Cites] J Biomed Mater Res A. 2008 Oct;87(1):165-75 [18085650.001]
  • [Cites] Ann Surg Oncol. 2008 Mar;15(3):889-99 [18181001.001]
  • [Cites] J Am Chem Soc. 2001 Jun 27;123(25):5908-17 [11414823.001]
  • [Cites] Contrast Media Mol Imaging. 2007 Mar-Apr;2(2):72-81 [17385788.001]
  • [Cites] PLoS One. 2009;4(2):e4343 [19183814.001]
  • [Cites] J Nucl Med. 2006 Jul;47(7):1153-60 [16818950.001]
  • [Cites] Arch Biochem Biophys. 1999 Jun 15;366(2):183-91 [10356282.001]
  • [Cites] Eur J Radiol. 2002 Oct;44(1):52-8 [12350413.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1999 Sep;8(9):775-82 [10498396.001]
  • [Cites] Adv Drug Deliv Rev. 2004 Apr 29;56(8):1127-41 [15094211.001]
  • [Cites] J Control Release. 1998 Apr 30;53(1-3):39-48 [9741912.001]
  • [Cites] J Biomed Mater Res A. 2006 Sep 1;78(3):550-7 [16736484.001]
  • [Cites] Drug Discov Today. 2001 Jan 1;6(1):44-51 [11165172.001]
  • [Cites] Blood. 1992 Jun 1;79(11):2807-20 [1586732.001]
  • [Cites] Cancer Res. 1991 Oct 1;51(19):5329-38 [1717147.001]
  • [Cites] Z Med Labortech. 1967;8(6):318-21 [4878525.001]
  • [Cites] J Nucl Med. 1996 Jun;37(6):1003-8 [8683292.001]
  • [Cites] J Biol Chem. 1994 Feb 4;269(5):3198-204 [8106354.001]
  • (PMID = 19636639.001).
  • [ISSN] 1860-2002
  • [Journal-full-title] Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging
  • [ISO-abbreviation] Mol Imaging Biol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Carrier Proteins; 0 / Contrast Media; 0 / Dendrimers; 0 / Folate Receptors, GPI-Anchored; 0 / RNA, Small Interfering; 0 / Receptors, Cell Surface; 30IQX730WE / Polyethylene Glycols; 935E97BOY8 / Folic Acid; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


17. Iorio E, Ricci A, Bagnoli M, Pisanu ME, Castellano G, Di Vito M, Venturini E, Glunde K, Bhujwalla ZM, Mezzanzanica D, Canevari S, Podo F: Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells. Cancer Res; 2010 Mar 1;70(5):2126-35
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
  • Altered phosphatidylcholine (PC) metabolism in epithelial ovarian cancer (EOC) could provide choline-based imaging approaches as powerful tools to improve diagnosis and identify new therapeutic targets.
  • PC-plc inhibition by tricyclodecan-9-yl-potassium xanthate (D609) in OVCAR3 and SKOV3 cancer cells induced a 30% to 40% reduction of PCho content and blocked cell proliferation.

  • Genetic Alliance. consumer health - Ovarian cancer.
  • Genetic Alliance. consumer health - Ovarian epithelial cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • SciCrunch. ArrayExpress: Data: Microarray .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] NMR Biomed. 1999 Nov;12(7):413-39 [10654290.001]
  • [Cites] Cancer Res. 2007 Dec 1;67(23):11284-90 [18056454.001]
  • [Cites] Cancer Res. 2001 May 1;61(9):3599-603 [11325827.001]
  • [Cites] Cancer Res. 2002 Apr 1;62(7):1966-70 [11929812.001]
  • [Cites] Oncogene. 2002 Jun 20;21(27):4317-22 [12082619.001]
  • [Cites] Methods Mol Biol. 2003;218:155-76 [12616720.001]
  • [Cites] J Nucl Med. 2003 Jul;44(7):1051-6 [12843219.001]
  • [Cites] J Cell Biochem. 2003 Oct 15;90(3):525-33 [14523987.001]
  • [Cites] J Lipid Res. 2003 Oct;44(10):1963-75 [12837850.001]
  • [Cites] Prog Lipid Res. 2004 May;43(3):266-81 [15003397.001]
  • [Cites] Cancer Res. 2004 Jun 15;64(12):4270-6 [15205341.001]
  • [Cites] Radiology. 2004 Aug;232(2):599-605 [15286325.001]
  • [Cites] Clin Cancer Res. 2004 Aug 1;10(15):5202-14 [15297424.001]
  • [Cites] Exp Cell Res. 2004 Oct 1;299(2):370-82 [15350536.001]
  • [Cites] Cancer Res. 2004 Sep 15;64(18):6732-9 [15374991.001]
  • [Cites] Nucl Med Biol. 2004 Oct;31(7):859-65 [15464387.001]
  • [Cites] NMR Biomed. 1992 Sep-Oct;5(5):303-24 [1333263.001]
  • [Cites] EMBO J. 1995 Dec 1;14(23):5859-68 [8846779.001]
  • [Cites] Anticancer Res. 1996 May-Jun;16(3B):1399-412 [8694508.001]
  • [Cites] J Biol Chem. 1997 Apr 25;272(17):11011-6 [9110992.001]
  • [Cites] Anal Biochem. 1997 Aug 15;251(1):45-9 [9300081.001]
  • [Cites] Anal Biochem. 1997 Oct 1;252(1):1-9 [9324933.001]
  • [Cites] Int J Cancer. 1997 Sep 26;73(1):143-50 [9334822.001]
  • [Cites] CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96 [18287387.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):11026-31 [18667693.001]
  • [Cites] Cancer Res. 2008 Aug 15;68(16):6541-9 [18701477.001]
  • [Cites] NMR Biomed. 2009 Jan;22(1):114-27 [19016452.001]
  • [Cites] Arch Biochem Biophys. 2009 Mar 1;483(1):90-8 [19135976.001]
  • [Cites] Cancer Res. 2009 Apr 15;69(8):3464-71 [19336572.001]
  • [Cites] Neoplasia. 2009 May;11(5):477-84 [19412432.001]
  • [Cites] Oncogene. 2009 Jul 2;28(26):2425-35 [19448670.001]
  • [Cites] Cancer Res. 1999 Jan 1;59(1):80-4 [9892190.001]
  • [Cites] Mol Imaging. 2004 Oct;3(4):319-23 [15802048.001]
  • [Cites] Annu Rev Biomed Eng. 2005;7:287-326 [16004573.001]
  • [Cites] Cancer Res. 2005 Oct 15;65(20):9369-76 [16230400.001]
  • [Cites] Cancer Res. 2005 Dec 1;65(23):11034-43 [16322253.001]
  • [Cites] Cancer Res. 2006 Jan 1;66(1):427-34 [16397258.001]
  • [Cites] Biochem J. 2006 Feb 15;394(Pt 1):299-308 [16255717.001]
  • [Cites] Radiology. 2006 Mar;238(3):958-69 [16424238.001]
  • [Cites] Curr Med Chem. 2006;13(10):1169-86 [16719778.001]
  • [Cites] Mol Pharm. 2006 Sep-Oct;3(5):496-506 [17009848.001]
  • [Cites] Pharmacogenomics. 2006 Oct;7(7):1109-23 [17054420.001]
  • [Cites] Mol Imaging. 2006 Oct-Dec;5(4):498-509 [17150162.001]
  • [Cites] Int J Cancer. 2007 Apr 15;120(8):1721-30 [17236204.001]
  • [Cites] J Cell Biochem. 2007 Oct 1;102(2):421-8 [17393430.001]
  • [Cites] Lancet Oncol. 2007 Oct;8(10):889-97 [17851129.001]
  • [Cites] Clin Cancer Res. 2000 Jun;6(6):2482-91 [10873103.001]
  • (PMID = 20179205.001).
  • [ISSN] 1538-7445
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA103175-05; United States / NCI NIH HHS / CA / P50 CA103175; United States / NCI NIH HHS / CA / P50 CA103175-05
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Membrane Transport Proteins; 0 / Phosphatidylcholines; 0 / choline transporter; EC 2.7.1.32 / Choline Kinase; EC 3.1.4.- / Phosphoric Diester Hydrolases; EC 3.1.4.- / Type C Phospholipases; EC 3.1.4.2 / glycerophosphocholine phosphodiesterase; EC 3.1.4.3 / phosphatidylcholine-specific phospholipase C; EC 3.1.4.4 / Phospholipase D
  • [Other-IDs] NLM/ NIHMS167358; NLM/ PMC2831129
  •  go-up   go-down


18. Laiakis EC, Morris GA, Fornace AJ, Howie SR: Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study. PLoS One; 2010 Sep 09;5(9)
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The objective of this pilot study is to apply metabolomic analysis to childhood pneumonia to explore its potential to improve pneumonia diagnosis in a high-burden setting.

  • MedlinePlus Health Information. consumer health - Pneumonia.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Free Radic Biol Med. 1993 Jun;14(6):615-31 [8325534.001]
  • [Cites] Nature. 2009 Feb 12;457(7231):910-4 [19212411.001]
  • [Cites] J Surg Res. 1997 Jul 15;71(1):61-6 [9271279.001]
  • [Cites] Nat Med. 1999 Oct;5(10):1199-202 [10502826.001]
  • [Cites] Expert Rev Proteomics. 2007 Jun;4(3):389-400 [17552923.001]
  • [Cites] J Proteome Res. 2009 Dec;8(12):5550-8 [19817432.001]
  • [Cites] J Proteome Res. 2009 Jun;8(6):3029-36 [19368345.001]
  • [Cites] Pediatr Infect Dis J. 1994 Nov;13(11):975-82 [7845751.001]
  • [Cites] Pediatr Pulmonol. 2003 Dec;36(6):469-74 [14618637.001]
  • [Cites] Bull World Health Organ. 2008 May;86(5):322-2A [18545727.001]
  • [Cites] Shock. 2010 Mar;33(3):258-62 [19543152.001]
  • [Cites] Curr Pharm Des. 2009;15(13):1415-27 [19442166.001]
  • [Cites] Eur J Surg. 1995 Mar;161(3):147-55 [7599292.001]
  • [Cites] Trop Med Int Health. 1997 Jan;2(1):28-37 [9018300.001]
  • [Cites] PLoS One. 2008;3(3):e1773 [18335047.001]
  • [Cites] Radiat Res. 2009 Aug;172(2):198-212 [19630524.001]
  • [Cites] PLoS One. 2009;4(4):e5328 [19390697.001]
  • [Cites] Anal Chem. 2008 Feb 1;80(3):665-74 [18173289.001]
  • [Cites] PLoS Med. 2008 Apr 22;5(4):e86 [19226734.001]
  • [Cites] Methods Mol Biol. 2009;520:273-95 [19381962.001]
  • [Cites] Crit Care Med. 2009 Sep;37(9):2506-11 [19602974.001]
  • [Cites] Acta Paediatr. 1993 Oct;82(10):849-52 [8241644.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2008 Jul;295(1):L152-61 [18441091.001]
  • [Cites] PLoS One. 2009;4(7):e6386 [19636438.001]
  • [Cites] BMC Ear Nose Throat Disord. 2006 May 10;6:10 [16686940.001]
  • [Cites] Anal Chem. 2008 Oct 1;80(19):7562-70 [18767870.001]
  • [Cites] Radiat Res. 2009 Jul;172(1):42-57 [19580506.001]
  • [Cites] World Health Stat Q. 1992;45(2-3):180-91 [1462653.001]
  • [Cites] J Proteome Res. 2009 Dec;8(12):5409-10 [19899780.001]
  • [Cites] Front Biosci. 2006;11:1977-86 [16368572.001]
  • [Cites] Crit Care Med. 2009 May;37(5):1655-62 [19325487.001]
  • [Cites] J Cell Mol Med. 2009 Jun;13(6):1125-35 [19602041.001]
  • [Cites] Blood. 2001 Feb 15;97(4):937-45 [11159520.001]
  • [Cites] J Proteome Res. 2007 Feb;6(2):498-505 [17269706.001]
  • [Cites] Lancet. 2006 Nov 11;368(9548):1646 [17098074.001]
  • [Cites] J Proteome Res. 2009 May;8(5):2361-75 [19275195.001]
  • [Cites] J Hypertens. 2008 Nov;26(11):2085-92 [18854744.001]
  • [Cites] Infect Immun. 2008 Mar;76(3):1230-8 [18174343.001]
  • [Cites] Nat Rev Microbiol. 2007 Jun;5(6):464-70 [17487146.001]
  • [Cites] Lancet. 2007 Jul 21;370(9583):285-9 [17658399.001]
  • [Cites] J Exp Med. 2006 Dec 25;203(13):2907-17 [17158962.001]
  • [Cites] Mass Spectrom Rev. 2010 May-Jun;29(3):503-21 [19890938.001]
  • [Cites] Ann Trop Paediatr. 1987 Jun;7(2):91-9 [2441658.001]
  • [Cites] Curr Pharm Des. 2009;15(13):1537-45 [19442171.001]
  • [Cites] Immunol Lett. 2003 Oct 31;89(2-3):229-36 [14556983.001]
  • [Cites] Hunan Yi Ke Da Xue Xue Bao. 1999;24(3):287-9 [12016810.001]
  • [Cites] Radiat Res. 2008 Jul;170(1):1-14 [18582157.001]
  • [Cites] Lancet. 2003 Jun 28;361(9376):2226-34 [12842379.001]
  • [Cites] Bull World Health Organ. 2008 May;86(5):408-16 [18545744.001]
  • [Cites] PLoS Pathog. 2009 Feb;5(2):e1000305 [19229321.001]
  • [Cites] Am J Respir Crit Care Med. 2009 May 15;179(10):903-13 [19218193.001]
  • (PMID = 20844590.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Grant] United Kingdom / Medical Research Council / / MC/ U190088478; United Kingdom / Medical Research Council / / MC/ UP/ A900/ 1124; United Kingdom / Medical Research Council / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers
  • [Other-IDs] NLM/ PMC2936566
  •  go-up   go-down


19. Fang Y: PROBING CANCER SIGNALING WITH RESONANT WAVEGUIDE GRATING BIOSENSORS. Expert Opin Drug Discov; 2010 Dec;5(12):1237-1248
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] PROBING CANCER SIGNALING WITH RESONANT WAVEGUIDE GRATING BIOSENSORS.
  • IMPORTANCE OF THE FIELD: Cancer is a collection of diseases that arise from the progressive accumulation of genetic alterations in somatic cells.
  • It is acknowledged that it is proteins, rather than genes, to fulfill most cellular functions; and signaling proteins largely operate through a large and complex network.
  • To this end, cancer is mostly a pathway dysregulated disease - a small number of core pathways are dominate in aberrant cell growth leading to cancer.
  • Thus, understanding the functional consequences of dysregulated and/or mutant signaling proteins in the context of native signaling networks is the frontier in cancer research.
  • AREAS COVERED IN THIS REVIEW: This article reviews why resonant waveguide grating (RWG) biosensor cellular assays are considered to be integrative in nature, and how RWG biosensor can be used for mining the surface markers of cancer cells, and discovering core pathway(s) of cancer receptor signaling.
  • WHAT THE READER WILL GAIN: The reader will gain an overview of cancer biology from pathway perspective, and have a glimpse of potential implications of integrative cellular assays, as promised by RWG biosensor, in cancer research and diagnosis.
  • TAKE HOME MESSAGE: Successful approaches for developing next-generation anti-cancer therapies and diagnostic protocols should take into account that the dysregulation of oncogenic pathways is central to tumorigenesis.
  • The biosensor cellular assays offer unprecedented advantage in characterizing cancer biology.
  • However, significant challenges are also presented in deconvoluting and validating cellular mechanisms identified in cancer receptor signaling using these assays.

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21113317.001).
  • [ISSN] 1746-045X
  • [Journal-full-title] Expert opinion on drug discovery
  • [ISO-abbreviation] Expert Opin Drug Discov
  • [Language] ENG
  • [Grant] United States / NIMH NIH HHS / MH / MH084691-01; United States / NIMH NIH HHS / MH / U54 MH084691
  • [Publication-type] JOURNAL ARTICLE
  • [Publication-country] England
  •  go-up   go-down


20. Jaffer FA, Libby P, Weissleder R: Optical and multimodality molecular imaging: insights into atherosclerosis. Arterioscler Thromb Vasc Biol; 2009 Jul;29(7):1017-24
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Imaging approaches that visualize molecular targets rather than anatomic structures aim to illuminate vital molecular and cellular aspects of atherosclerosis biology in vivo.

  • MedlinePlus Health Information. consumer health - Atherosclerosis.
  • MedlinePlus Health Information. consumer health - Diagnostic Imaging.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Circulation. 2002 Jun 11;105(23):2766-71 [12057992.001]
  • [Cites] Nature. 2008 Feb 21;451(7181):953-7 [18288186.001]
  • [Cites] Nat Med. 2003 Jan;9(1):123-8 [12514725.001]
  • [Cites] Circulation. 2003 May 20;107(19):2453-8 [12719280.001]
  • [Cites] N Engl J Med. 2003 Jun 19;348(25):2491-9 [12815134.001]
  • [Cites] Circulation. 2003 Oct 7;108(14):1664-72 [14530185.001]
  • [Cites] Nat Med. 2008 Apr;14(4):459-65 [18376410.001]
  • [Cites] Bioconjug Chem. 2008 May;19(5):1001-8 [18396900.001]
  • [Cites] J Nucl Cardiol. 2008 May-Jun;15(3):417-28 [18513648.001]
  • [Cites] NMR Biomed. 2008 Jun;21(5):453-63 [17918777.001]
  • [Cites] Nat Med. 2001 Jun;7(6):743-8 [11385514.001]
  • [Cites] Circulation. 2003 Nov 4;108(18):2270-4 [14557370.001]
  • [Cites] Cancer Res. 2003 Dec 1;63(23):8122-5 [14678964.001]
  • [Cites] Stroke. 2004 Jul;35(7):1631-5 [15166394.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12294-9 [15304657.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12634-9 [15304647.001]
  • [Cites] J Am Coll Cardiol. 1986 Mar;7(3):472-8 [3950227.001]
  • [Cites] AJR Am J Roentgenol. 1998 Jul;171(1):137-43 [9648777.001]
  • [Cites] Circulation. 1999 Apr 6;99(13):1726-32 [10190883.001]
  • [Cites] Nat Biotechnol. 1999 Apr;17(4):375-8 [10207887.001]
  • [Cites] Circ Res. 2004 Dec 10;95(12):1225-33 [15539632.001]
  • [Cites] Circ Res. 2005 Feb 18;96(3):327-36 [15653572.001]
  • [Cites] Nat Biotechnol. 2005 Mar;23(3):313-20 [15765087.001]
  • [Cites] Magn Reson Med. 2005 May;53(5):999-1005 [15844142.001]
  • [Cites] NeuroRx. 2005 Apr;2(2):215-25 [15897946.001]
  • [Cites] Magn Reson Med. 2005 Sep;54(3):718-24 [16086367.001]
  • [Cites] Magn Reson Med. 2006 Jan;55(1):126-35 [16342148.001]
  • [Cites] Cardiovasc Res. 2006 Feb 15;69(3):625-35 [16376322.001]
  • [Cites] J Control Release. 2008 Jun 24;128(3):217-23 [18457896.001]
  • [Cites] Stroke. 2008 Jul;39(7):2144-7 [18451355.001]
  • [Cites] Adv Drug Deliv Rev. 2008 Aug 17;60(11):1241-51 [18508157.001]
  • [Cites] J Am Coll Cardiol. 2008 Aug 5;52(6):483-91 [18672170.001]
  • [Cites] Mol Imaging. 2008 Mar-Apr;7(2):68-76 [18706289.001]
  • [Cites] Circulation. 2008 Oct 28;118(18):1802-9 [18852366.001]
  • [Cites] J Nucl Med. 2008 Nov;49(11):1845-51 [18927332.001]
  • [Cites] Anal Biochem. 2009 Jan 15;384(2):254-62 [18938129.001]
  • [Cites] FASEB J. 2008 Dec;22(12):4179-89 [18697838.001]
  • [Cites] JACC Cardiovasc Imaging. 2008 Sep;1(5):624-34 [19356492.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):992-1000 [19057023.001]
  • [Cites] J Biomed Opt. 2006 Mar-Apr;11(2):021009 [16674184.001]
  • [Cites] Bioconjug Chem. 2006 May-Jun;17(3):662-9 [16704203.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1601-6 [16627809.001]
  • [Cites] Nat Rev Immunol. 2006 Jul;6(7):508-19 [16778830.001]
  • [Cites] Circulation. 2006 Jul 4;114(1):55-62 [16801460.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2103-9 [16825592.001]
  • [Cites] Stroke. 2006 Sep;37(9):2266-70 [16917091.001]
  • [Cites] Mol Imaging. 2006 Apr-Jun;5(2):85-92 [16954022.001]
  • [Cites] Circulation. 2006 Oct 3;114(14):1504-11 [17000904.001]
  • [Cites] Small. 2006 Aug;2(8-9):983-7 [17193154.001]
  • [Cites] Nat Med. 2007 Mar;13(3):372-7 [17322898.001]
  • [Cites] Circulation. 2007 May 1;115(17):2292-8 [17420353.001]
  • [Cites] Nat Clin Pract Cardiovasc Med. 2007 Sep;4(9):491-502 [17712362.001]
  • [Cites] Circulation. 2007 Aug 28;116(9):1052-61 [17724271.001]
  • [Cites] Nat Chem Biol. 2007 Oct;3(10):668-77 [17828252.001]
  • [Cites] Chem Biol. 2007 Nov;14(11):1221-31 [18022561.001]
  • [Cites] Circulation. 2007 Dec 11;116(24):2841-50 [18040026.001]
  • [Cites] Photochem Photobiol Sci. 2008 Jan;7(1):33-9 [18167594.001]
  • [Cites] Circulation. 2008 Jan 22;117(3):379-87 [18158358.001]
  • [Cites] Nat Med. 2002 Jul;8(7):757-60 [12091907.001]
  • (PMID = 19359659.001).
  • [ISSN] 1524-4636
  • [Journal-full-title] Arteriosclerosis, thrombosis, and vascular biology
  • [ISO-abbreviation] Arterioscler. Thromb. Vasc. Biol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R24 CA092782; United States / NHLBI NIH HHS / HL / U01 HL080731; United States / NHLBI NIH HHS / HL / UO1-HL080731; United States / NHLBI NIH HHS / HL / R01-HL078641; United States / NHLBI NIH HHS / HL / R01 HL078641; United States / NCI NIH HHS / CA / R24-CA92782; United States / Howard Hughes Medical Institute / / ; United States / NHLBI NIH HHS / HL / HL078641-04; United States / NCI NIH HHS / CA / R24 CA092782-05; United States / NHLBI NIH HHS / HL / R01 HL078641-04; United States / NHLBI NIH HHS / HL / U01 HL080731-04
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Photosensitizing Agents
  • [Number-of-references] 61
  • [Other-IDs] NLM/ NIHMS130290; NLM/ PMC2733228
  •  go-up   go-down


21. Ozben B, Dursun E, Monari E, Cuoghi A, Bergamini S, Tomasi A, Ozben T: Proteomic profiling during atherosclerosis progression: Effect of nebivolol treatment. Mol Cell Biochem; 2009 Nov;331(1-2):9-17
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There is a great need for the identification of biomarkers for the early diagnosis of atherosclerosis and the agents to prevent its progression.

  • MedlinePlus Health Information. consumer health - Atherosclerosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Cardiol. 2008 Mar 28;125(1):4-10 [17467819.001]
  • [Cites] Clin Chem. 2002 Aug;48(8):1296-304 [12142387.001]
  • [Cites] Anal Biochem. 2003 Oct 1;321(1):116-24 [12963062.001]
  • [Cites] Eur Heart J. 2005 Feb;26(3):215-25 [15642700.001]
  • [Cites] Acta Histochem. 2006;108(6):415-24 [17007910.001]
  • [Cites] Mol Med. 2001 Jun;7(6):383-92 [11474131.001]
  • [Cites] Kidney Int Suppl. 2005 Dec;(99):S103-7 [16336560.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Apr 5;292(3):587-92 [11922607.001]
  • [Cites] Clin Exp Pharmacol Physiol. 2006 Apr;33(4):305-9 [16620292.001]
  • [Cites] BMC Bioinformatics. 2005 Jul 15;6 Suppl 2:S5 [16026602.001]
  • [Cites] J Nutr. 2005 Apr;135(4):722-8 [15795424.001]
  • [Cites] J Agric Food Chem. 2008 Feb 13;56(3):1148-57 [18173244.001]
  • [Cites] Cardiovasc Res. 2001 Feb 1;49(2):430-9 [11164853.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2135-42 [16123314.001]
  • [Cites] Nutr Metab Cardiovasc Dis. 2000 Aug;10(4):209-15 [11079259.001]
  • [Cites] Prostate Cancer Prostatic Dis. 1999 Dec;2(5/6):264-276 [12497173.001]
  • [Cites] Proteomics. 2004 Dec;4(12):3751-61 [15540213.001]
  • [Cites] J Agric Food Chem. 2006 Mar 8;54(5):1928-35 [16506855.001]
  • [Cites] J Cardiovasc Pharmacol. 2004 Jan;43(1):148-53 [14668581.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2003 Apr 1;23 (4):615-21 [12692005.001]
  • [Cites] Atherosclerosis. 2005 Nov;183(1):25-33 [16216589.001]
  • [Cites] Cardiovasc Res. 2006 Oct 1;72(1):18-29 [16814757.001]
  • [Cites] Physiol Genomics. 2006 Apr 13;25(2):194-202 [16418319.001]
  • [Cites] Circulation. 2001 Jul 31;104(5):511-4 [11479245.001]
  • [Cites] Nitric Oxide. 2002 Sep;7(2):83-90 [12223177.001]
  • [Cites] J Proteome Res. 2005 Jul-Aug;4(4):1181-91 [16083268.001]
  • [Cites] J Am Coll Cardiol. 2003 Nov 19;42(10):1838-44 [14642697.001]
  • [Cites] Trends Cardiovasc Med. 2007 Feb;17(2):43-8 [17292045.001]
  • [Cites] Expert Opin Pharmacother. 2004 Apr;5(4):893-9 [15102571.001]
  • [Cites] Circ Res. 2001 Apr 27;88(8):763-73 [11325867.001]
  • [Cites] Acta Histochem. 2007;109(1):45-51 [17046051.001]
  • (PMID = 19421716.001).
  • [ISSN] 1573-4919
  • [Journal-full-title] Molecular and cellular biochemistry
  • [ISO-abbreviation] Mol. Cell. Biochem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Benzopyrans; 0 / Ethanolamines; 030Y90569U / Nebivolol
  •  go-up   go-down


22. Boustany NN, Boppart SA, Backman V: Microscopic imaging and spectroscopy with scattered light. Annu Rev Biomed Eng; 2010 Aug 15;12:285-314
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Optical contrast based on elastic scattering interactions between light and matter can be used to probe cellular structure, cellular dynamics, and image tissue architecture.
  • Cellular and tissue data enabled by current advances in optical scatter spectroscopy and imaging stand to impact a variety of biomedical applications including clinical tissue diagnosis, in vivo imaging, drug discovery, and basic cell biology.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biomed Opt. 2005 Nov-Dec;10(6):060503 [16409066.001]
  • [Cites] Int J Cancer. 2008 Jan 15;122(2):363-71 [17935126.001]
  • [Cites] Biophys J. 2008 Jan 1;94(1):286-97 [17766334.001]
  • [Cites] Opt Lett. 2008 Apr 1;33(7):714-6 [18382527.001]
  • [Cites] J Biomed Opt. 2008 Mar-Apr;13(2):024015 [18465978.001]
  • [Cites] Opt Express. 2008 Feb 18;16(4):2555-69 [18542337.001]
  • [Cites] Opt Express. 2008 Jul 21;16(15):11525-39 [18648474.001]
  • [Cites] Opt Lett. 2008 Oct 1;33(19):2209-11 [18830354.001]
  • [Cites] Nature. 1948 May 15;161(4098):777 [18860291.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20118-23 [19073935.001]
  • [Cites] J Opt Soc Am A Opt Image Sci Vis. 2007 Apr;24(4):1034-41 [17361289.001]
  • [Cites] Opt Lett. 2007 Mar 1;32(5):503-5 [17392902.001]
  • [Cites] Microsc Res Tech. 2007 Apr;70(4):361-71 [17262787.001]
  • [Cites] Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Mar;75(3 Pt 2):037601 [17500837.001]
  • [Cites] J Biomed Opt. 2007 May-Jun;12(3):030503 [17614706.001]
  • [Cites] Opt Lett. 2007 Aug 15;32(16):2348-50 [17700781.001]
  • [Cites] Nat Methods. 2007 Sep;4(9):717-9 [17694065.001]
  • [Cites] J Opt Soc Am A Opt Image Sci Vis. 2007 Sep;24(9):2527-42 [17767224.001]
  • [Cites] Opt Lett. 2007 Sep 1;32(17):2517-9 [17767290.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17255-60 [17956980.001]
  • [Cites] J Biol Chem. 2002 Nov 8;277(45):42802-7 [12207028.001]
  • [Cites] J Biomed Opt. 2003 Jan;8(1):7-16 [12542374.001]
  • [Cites] Cancer Res. 2003 May 1;63(9):1999-2004 [12727808.001]
  • [Cites] Opt Lett. 2003 Jul 15;28(14):1218-20 [12885026.001]
  • [Cites] Opt Lett. 2003 Sep 1;28(17):1546-8 [12956374.001]
  • [Cites] Opt Lett. 2003 Nov 1;28(21):2067-9 [14587817.001]
  • [Cites] Nat Biotechnol. 2003 Nov;21(11):1361-7 [14595364.001]
  • [Cites] Technol Cancer Res Treat. 2004 Feb;3(1):33-40 [14750891.001]
  • [Cites] Opt Lett. 2004 Jun 1;29(11):1239-41 [15209259.001]
  • [Cites] Opt Lett. 2004 Jun 15;29(12):1393-5 [15233446.001]
  • [Cites] Opt Lett. 2004 Jul 15;29(14):1647-9 [15309847.001]
  • [Cites] Opt Lett. 2004 Aug 15;29(16):1906-8 [15357355.001]
  • [Cites] Opt Lett. 2004 Sep 1;29(17):2028-30 [15455769.001]
  • [Cites] J Cell Biol. 1966 Aug;30(2):269-97 [5968972.001]
  • [Cites] J Histochem Cytochem. 1974 Jul;22(7):598-604 [4137305.001]
  • [Cites] Cancer Res. 2009 Feb 1;69(3):1199-204 [19141640.001]
  • [Cites] Biosens Bioelectron. 2009 Feb 15;24(6):1685-92 [18945607.001]
  • [Cites] J Opt Soc Am A Opt Image Sci Vis. 2009 Feb;26(2):376-86 [19183692.001]
  • [Cites] Dis Markers. 2008;25(6):291-301 [19208947.001]
  • [Cites] Opt Lett. 2009 Mar 1;34(5):653-5 [19252582.001]
  • [Cites] J Biomed Opt. 2009 Jan-Feb;14(1):014004 [19256692.001]
  • [Cites] Appl Opt. 2009 Apr 1;48(10):D109-20 [19340098.001]
  • [Cites] Appl Opt. 2009 Apr 1;48(10):D20-5 [19340110.001]
  • [Cites] Appl Opt. 2009 Apr 1;48(10):D45-51 [19340123.001]
  • [Cites] J Biomed Opt. 2009 Mar-Apr;14(2):024033 [19405762.001]
  • [Cites] Cancer Res. 2009 May 15;69(10):4476-83 [19417131.001]
  • [Cites] Opt Lett. 2009 Jun 15;34(12):1891-3 [19529738.001]
  • [Cites] J Biomed Opt. 2009 May-Jun;14(3):034034 [19566327.001]
  • [Cites] Cancer Res. 2009 Jul 1;69(13):5357-63 [19549915.001]
  • [Cites] Opt Express. 2009 Jul 6;17(14):12001-12 [19582115.001]
  • [Cites] Opt Express. 2009 Aug 3;17(16):13447-57 [19654752.001]
  • [Cites] Opt Lett. 2009 Sep 1;34(17):2679-81 [19724530.001]
  • [Cites] J Biomed Opt. 2009 Jul-Aug;14(4):044022 [19725733.001]
  • [Cites] Anal Quant Cytol Histol. 2009 Aug;31(4):197-207 [19736867.001]
  • [Cites] Opt Lett. 2009 Oct 15;34(20):3235-7 [19838284.001]
  • [Cites] Opt Express. 2009 Oct 26;17(22):20401-14 [19997269.001]
  • [Cites] Opt Express. 2009 Dec 7;17(25):23114-22 [20052238.001]
  • [Cites] Gastroenterology. 2001 Jun;120(7):1620-9 [11375944.001]
  • [Cites] Biophys J. 2001 Nov;81(5):2964-71 [11606306.001]
  • [Cites] Acad Radiol. 2002 May;9 Suppl 1:S52-5 [12019894.001]
  • [Cites] Biophys J. 2002 Sep;83(3):1691-700 [12202392.001]
  • [Cites] Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):961-8 [16467111.001]
  • [Cites] Opt Lett. 2006 Mar 15;31(6):775-7 [16544620.001]
  • [Cites] Opt Lett. 2006 Apr 15;31(8):1079-81 [16625909.001]
  • [Cites] J Opt Soc Am A Opt Image Sci Vis. 2006 May;23(5):1027-37 [16642179.001]
  • [Cites] Opt Lett. 2006 May 15;31(10):1459-61 [16642138.001]
  • [Cites] J Biomed Opt. 2006 Jul-Aug;11(4):041125 [16965153.001]
  • [Cites] J Opt Soc Am A Opt Image Sci Vis. 2006 Oct;23(10):2433-9 [16985528.001]
  • [Cites] Nature. 2006 Oct 12;443(7112):658-62 [17035996.001]
  • [Cites] Opt Lett. 2006 Dec 15;31(24):3585-7 [17130911.001]
  • [Cites] J Biomed Opt. 2006 Nov-Dec;11(6):064007 [17212530.001]
  • [Cites] Opt Lett. 2007 Mar 15;32(6):626-8 [17308582.001]
  • [Cites] J Biomed Opt. 2007 Jan-Feb;12(1):014010 [17343485.001]
  • [Cites] Appl Opt. 2007 Apr 1;46(10):1760-9 [17356619.001]
  • [Cites] Arch Biochem Biophys. 1979 Jul;195(2):453-9 [383019.001]
  • [Cites] Scan Electron Microsc. 1981;(Pt 2):9-31 [7034182.001]
  • [Cites] J Opt Soc Am A. 1985 Jul;2(7):1160-9 [4020513.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9382-6 [1946349.001]
  • [Cites] Science. 1991 Nov 22;254(5035):1178-81 [1957169.001]
  • [Cites] J Biol Chem. 1992 May 5;267(13):8834-9 [1374381.001]
  • [Cites] J Biol Chem. 1994 Jun 17;269(24):16638-42 [7515881.001]
  • [Cites] J Exp Med. 1996 Apr 1;183(4):1533-44 [8666911.001]
  • [Cites] Nature. 1996 Jun 27;381(6585):811-2 [8657288.001]
  • [Cites] Cell. 1997 Nov 28;91(5):627-37 [9393856.001]
  • [Cites] Biophys J. 1998 Jan;74(1):645-54 [9449366.001]
  • [Cites] Mol Biol Cell. 1999 Jan;10(1):197-210 [9880336.001]
  • [Cites] J Invest Dermatol. 1999 Sep;113(3):293-303 [10469324.001]
  • [Cites] Nature. 1954 May 1;173(4409):821-2 [13165653.001]
  • [Cites] Biophys J. 2004 Dec;87(6):4163-71 [15377529.001]
  • [Cites] Appl Opt. 2005 Jan 20;44(3):366-77 [15717826.001]
  • [Cites] Nano Lett. 2005 Mar;5(3):473-7 [15755097.001]
  • [Cites] Opt Lett. 2005 Apr 1;30(7):741-3 [15832924.001]
  • [Cites] Opt Lett. 2005 Apr 1;30(7):747-9 [15832926.001]
  • [Cites] J Biomed Opt. 2005 Mar-Apr;10(2):024005 [15910079.001]
  • [Cites] Photochem Photobiol. 2005 Mar-Apr;81(2):215-37 [15588122.001]
  • [Cites] Biophys J. 2005 Jun;88(6):4170-7 [15805175.001]
  • [Cites] J Biomed Opt. 2005 Jul-Aug;10(4):41208 [16178632.001]
  • [Cites] Opt Lett. 2005 Sep 15;30(18):2445-7 [16196347.001]
  • [Cites] Biomed Microdevices. 2005 Dec;7(4):331-9 [16404511.001]
  • (PMID = 20617940.001).
  • [ISSN] 1545-4274
  • [Journal-full-title] Annual review of biomedical engineering
  • [ISO-abbreviation] Annu Rev Biomed Eng
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA128641; United States / NCI NIH HHS / CA / R01 CA128641; United States / NIBIB NIH HHS / EB / R01 EB003682; United States / NIBIB NIH HHS / EB / R01 EB003682; United States / NIBIB NIH HHS / EB / R01 EB005221; United States / NIBIB NIH HHS / EB / R01 EB005221; United States / NIBIB NIH HHS / EB / R21 EB005321; United States / NIBIB NIH HHS / EB / R21 EB005321
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Review
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS376319; NLM/ PMC3357207
  •  go-up   go-down


23. Czaja AJ: Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly. Drugs Aging; 2008;25(3):219-39
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly.
  • Diagnostic criteria have been codified, and a scoring system allows systemic assessment of all clinical features and quantifies the strength of the diagnosis.
  • Treatment failure is uncommon in the elderly, and age-related changes in the cellular immune response may attenuate the disease and enhance its response to therapy.
  • [MeSH-major] Azathioprine / therapeutic use. Glucocorticoids / therapeutic use. Hepatitis, Autoimmune / diagnosis. Hepatitis, Autoimmune / therapy. Immunosuppressive Agents / therapeutic use. Prednisone / therapeutic use
  • [MeSH-minor] Aged. Diagnosis, Differential. Drug Therapy, Combination. Humans. Liver Transplantation. Prognosis

  • Genetic Alliance. consumer health - Hepatitis.
  • Genetic Alliance. consumer health - Autoimmune Hepatitis.
  • MedlinePlus Health Information. consumer health - Steroids.
  • Hazardous Substances Data Bank. AZATHIOPRINE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Gastroenterol Hepatol. 2005 Apr;17(4):457-61 [15756101.001]
  • [Cites] Rev Esp Enferm Dig. 1999 Sep;91(9):630-8 [10502711.001]
  • [Cites] Liver Int. 2006 Dec;26(10):1201-8 [17105585.001]
  • [Cites] Gut. 1975 Nov;16(11):876-83 [1104411.001]
  • [Cites] N Engl J Med. 1999 Jun 3;340(22):1704-14 [10352162.001]
  • [Cites] Hepatology. 2002 Mar;35(3):658-64 [11870381.001]
  • [Cites] Clin Immunol Immunopathol. 1988 Sep;48(3):290-6 [2456868.001]
  • [Cites] Lancet. 1968 Jul 6;2(7558):24-6 [4172688.001]
  • [Cites] Gastroenterology. 1987 Jan;92(1):215-9 [3781190.001]
  • [Cites] Dig Dis Sci. 2006 May;51(5):968-75 [16773433.001]
  • [Cites] Hepatology. 1997 Feb;25(2):317-23 [9021941.001]
  • [Cites] Gastroenterology. 1992 Oct;103(4):1290-5 [1397887.001]
  • [Cites] Liver Int. 2006 Jun;26(5):552-8 [16761999.001]
  • [Cites] Hepatology. 1989 Jul;10(1):39-43 [2737603.001]
  • [Cites] Compr Ther. 1992 Nov;18(11):26-34 [1478056.001]
  • [Cites] Liver Int. 2006 Jun;26(5):625-9 [16762009.001]
  • [Cites] Am J Gastroenterol. 2001 Dec;96(12):3390-4 [11774954.001]
  • [Cites] Hepatology. 1984 Jul-Aug;4(4):622-7 [6745850.001]
  • [Cites] Gastroenterology. 1996 Mar;110(3):848-57 [8608895.001]
  • [Cites] Hepatology. 2006 Aug;44(2):489-501 [16871565.001]
  • [Cites] Gastroenterology. 1993 Nov;105(5):1502-7 [8224654.001]
  • [Cites] Clin Exp Immunol. 1992 Nov;90(2):351-4 [1424294.001]
  • [Cites] J Hepatol. 2002 Oct;37(4):441-7 [12217596.001]
  • [Cites] Immunol Invest. 1988 Jul;17(5):389-424 [3058585.001]
  • [Cites] J Hepatol. 1999 Jan;30(1):131-41 [9927160.001]
  • [Cites] J Hepatol. 1999 Nov;31(5):929-38 [10580593.001]
  • [Cites] Cancer Invest. 1992;10(6):525-31 [1422890.001]
  • [Cites] Clin Gastroenterol Hepatol. 2004 Jul;2(7):625-31 [15224287.001]
  • [Cites] J Gastroenterol Hepatol. 2003 Jan;18(1):63-7 [12519226.001]
  • [Cites] Liver Transpl. 2001 Apr;7(4):302-10 [11303289.001]
  • [Cites] Gastroenterology. 1993 Dec;105(6):1824-32 [8253358.001]
  • [Cites] J Immunol. 1998 Oct 1;161(7):3527-35 [9759873.001]
  • [Cites] Am J Gastroenterol. 2002 Oct;97(10):2670-3 [12385459.001]
  • [Cites] Hepatology. 2000 Jun;31(6):1231-8 [10827147.001]
  • [Cites] Ann Clin Res. 1976 Jun;8(3):221-7 [793499.001]
  • [Cites] Aliment Pharmacol Ther. 2005 May 15;21(10):1273-7 [15882249.001]
  • [Cites] Age Ageing. 1997 Nov;26(6):441-4 [9466294.001]
  • [Cites] Hepatology. 1989 Feb;9(2):193-7 [2783576.001]
  • [Cites] Hepatology. 1991 Apr;13(4):701-6 [2010165.001]
  • [Cites] J Hepatol. 2005 Apr;42(4):578-84 [15763345.001]
  • [Cites] Am J Gastroenterol. 2002 Sep;97(9):2402-7 [12358264.001]
  • [Cites] Gastroenterology. 1997 Jun;112(6):2028-35 [9178696.001]
  • [Cites] Dig Dis Sci. 1996 Sep;41(9):1733-40 [8794787.001]
  • [Cites] Gastroenterology. 1993 Nov;105(5):1522-8 [8224657.001]
  • [Cites] J Hepatol. 2002 Sep;37(3):302-8 [12175624.001]
  • [Cites] Dig Dis Sci. 1985 Sep;30(9):824-8 [3875463.001]
  • [Cites] Adv Clin Chem. 2005;40:127-64 [16355922.001]
  • [Cites] Hum Immunol. 2000 Jul;61(7):640-50 [10880734.001]
  • [Cites] J Hepatol. 2004 Apr;40(4):646-52 [15030981.001]
  • [Cites] Liver Int. 2005 Aug;25(4):723-7 [15998421.001]
  • [Cites] Clin Liver Dis. 2002 Aug;6(3):799-824 [12362582.001]
  • [Cites] Aliment Pharmacol Ther. 1994 Dec;8(6):585-90 [7696446.001]
  • [Cites] Autoimmunity. 1991;8(3):245-9 [1822969.001]
  • [Cites] Minerva Gastroenterol Dietol. 2005 Dec;51(4):313-33 [16282960.001]
  • [Cites] Hepatology. 1996 Nov;24(5):1068-73 [8903377.001]
  • [Cites] Ann Rheum Dis. 2004 Feb;63(2):123-9 [14722198.001]
  • [Cites] Liver Transpl. 2007 Oct;13(10):1382-8 [17902123.001]
  • [Cites] Ann Hepatol. 2005 Jan-Mar;4(1):6-24 [15798657.001]
  • [Cites] Dig Dis Sci. 1986 Jul;31(7):705-11 [3720467.001]
  • [Cites] Hepatology. 1990 Jun;11(6):1044-9 [2365282.001]
  • [Cites] Am J Dig Dis. 1977 Nov;22(11):973-80 [920708.001]
  • [Cites] Am J Gastroenterol. 1999 Jan;94(1):241-8 [9934764.001]
  • [Cites] Hepatology. 2002 Feb;35(2):349-56 [11826408.001]
  • [Cites] N Engl J Med. 1995 Oct 12;333(15):958-63 [7666914.001]
  • [Cites] Am J Gastroenterol. 2002 Feb;97(2):413-9 [11866281.001]
  • [Cites] Hepatology. 2006 Mar;43(3):532-8 [16496338.001]
  • [Cites] Hepatol Res. 2003 Mar;25(3):263-270 [12697247.001]
  • [Cites] Am J Gastroenterol. 1995 May;90(5):771-6 [7537444.001]
  • [Cites] J Hepatol. 1998 Dec;29(6):990-3 [9875647.001]
  • [Cites] Hepatol Res. 2006 Oct;36(2):139-42 [16872893.001]
  • [Cites] Am J Med. 1976 Jun;60(7):941-8 [937354.001]
  • [Cites] Am J Gastroenterol. 1997 Dec;92(12):2197-200 [9399751.001]
  • [Cites] Clin Transpl. 1998;:17-37 [10503083.001]
  • [Cites] Gastroenterology. 1999 Oct;117(4):761-9 [10500056.001]
  • [Cites] Am J Gastroenterol. 2001 May;96(5):1587-91 [11374704.001]
  • [Cites] J Gastroenterol Hepatol. 1998 May;13(5):490-5 [9641646.001]
  • [Cites] Can J Gastroenterol. 2004 May;18(5):321-6 [15152283.001]
  • [Cites] Dig Dis Sci. 1998 Oct;43(10):2190-5 [9790453.001]
  • [Cites] Hepatology. 1993 Oct;18(4):816-22 [8406354.001]
  • [Cites] Ann Rheum Dis. 2005 Oct;64(10):1519-20 [16162908.001]
  • [Cites] Liver Int. 2005 Apr;25(2):325-30 [15780057.001]
  • [Cites] J Hepatol. 2006 Oct;45(4):575-83 [16899323.001]
  • [Cites] Hepatology. 1998 Aug;28(2):360-5 [9695997.001]
  • [Cites] QJM. 1997 Apr;90(4):289-96 [9307764.001]
  • [Cites] World J Gastroenterol. 2006 Mar 7;12(9):1362-6 [16552802.001]
  • [Cites] Hepatogastroenterology. 2005 Jul-Aug;52(64):1233-5 [16001669.001]
  • [Cites] Hepatology. 2005 Jul;42(1):53-62 [15954109.001]
  • [Cites] Am J Surg Pathol. 1995 Jun;19(6):699-708 [7755156.001]
  • [Cites] Am J Gastroenterol. 2007 May;102(5):1005-12 [17319926.001]
  • [Cites] JAMA. 1990 Nov 28;264(20):2660-2 [2232043.001]
  • [Cites] Gastroenterology. 2000 Apr;118(4):655-60 [10734016.001]
  • [Cites] N Engl J Med. 2002 Sep 19;347(12):911-20 [12239261.001]
  • [Cites] Hum Immunol. 2001 Aug;62(8):826-49 [11476907.001]
  • [Cites] Hepatology. 1987 Nov-Dec;7(6):1333-9 [3679093.001]
  • [Cites] Dig Dis Sci. 1997 May;42(5):1100-3 [9149070.001]
  • [Cites] J Hepatol. 2000 Sep;33(3):371-5 [11019991.001]
  • [Cites] J Hepatol. 1998 Jun;28(6):985-90 [9672174.001]
  • [Cites] J Hepatol. 2006 Oct;45(4):480-2 [16901573.001]
  • [Cites] Hepatology. 2002 Apr;35(4):890-7 [11915036.001]
  • [Cites] Hepatology. 2002 Aug;36(2):479-97 [12143059.001]
  • [Cites] Gut. 2002 May;50(5):713-7 [11950822.001]
  • [Cites] J Clin Lab Anal. 2005;19(1):6-10 [15645466.001]
  • [Cites] J Hepatol. 2006 Dec;45(6):844-50 [17050030.001]
  • [Cites] Q J Med. 1971 Apr;40(158):159-85 [4933363.001]
  • [Cites] Hepatology. 1986 May-Jun;6(3):345-8 [3710424.001]
  • [Cites] J Clin Pathol. 2006 Mar;59(3):280-4 [16505279.001]
  • [Cites] Liver Int. 2005 Oct;25(5):927-34 [16162148.001]
  • [Cites] Hum Immunol. 1994 Oct;41(2):146-50 [7860360.001]
  • [Cites] Q J Med. 1987 Jan;62(237):59-66 [3423206.001]
  • [Cites] Curr Top Microbiol Immunol. 1996;210:167-79 [8565555.001]
  • [Cites] Lancet. 1984 Oct 27;2(8409):954-6 [6149344.001]
  • [Cites] J Clin Gastroenterol. 2005 Oct;39(9):819-25 [16145346.001]
  • [Cites] Z Gastroenterol. 1997 Jul;35(7):571-8 [9273991.001]
  • [Cites] Hepatology. 2001 Sep;34(3):464-70 [11526530.001]
  • [Cites] Hepatology. 1998 Jun;27(6):1536-43 [9620324.001]
  • [Cites] Hepatology. 2001 Oct;34(4 Pt 1):659-65 [11584360.001]
  • [Cites] Autoimmunity. 2002 Dec;35(8):475-83 [12765472.001]
  • [Cites] Clin Exp Immunol. 1972 Sep;12(1):79-87 [4563336.001]
  • [Cites] J Hepatol. 2006 Oct;45(4):584-91 [16876902.001]
  • [Cites] Ann N Y Acad Sci. 1992 Nov 21;663:36-42 [1482065.001]
  • [Cites] Am J Gastroenterol. 1995 Aug;90(8):1206-11 [7639216.001]
  • [Cites] J Clin Gastroenterol. 2002 Jul;35(1):75-81 [12080231.001]
  • [Cites] Gastroenterology. 1975 Aug;69(2):289-302 [1150039.001]
  • [Cites] Dig Dis Sci. 2001 Jun;46(6):1321-7 [11414311.001]
  • [Cites] Arch Intern Med. 1975 Feb;135(2):319-21 [1147734.001]
  • [Cites] Ann Intern Med. 1980 Jan;92 (1):14-9 [7350868.001]
  • [Cites] J Clin Invest. 1991 Oct;88(4):1370-8 [1717511.001]
  • [Cites] J Gastroenterol. 1997 Oct;32(5):689-95 [9349999.001]
  • [Cites] Clin Liver Dis. 2002 Aug;6(3):727-37 [12362577.001]
  • [Cites] J Clin Gastroenterol. 2004 Oct;38(9):805-9 [15365410.001]
  • [Cites] Gastroenterology. 2000 Nov;119(5):1312-6 [11054389.001]
  • [Cites] Liver Transpl Surg. 1998 May;4(3):208-14 [9563959.001]
  • [Cites] Science. 1999 Jul 2;285(5424):113-6 [10390361.001]
  • [Cites] Am J Surg Pathol. 2004 Apr;28(4):471-8 [15087666.001]
  • [Cites] Clin Exp Rheumatol. 1992 Jan-Feb;10(1):13-7 [1551275.001]
  • [Cites] Hepatology. 1990 Dec;12(6):1300-4 [2175292.001]
  • [Cites] Minerva Gastroenterol Dietol. 2007 Mar;53(1):43-78 [17415344.001]
  • [Cites] Annu Rev Gerontol Geriatr. 1990;10:71-96 [2102713.001]
  • [Cites] Gastroenterology. 1989 Nov;97(5):1288-93 [2792661.001]
  • [Cites] J Hepatol. 1994 Nov;21(5):866-71 [7890904.001]
  • [Cites] Am J Gastroenterol. 2004 Aug;99(8):1510-6 [15307869.001]
  • [Cites] Inflamm Res. 1999 Mar;48(3):106-19 [10219652.001]
  • [Cites] Dig Dis Sci. 1998 Sep;43(9):2149-55 [9753285.001]
  • [Cites] Gastroenterology. 1980 Mar;78(3):518-23 [7351290.001]
  • [Cites] Aliment Pharmacol Ther. 2005 Mar 15;21(6):695-9 [15771755.001]
  • [Cites] Gastroenterology. 1992 Sep;103(3):1041-7 [1354193.001]
  • [Cites] Am J Gastroenterol. 1999 Jul;94(7):1906-13 [10406258.001]
  • [Cites] World J Gastroenterol. 2003 Dec;9(12):2681-5 [14669312.001]
  • [Cites] Lancet. 1973 Apr 7;1(7806):735-7 [4121073.001]
  • [Cites] Liver. 1984 Apr;4(2):105-16 [6727581.001]
  • [Cites] Hepatology. 1983 Sep-Oct;3(5):685-9 [6618435.001]
  • [Cites] J Hepatol. 2005 Dec;43(6):951-7 [16143423.001]
  • [Cites] J Clin Gastroenterol. 1984 Aug;6(4):331-5 [6481116.001]
  • [Cites] World J Gastroenterol. 2005 Mar 28;11(12):1862-6 [15793882.001]
  • [Cites] Am J Gastroenterol. 2001 Apr;96(4):1224-31 [11316174.001]
  • [Cites] Gastroenterology. 1972 Nov;63(5):820-33 [4538724.001]
  • [Cites] Eur J Immunol. 1992 Nov;22(11):2989-93 [1425923.001]
  • [Cites] Clin Liver Dis. 2002 Aug;6(3):825-50, ix [12362583.001]
  • [Cites] Semin Liver Dis. 2002 Nov;22(4):365-78 [12447708.001]
  • [Cites] Am J Gastroenterol. 2002 Aug;97(8):2051-7 [12190176.001]
  • (PMID = 18331074.001).
  • [ISSN] 1170-229X
  • [Journal-full-title] Drugs & aging
  • [ISO-abbreviation] Drugs Aging
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] New Zealand
  • [Chemical-registry-number] 0 / Glucocorticoids; 0 / Immunosuppressive Agents; MRK240IY2L / Azathioprine; VB0R961HZT / Prednisone
  • [Number-of-references] 161
  •  go-up   go-down


24. Maiese K, Hou J, Chong ZZ, Shang YC: Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology. ScientificWorldJournal; 2009 Oct 02;9:1072-104
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Oxidative stress significantly impacts multiple cellular pathways that can lead to the initiation and progression of varied disorders throughout the body.
  • It therefore becomes imperative to elucidate the components and function of novel therapeutic strategies against oxidative stress to further clinical diagnosis and care.
  • In particular, both the growth factor and cytokine erythropoietin (EPO), and members of the mammalian forkhead transcription factors of the O class (FoxOs), may offer the greatest promise for new treatment regimens, since these agents and the cellular pathways they oversee cover a range of critical functions that directly influence progenitor cell development, cell survival and degeneration, metabolism, immune function, and cancer cell invasion.
  • Furthermore, both EPO and FoxOs function not only as therapeutic targets, but also as biomarkers of disease onset and progression, since their cellular pathways are closely linked and overlap with several unique signal transduction pathways.
  • Here we present the exciting as well as the complex role that EPO and FoxOs possess to uncover the benefits as well as the risks of these agents for cell biology and clinical care in processes that range from stem cell development to uncontrolled cellular proliferation.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Exp Med. 2004 Oct 18;200(8):1051-62 [15492127.001]
  • [Cites] Trends Pharmacol Sci. 2004 Nov;25(11):577-83 [15491780.001]
  • [Cites] Blood. 1974 Jul;44(1):77-85 [4834517.001]
  • [Cites] Nature. 1985 Feb 28-Mar 6;313(6005):806-10 [3838366.001]
  • [Cites] Proc Natl Acad Sci U S A. 1985 Nov;82(22):7580-4 [3865178.001]
  • [Cites] Biochemistry. 1988 Jul 26;27(15):5646-54 [3179269.001]
  • [Cites] Cell. 1989 May 19;57(4):645-58 [2566386.001]
  • [Cites] Eur J Biochem. 1990 Mar 10;188(2):405-11 [2156701.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Aug;87(15):5978-82 [2165612.001]
  • [Cites] Kidney Int. 1990 Nov;38(5):969-75 [2266682.001]
  • [Cites] Blood. 1991 Feb 1;77(3):419-34 [1991159.001]
  • [Cites] Neurobiol Aging. 1999 Nov-Dec;20(6):581-9 [10674423.001]
  • [Cites] J Neurosci Res. 2000 Feb 15;59(4):568-80 [10679797.001]
  • [Cites] Genes Dev. 2000 Jan 15;14(2):142-6 [10702024.001]
  • [Cites] J Neurosci Res. 1999 Feb 15;55(4):472-85 [10723057.001]
  • [Cites] J Autoimmun. 2000 May;14(3):221-9 [10756084.001]
  • [Cites] Cell Mol Neurobiol. 2000 Jun;20(3):383-400 [10789835.001]
  • [Cites] Int J Dev Neurosci. 2000 Jul-Aug;18(4-5):423-31 [10817926.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2000 Jun;278(6):E1038-44 [10827006.001]
  • [Cites] J Cereb Blood Flow Metab. 2000 Sep;20(9):1380-91 [10994860.001]
  • [Cites] J Neurosci Res. 2000 Oct 15;62(2):257-72 [11020218.001]
  • [Cites] J Biochem. 2000 Nov;128(5):731-7 [11056384.001]
  • [Cites] J Biol Chem. 2000 Dec 15;275(50):39754-61 [10995753.001]
  • [Cites] Biochem J. 2000 Jul 15;349(Pt 2):629-34 [10880363.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2000 Dec;279(6):E1242-8 [11093910.001]
  • [Cites] ScientificWorldJournal. 2008;8:270-4 [18661049.001]
  • [Cites] Oncogene. 2008 Aug 7;27(34):4733-44 [18408765.001]
  • [Cites] Curr Neurovasc Res. 2008 Aug;5(3):159-70 [18691073.001]
  • [Cites] J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1125-31 [18086112.001]
  • [Cites] J Mol Cell Cardiol. 2008 Aug;45(2):250-60 [18586265.001]
  • [Cites] J Immunol. 2008 Sep 1;181(5):2980-9 [18713968.001]
  • [Cites] Mol Cancer Ther. 2008 Aug;7(8):2263-71 [18687658.001]
  • [Cites] Arch Immunol Ther Exp (Warsz). 2008 Jul-Aug;56(4):257-66 [18726147.001]
  • [Cites] Hear Res. 2008 Sep;243(1-2):121-6 [18672044.001]
  • [Cites] Carcinogenesis. 2008 Sep;29(9):1837-44 [18390843.001]
  • [Cites] J Neurosci Res. 2008 Oct;86(13):3018-27 [18512763.001]
  • [Cites] J Cereb Blood Flow Metab. 2001 Mar;21(3):262-75 [11295881.001]
  • [Cites] J Neuropathol Exp Neurol. 2001 Apr;60(4):386-92 [11305874.001]
  • [Cites] Mamm Genome. 2001 Jun;12(6):416-25 [11353388.001]
  • [Cites] J Biol Chem. 2001 Jan 26;276(4):2571-5 [11073947.001]
  • [Cites] J Am Coll Cardiol. 2001 Jun 1;37(7):1775-80 [11401110.001]
  • [Cites] Pediatr Res. 2002 Apr;51(4):472-8 [11919332.001]
  • [Cites] J Cereb Blood Flow Metab. 2002 May;22(5):503-14 [11973422.001]
  • [Cites] J Cell Mol Med. 2002 Jan-Mar;6(1):82-92 [12003671.001]
  • [Cites] J Vasc Res. 2002 Mar-Apr;39(2):131-47 [12011585.001]
  • [Cites] J Biol Chem. 2002 Jul 26;277(30):26729-32 [12048180.001]
  • [Cites] Eur J Neurosci. 2002 Aug;16(4):584-92 [12270034.001]
  • [Cites] Microsc Res Tech. 2002 Nov 15;59(4):331-4 [12424797.001]
  • [Cites] J Biol Chem. 2002 Dec 6;277(49):47928-37 [12351634.001]
  • [Cites] Circulation. 2002 Dec 3;106(23):2973-9 [12460881.001]
  • [Cites] Histol Histopathol. 2003 Jan;18(1):173-89 [12507297.001]
  • [Cites] Exp Biol Med (Maywood). 2003 Jan;228(1):1-14 [12524467.001]
  • [Cites] Circulation. 2003 Jan 21;107(2):294-9 [12538431.001]
  • [Cites] J Neurosci Res. 2003 Mar 1;71(5):659-69 [12584724.001]
  • [Cites] J Biol Chem. 2003 Feb 21;278(8):5871-82 [12488318.001]
  • [Cites] J Hematother Stem Cell Res. 2002 Dec;11(6):863-71 [12590701.001]
  • [Cites] J Cereb Blood Flow Metab. 2003 Mar;23(3):320-30 [12621307.001]
  • [Cites] J Biol Chem. 2003 Apr 4;278(14):12361-6 [12517744.001]
  • [Cites] Br J Pharmacol. 2003 Mar;138(6):1107-18 [12684267.001]
  • [Cites] J Biol Chem. 2003 Apr 18;278(16):13898-904 [12578834.001]
  • [Cites] Transplantation. 2003 Apr 27;75(8):1356-60 [12717230.001]
  • [Cites] Arch Toxicol. 2003 May;77(5):267-73 [12734640.001]
  • [Cites] Trends Pharmacol Sci. 2003 May;24(5):228-32 [12767721.001]
  • [Cites] Science. 2003 Jul 11;301(5630):215-8 [12855809.001]
  • [Cites] Blood. 2003 Aug 15;102(4):1340-6 [12702503.001]
  • [Cites] Circulation. 2003 Aug 5;108(5):616-22 [12835226.001]
  • [Cites] Mol Pharmacol. 2003 Sep;64(3):557-69 [12920191.001]
  • [Cites] J Neurosci Res. 2003 Oct 1;74(1):37-51 [13130504.001]
  • [Cites] Cell Mol Neurobiol. 2003 Oct;23(4-5):561-78 [14514016.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11285-90 [13679577.001]
  • [Cites] Am J Obstet Gynecol. 2003 Dec;189(6):1764-70 [14710111.001]
  • [Cites] Arch Intern Med. 2004 Feb 9;164(3):262-76 [14769622.001]
  • [Cites] Clin Nephrol. 2004 Feb;61(2):127-9 [14989632.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2975-80 [14978268.001]
  • [Cites] Antioxid Redox Signal. 2004 Apr;6(2):277-87 [15025929.001]
  • [Cites] Science. 2004 Mar 26;303(5666):2011-5 [14976264.001]
  • [Cites] Cell. 2004 Apr 16;117(2):225-37 [15084260.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2004 May;31(5):733-9 [14985868.001]
  • [Cites] Exp Cell Res. 2004 Jun 10;296(2):196-207 [15149850.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9855-60 [15210945.001]
  • [Cites] J Am Coll Cardiol. 2004 Jul 7;44(1):63-7 [15234408.001]
  • [Cites] J Cereb Blood Flow Metab. 2004 Jul;24(7):728-43 [15241181.001]
  • [Cites] Restor Neurol Neurosci. 2004;22(2):87-104 [15272144.001]
  • [Cites] Restor Neurol Neurosci. 2004;22(2):105-19 [15272145.001]
  • [Cites] J Biol Chem. 2004 Aug 13;279(33):34741-9 [15184386.001]
  • [Cites] Immunity. 2004 Aug;21(2):203-13 [15308101.001]
  • [Cites] Front Biosci. 2004 Sep 1;9:2500-20 [15353303.001]
  • [Cites] Cancer Lett. 2004 Oct 28;214(2):171-9 [15363543.001]
  • [Cites] J Biol Chem. 2004 Sep 24;279(39):41114-23 [15272020.001]
  • [Cites] J Neuroimmunol. 2009 Jun 25;211(1-2):92-100 [19428125.001]
  • [Cites] Clin Transl Oncol. 2009 Jul;11(7):411-27 [19574199.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2009;16(4):530-7 [19333535.001]
  • [Cites] Neurobiol Dis. 2009 Aug;35(2):278-85 [19481149.001]
  • [Cites] Glia. 2009 Sep;57(12):1351-61 [19229997.001]
  • [Cites] Clin Pharmacol Ther. 2009 Aug;86(2):154-9 [19458615.001]
  • [Cites] Eur J Heart Fail. 2009 Aug;11(8):732-8 [19633100.001]
  • [Cites] ScientificWorldJournal. 2009;9:781-91 [19705038.001]
  • [Cites] Am J Nephrol. 2009;30(3):253-60 [19494484.001]
  • [Cites] Molecules. 2009;14(9):3446-85 [19783937.001]
  • [Cites] J Alzheimers Dis. 2009;17(2):267-76 [19221404.001]
  • [Cites] Am J Kidney Dis. 1991 Oct;18(4 Suppl 1):14-9 [1928074.001]
  • [Cites] Am Heart J. 1992 Aug;124(2):424-7 [1386184.001]
  • [Cites] Nature. 1993 Jul 29;364(6436):412-20 [8332212.001]
  • [Cites] J Neurosci Res. 1993 Sep 1;36(1):77-87 [8230323.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3974-8 [8171022.001]
  • [Cites] Genes Chromosomes Cancer. 1994 Oct;11(2):79-84 [7529552.001]
  • [Cites] J Cereb Blood Flow Metab. 1995 May;15(3):440-9 [7714002.001]
  • [Cites] Eur J Biochem. 1996 Jul 15;239(2):494-500 [8706759.001]
  • [Cites] J Neurochem. 1997 Feb;68(2):710-4 [9003060.001]
  • [Cites] Circulation. 1997 May 6;95(9):2303-11 [9142009.001]
  • [Cites] J Cereb Blood Flow Metab. 1997 May;17(5):560-6 [9183294.001]
  • [Cites] Blood. 1997 Nov 1;90(9):3714-9 [9345057.001]
  • [Cites] Free Radic Res. 1997 Sep;27(3):311-23 [9350435.001]
  • [Cites] Nature. 1997 Oct 30;389(6654):994-9 [9353126.001]
  • [Cites] Science. 1997 Nov 14;278(5341):1319-22 [9360933.001]
  • [Cites] Biochemistry. 1998 Apr 28;37(17):6179-87 [9558357.001]
  • [Cites] Arch Biochem Biophys. 1998 May 15;353(2):312-21 [9606965.001]
  • [Cites] J Biol Chem. 1998 Sep 25;273(39):25381-7 [9738005.001]
  • [Cites] Exp Neurol. 1999 Jan;155(1):79-94 [9918707.001]
  • [Cites] Exp Cell Res. 1999 Feb 1;246(2):290-300 [9925743.001]
  • [Cites] Cell Biochem Biophys. 1999;30(1):153-66 [10099826.001]
  • [Cites] J Histochem Cytochem. 1999 May;47(5):661-72 [10219058.001]
  • [Cites] J Biol Chem. 1999 Jun 4;274(23):15982-5 [10347145.001]
  • [Cites] J Biol Chem. 1999 Jun 11;274(24):17184-92 [10358076.001]
  • [Cites] J Neurobiol. 1999 Aug;40(2):171-84 [10413448.001]
  • [Cites] Blood. 1950 Apr;5(4):372-80 [15411424.001]
  • [Cites] Science. 2004 Nov 12;306(5699):1190-4 [15498972.001]
  • [Cites] Acta Med Okayama. 2004 Aug;58(4):197-205 [15551757.001]
  • [Cites] Diabetologia. 2004 Oct;47(10):1695-703 [15502930.001]
  • [Cites] Circ Res. 2008 Mar 28;102(6):686-94 [18218983.001]
  • [Cites] J Biol Chem. 2008 Apr 4;283(14):9224-30 [18250171.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):152-9 [17967510.001]
  • [Cites] Cancer Res. 2008 Apr 15;68(8):3001-9 [18413770.001]
  • [Cites] Breast Cancer Res. 2008;10(1):R21 [18312651.001]
  • [Cites] Adv Exp Med Biol. 2008;615:13-23 [18437889.001]
  • [Cites] Pharmacol Ther. 2008 Apr;118(1):58-81 [18313758.001]
  • [Cites] Acta Trop. 2008 May;106(2):104-8 [18359468.001]
  • [Cites] BJU Int. 2008 Jun;101(11):1454-60 [18336616.001]
  • [Cites] Biomed Pharmacother. 2008 Apr-May;62(4):218-32 [18342481.001]
  • [Cites] Trends Mol Med. 2008 May;14(5):219-27 [18403263.001]
  • [Cites] Curr Neurovasc Res. 2008 May;5(2):125-42 [18473829.001]
  • [Cites] N Engl J Med. 2008 May 15;358(20):2107-16 [18480203.001]
  • [Cites] Prog Neurobiol. 2008 Jun;85(2):194-213 [18396368.001]
  • [Cites] Brain Res Bull. 2008 Jul 1;76(4):424-38 [18502319.001]
  • [Cites] Neuropsychopharmacology. 2008 Jul;33(8):1942-51 [17805306.001]
  • [Cites] Eur J Pharmacol. 2008 Jul 7;588(2-3):178-88 [18502414.001]
  • [Cites] Expert Opin Ther Targets. 2008 Jul;12(7):905-16 [18554157.001]
  • [Cites] Brain Res. 2008 Jul 7;1218:224-9 [18533137.001]
  • [Cites] Biochim Biophys Acta. 2008 Jul-Aug;1777(7-8):834-46 [18452700.001]
  • [Cites] Neurochem Res. 2008 Aug;33(8):1599-609 [18461448.001]
  • [Cites] Neuroscience. 2008 Jul 17;154(4):1458-66 [18555616.001]
  • [Cites] J Nephrol. 2008 Jul-Aug;21(4):543-9 [18651544.001]
  • [Cites] Oncogene. 2008 Jul 24;27(32):4422-33 [18391984.001]
  • [Cites] J Pharmacol Exp Ther. 2006 Apr;317(1):68-75 [16377761.001]
  • [Cites] J Am Soc Nephrol. 2006 Apr;17(4):932-42 [16481411.001]
  • [Cites] Obesity (Silver Spring). 2006 Feb;14(2):188-93 [16571842.001]
  • [Cites] Curr Med Chem. 2006;13(8):883-95 [16611073.001]
  • [Cites] Neurosci Lett. 2006 May 1;398(1-2):39-43 [16423457.001]
  • [Cites] PLoS Med. 2006 Apr;3(4):e101 [16478293.001]
  • [Cites] Eur J Cardiothorac Surg. 2006 Jun;29(6):902-7 [16675226.001]
  • [Cites] Cancer Immunol Immunother. 2006 Sep;55(9):1064-71 [16328385.001]
  • [Cites] Curr Neurovasc Res. 2006 May;3(2):107-17 [16719794.001]
  • [Cites] J Am Soc Nephrol. 2006 Jun;17(6):1576-84 [16672321.001]
  • [Cites] Nature. 2006 May 25;441(7092):523-7 [16680151.001]
  • [Cites] Blood. 2008 Oct 1;112(7):2787-94 [18628488.001]
  • [Cites] J Ocul Pharmacol Ther. 2008 Oct;24(5):453-9 [18788995.001]
  • [Cites] J Biol Chem. 2008 Oct 10;283(41):27810-9 [18678867.001]
  • [Cites] J Neurochem. 2008 Oct;107(1):127-40 [18665912.001]
  • [Cites] Biochem Biophys Res Commun. 2008 Nov 14;376(2):251-5 [18774777.001]
  • [Cites] Cell Cycle. 2008 Oct;7(20):3162-70 [18927507.001]
  • [Cites] Epilepsia. 2008 Oct;49(10):1723-32 [18479396.001]
  • [Cites] Neurosci Lett. 2008 Dec 31;448(3):245-9 [18973793.001]
  • [Cites] Perfusion. 2008 May;23(3):187-92 [19029270.001]
  • [Cites] J Physiol. 2008 Dec 1;586(Pt 23):5757-69 [18845609.001]
  • [Cites] Crit Care. 2008;12(5):227 [18983707.001]
  • [Cites] Neuroepidemiology. 2009;32(1):40-6 [19001795.001]
  • [Cites] Ann Neurol. 2008 Nov;64(5):523-34 [19067366.001]
  • [Cites] J Neurosci Res. 2009 Jan;87(1):150-63 [18711747.001]
  • [Cites] Cell Mol Life Sci. 2008 Dec;65(24):4000-18 [18820996.001]
  • [Cites] Clin Sci (Lond). 2009 Feb;116(3):191-203 [19118491.001]
  • [Cites] J Ren Nutr. 2009 Jan;19(1):20-4 [19121765.001]
  • [Cites] Brain Res. 2009 Jan 16;1249:212-21 [18977207.001]
  • [Cites] Eur J Pharmacol. 2009 Jan 14;602(2-3):406-12 [19061883.001]
  • [Cites] Trends Parasitol. 2009 Jan;25(1):30-6 [19008152.001]
  • [Cites] Cell Cycle. 2008 Dec 15;7(24):3829-39 [19066462.001]
  • [Cites] J Biol Chem. 2009 Jan 23;284(4):2001-11 [19047055.001]
  • [Cites] Exp Cell Res. 2009 Feb 1;315(3):419-31 [19056379.001]
  • [Cites] Life Sci. 2009 Feb 13;84(7-8):205-10 [19101571.001]
  • [Cites] Brain Behav Immun. 2009 Feb;23(2):193-203 [18835350.001]
  • [Cites] FASEB J. 2009 Feb;23(2):351-61 [18827024.001]
  • [Cites] Acta Pharmacol Sin. 2009 Feb;30(2):202-8 [19122671.001]
  • [Cites] Pharmacol Biochem Behav. 2009 Apr;92(2):251-9 [19138703.001]
  • [Cites] Neonatology. 2009;95(2):105-16 [18776724.001]
  • [Cites] Placenta. 2009 Mar;30(3):256-62 [19150739.001]
  • [Cites] Crit Care Med. 2009 Mar;37(3):889-98 [19237893.001]
  • [Cites] Adv Exp Med Biol. 2009;643:359-68 [19239167.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1329-35 [18952918.001]
  • [Cites] J Urol. 2009 Mar;181(3):1434-43 [19157461.001]
  • [Cites] Mech Ageing Dev. 2009 Apr;130(4):253-61 [19162061.001]
  • [Cites] Trends Cell Biol. 2009 Mar;19(3):119-29 [19208479.001]
  • [Cites] Immunol Rev. 2009 Mar;228(1):149-69 [19290926.001]
  • [Cites] Cell Calcium. 2009 Apr;45(4):358-68 [19201465.001]
  • [Cites] Chin Med J (Engl). 2009 Mar 5;122(5):566-70 [19323909.001]
  • [Cites] Biochem Biophys Res Commun. 2009 Apr 17;381(4):491-5 [19233143.001]
  • [Cites] Hellenic J Cardiol. 2009 Mar-Apr;50(2):127-32 [19329414.001]
  • [Cites] J Neurochem. 2009 Apr;109(2):360-70 [19220704.001]
  • [Cites] Free Radic Biol Med. 2009 Apr 15;46(8):1032-41 [19136057.001]
  • [Cites] Med Res Rev. 2009 May;29(3):395-418 [18985696.001]
  • [Cites] Glia. 2009 May;57(7):734-43 [18985732.001]
  • [Cites] Curr Neurovasc Res. 2009 Feb;6(1):20-31 [19355923.001]
  • [Cites] J Comp Neurol. 2009 Jun 1;514(4):403-14 [19330822.001]
  • [Cites] Brain. 2009 Apr;132(Pt 4):879-88 [19244253.001]
  • [Cites] Brain Res. 2009 Mar 31;1263:23-32 [19368821.001]
  • [Cites] Stem Cells Dev. 2009 Apr;18(3):411-21 [18590375.001]
  • [Cites] J Neurochem. 2009 May;109(4):1157-67 [19302476.001]
  • [Cites] Neuropharmacology. 2009 May-Jun;56(6-7):1027-34 [19268480.001]
  • [Cites] J Cell Mol Med. 2009 Apr;13(4):701-11 [18410524.001]
  • [Cites] Cell Signal. 2007 Jun;19(6):1150-62 [17289346.001]
  • [Cites] Eur Surg Res. 2007;39(3):189-97 [17377393.001]
  • [Cites] J Cereb Blood Flow Metab. 2007 May;27(5):1043-54 [17077815.001]
  • [Cites] J Neuropathol Exp Neurol. 2007 May;66(5):389-98 [17483696.001]
  • [Cites] Biochim Biophys Acta. 2007 Apr;1769(4):244-52 [17482685.001]
  • [Cites] Mol Cell Biol. 2007 May;27(10):3839-3854 [17353275.001]
  • [Cites] Nat Rev Mol Cell Biol. 2007 Jun;8(6):440-50 [17522590.001]
  • [Cites] Adv Ther. 2007 Mar-Apr;24(2):346-52 [17565925.001]
  • [Cites] Clin Cancer Res. 2007 Jun 15;13(12):3536-44 [17575216.001]
  • [Cites] Mol Cell Biol. 2007 Jul;27(13):4917-30 [17452451.001]
  • [Cites] J Cereb Blood Flow Metab. 2007 Jul;27(7):1369-76 [17264861.001]
  • [Cites] Biochim Biophys Acta. 2010 Jan;1802(1):167-85 [19751830.001]
  • [Cites] Oxid Med Cell Longev. 2009 Jan-Mar;2(1):1 [20046637.001]
  • [Cites] Oxid Med Cell Longev. 2009 Jan-Mar;2(1):19-25 [20046641.001]
  • [Cites] Oxid Med Cell Longev. 2009 Jan-Mar;2(1):43-51 [20046644.001]
  • [Cites] Adv Exp Med Biol. 2009;665:242-60 [20429429.001]
  • [Cites] Oxid Med Cell Longev. 2008 Oct-Dec;1(1):1-14 [19750024.001]
  • [Cites] BMC Neurosci. 2004 Nov 29;5:48 [15569384.001]
  • [Cites] Neurosignals. 2004 Nov-Dec;13(6):265-89 [15627815.001]
  • [Cites] JAMA. 2005 Jan 5;293(1):90-5 [15632341.001]
  • [Cites] Cancer Res. 2005 Jan 1;65(1):284-90 [15665305.001]
  • [Cites] Curr Opin Neurobiol. 2005 Feb;15(1):101-7 [15721751.001]
  • [Cites] Arch Intern Med. 2005 Feb 28;165(4):466-9 [15738380.001]
  • [Cites] Arthritis Rheum. 2005 Mar;52(3):940-50 [15751086.001]
  • [Cites] J Mol Neurosci. 2005;25(2):183-9 [15784966.001]
  • [Cites] Mol Cancer Res. 2005 Mar;3(3):163-9 [15798096.001]
  • [Cites] J Cell Biol. 2005 Apr 25;169(2):331-9 [15837797.001]
  • [Cites] J Am Coll Cardiol. 2005 May 3;45(9):1406-12 [15862410.001]
  • [Cites] Prog Neurobiol. 2005 Feb;75(3):207-46 [15882775.001]
  • [Cites] Nat Med. 2005 Jun;11(6):666-71 [15895074.001]
  • [Cites] Brain Res Brain Res Rev. 2005 Jul;49(1):1-21 [15960984.001]
  • [Cites] Brain Res. 2005 Jul 19;1050(1-2):15-26 [15979589.001]
  • [Cites] Mol Ther. 2005 Aug;12(2):283-9 [15935736.001]
  • [Cites] Dev Cell. 2005 Aug;9(2):261-70 [16054032.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11278-83 [16076959.001]
  • [Cites] J Biol Chem. 2005 Aug 19;280(33):29864-73 [15961397.001]
  • [Cites] Neurosci Lett. 2005 Oct 14;387(1):5-10 [16054296.001]
  • [Cites] Antioxid Redox Signal. 2005 Sep-Oct;7(9-10):1223-33 [16115027.001]
  • [Cites] Endocrinology. 2005 Oct;146(10):4370-6 [16020479.001]
  • [Cites] Curr Neurovasc Res. 2005 Jan;2(1):55-72 [16181100.001]
  • [Cites] Curr Neurovasc Res. 2005 Jul;2(3):197-211 [16181114.001]
  • [Cites] Curr Neurovasc Res. 2005 Oct;2(4):271-85 [16181120.001]
  • [Cites] Curr Neurovasc Res. 2005 Oct;2(4):331-40 [16181124.001]
  • [Cites] J Biol Chem. 2005 Sep 30;280(39):33558-65 [16061480.001]
  • [Cites] Sports Med. 2005;35(10):831-40 [16180943.001]
  • [Cites] Genes Dev. 2005 Oct 15;19(20):2435-46 [16230533.001]
  • [Cites] Biochem J. 2005 Nov 1;391(Pt 3):623-9 [15987244.001]
  • [Cites] Histol Histopathol. 2006 Jan;21(1):103-24 [16267791.001]
  • [Cites] Curr Neurovasc Res. 2005 Dec;2(5):387-99 [16375720.001]
  • [Cites] Curr Neurovasc Res. 2005 Dec;2(5):425-46 [16375723.001]
  • [Cites] Ann Hematol. 2006 Feb;85(2):79-85 [16132904.001]
  • [Cites] Cancer Res. 2006 Jan 1;66(1):212-20 [16397234.001]
  • [Cites] Gene Expr Patterns. 2006 Jan;6(2):134-40 [16326148.001]
  • [Cites] J Neurochem. 2006 Feb;96(4):1101-10 [16417583.001]
  • [Cites] J Clin Invest. 2006 Feb;116(2):344-56 [16453021.001]
  • [Cites] Curr Neurovasc Res. 2006 Feb;3(1):25-39 [16472123.001]
  • [Cites] Mutat Res. 2006 Feb 22;594(1-2):155-61 [16289600.001]
  • [Cites] J Pharmacol Exp Ther. 2006 Mar;316(3):999-1005 [16306273.001]
  • [Cites] Nat Genet. 2006 Mar;38(3):320-3 [16415884.001]
  • [Cites] Mol Cancer Ther. 2006 Feb;5(2):356-61 [16505109.001]
  • [Cites] J Neurosci Res. 2006 Mar;83(4):584-93 [16435392.001]
  • [Cites] J Infect Dis. 2006 Apr 1;193(7):987-95 [16518761.001]
  • [Cites] Brain Res Bull. 2006 Mar 31;69(2):117-22 [16533659.001]
  • [Cites] J Pharmacol Exp Ther. 2006 Apr;317(1):109-16 [16357210.001]
  • [Cites] Mol Cell Endocrinol. 2008 Jan 16;281(1-2):47-55 [18035477.001]
  • [Cites] Mol Cell. 2007 Dec 28;28(6):941-53 [18158893.001]
  • [Cites] Cell Death Differ. 2008 Feb;15(2):299-311 [17992191.001]
  • [Cites] Resuscitation. 2008 Mar;76(3):397-404 [18037223.001]
  • [Cites] Rejuvenation Res. 2008 Feb;11(1):139-50 [18069916.001]
  • [Cites] Gynecol Oncol. 2008 Mar;108(3):609-18 [18234299.001]
  • [Cites] Diabetes. 2008 Mar;57(3):563-76 [18162510.001]
  • [Cites] Clin Dev Immunol. 2007;2007:89195 [18317534.001]
  • [Cites] Br J Haematol. 2008 Apr;141(1):14-31 [18324962.001]
  • [Cites] Cell Signal. 2008 May;20(5):892-906 [18276109.001]
  • [Cites] Expert Rev Cardiovasc Ther. 2008 Mar;6(3):281-4 [18327989.001]
  • [Cites] Cell. 2006 Jun 2;125(5):987-1001 [16751106.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9051-6 [16757565.001]
  • [Cites] Biochem J. 2006 Jul 15;397(2):233-46 [16792526.001]
  • [Cites] J Cardiovasc Pharmacol. 2006 Jun;47(6):736-41 [16810073.001]
  • [Cites] Diabetes. 2006 Aug;55(8):2231-7 [16873685.001]
  • [Cites] Clin Sci (Lond). 2006 Sep;111(3):171-83 [16901264.001]
  • [Cites] Eur J Neurosci. 2006 Jul;24(2):361-70 [16903847.001]
  • [Cites] Diabet Med. 2006 Aug;23(8):839-44 [16911620.001]
  • [Cites] Acta Biomed. 2005;76 Suppl 3:49-54 [16915797.001]
  • [Cites] Curr Neurovasc Res. 2006 Aug;3(3):187-201 [16918383.001]
  • [Cites] Cancer Biol Ther. 2006 Jul;5(7):875-83 [16861905.001]
  • [Cites] Nat Clin Pract Nephrol. 2005 Dec;1(2):87-97 [16932374.001]
  • [Cites] Diabetes. 2006 Sep;55(9):2649-53 [16936217.001]
  • [Cites] Pediatrics. 2006 Sep;118(3):e635-40 [16908620.001]
  • [Cites] Semin Nephrol. 2006 Jul;26(4):296-306 [16949468.001]
  • [Cites] Circulation. 2006 Sep 19;114(12):1269-76 [16952980.001]
  • [Cites] Eur J Endocrinol. 2006 Oct;155(4):609-14 [16990661.001]
  • [Cites] Int J Cardiol. 2006 Oct 10;112(3):341-7 [16309765.001]
  • [Cites] Diabetes. 2006 Oct;55(10):2863-70 [17003354.001]
  • [Cites] J Am Soc Nephrol. 2006 Oct;17(10):2812-20 [16943306.001]
  • [Cites] J Clin Oncol. 2006 Oct 10;24(29):4675-6 [17028292.001]
  • [Cites] J Med Genet. 2006 Oct;43(10):798-803 [16723389.001]
  • [Cites] Nephron Exp Nephrol. 2006;104(3):e83-8 [16837817.001]
  • [Cites] Fertil Steril. 2006 Nov;86(5):1518-21 [16979636.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16260-5 [17053067.001]
  • [Cites] Eur J Immunol. 2006 Nov;36(11):2971-80 [17051618.001]
  • [Cites] J Thromb Haemost. 2006 Dec;4(12):2656-63 [16961585.001]
  • [Cites] J Control Release. 2006 Nov10;116(1):28-34 [17081643.001]
  • [Cites] Am Heart J. 2006 Dec;152(6):1096.e9-15 [17161060.001]
  • [Cites] Development. 2007 Jan;134(1):199-209 [17164425.001]
  • [Cites] Prog Retin Eye Res. 2007 Jan;26(1):1-37 [17074526.001]
  • [Cites] J Neurooncol. 2007 Jan;81(1):81-91 [16858513.001]
  • [Cites] Int J Mol Med. 2007 Feb;19(2):263-72 [17203200.001]
  • [Cites] J Virol. 2007 Feb;81(3):1511-6 [17108038.001]
  • [Cites] Cell Signal. 2007 Mar;19(3):634-45 [17045782.001]
  • [Cites] Epilepsia. 2007 Jan;48(1):175-81 [17241225.001]
  • [Cites] Cell. 2007 Jan 26;128(2):309-23 [17254969.001]
  • [Cites] Cell. 2007 Jan 26;128(2):325-39 [17254970.001]
  • [Cites] Neurobiol Dis. 2007 Feb;25(2):412-26 [17166730.001]
  • [Cites] Diabetes. 2007 Feb;56(2):295-303 [17259372.001]
  • [Cites] Diabetes. 2007 Feb;56(2):389-93 [17259383.001]
  • [Cites] Blood. 2007 Feb 15;109(4):1627-35 [17062728.001]
  • [Cites] Cell Death Differ. 2007 Mar;14(3):534-47 [16888645.001]
  • [Cites] Curr Neurovasc Res. 2007 Feb;4(1):63-71 [17311546.001]
  • [Cites] J Cereb Blood Flow Metab. 2007 Mar;27(3):469-76 [16804549.001]
  • [Cites] J Clin Neurosci. 2007 Apr;14(4):364-8 [17236773.001]
  • [Cites] Br J Cancer. 2007 Mar 12;96(5):692-700 [17299396.001]
  • [Cites] Exp Neurol. 2007 Mar;204(1):106-17 [17157835.001]
  • [Cites] Mol Cell Biol. 2007 Apr;27(7):2676-86 [17242183.001]
  • [Cites] Mediators Inflamm. 2006;2006(5):18061 [17392570.001]
  • [Cites] Br J Pharmacol. 2007 Apr;150(7):839-50 [17339844.001]
  • [Cites] Clin Exp Dermatol. 2007 May;32(3):287-90 [17397351.001]
  • [Cites] J Biol Chem. 2007 Apr 13;282(15):11590-601 [17308309.001]
  • [Cites] Apoptosis. 2007 Aug;12(8):1365-75 [17508273.001]
  • [Cites] FASEB J. 2007 Jul;21(9):2226-36 [17369508.001]
  • [Cites] Eur J Neurosci. 2007 Jul;26(1):90-100 [17614942.001]
  • [Cites] Anal Bioanal Chem. 2007 Aug;388(7):1521-9 [17516052.001]
  • [Cites] Cancer Lett. 2007 Aug 18;253(2):170-9 [17462819.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H274-83 [17337594.001]
  • [Cites] Curr Med Chem. 2007;14(16):1729-38 [17627510.001]
  • [Cites] J Biol Chem. 2007 Jul 20;282(29):21542-50 [17522055.001]
  • [Cites] Semin Hematol. 2007 Jul;44(3):212-7 [17631185.001]
  • [Cites] Mod Pathol. 2007 Aug;20(8):835-42 [17491598.001]
  • [Cites] Antioxid Redox Signal. 2007 Aug;9(8):1059-96 [17571960.001]
  • [Cites] Free Radic Biol Med. 2007 Aug 15;43(4):477-503 [17640558.001]
  • [Cites] J Pharmacol Exp Ther. 2007 Aug;322(2):789-94 [17470644.001]
  • [Cites] Histol Histopathol. 2007 Nov;22(11):1251-67 [17647198.001]
  • [Cites] BMC Genet. 2007;8:43 [17601350.001]
  • [Cites] Arthritis Rheum. 2007 Jul;56(7):2180-91 [17599731.001]
  • [Cites] Curr Neurovasc Res. 2007 Aug;4(3):194-204 [17691973.001]
  • [Cites] JAMA. 2007 Aug 15;298(7):765-75 [17699010.001]
  • [Cites] N Engl J Med. 2007 Aug 16;357(7):673-81 [17699817.001]
  • [Cites] Biomed Pharmacother. 2007 Aug;61(7):390-9 [17178208.001]
  • [Cites] J Biol Chem. 2007 Aug 24;282(34):24574-82 [17604275.001]
  • [Cites] Dev Neurosci. 2007;29(4-5):321-30 [17762200.001]
  • [Cites] J Cell Physiol. 2007 Nov;213(2):434-9 [17520690.001]
  • [Cites] N Engl J Med. 2007 Sep 6;357(10):965-76 [17804841.001]
  • [Cites] Br J Pharmacol. 2007 Sep;152(2):230-9 [17641676.001]
  • [Cites] J Glaucoma. 2007 Sep;16(6):567-71 [17873720.001]
  • [Cites] J Cardiovasc Pharmacol Ther. 2007 Sep;12(3):237-47 [17875952.001]
  • [Cites] Mol Ther. 2007 Oct;15(10):1751-66 [17680029.001]
  • [Cites] Am Heart J. 2007 Oct;154(4):645.e9-15 [17892986.001]
  • [Cites] Curr Med Chem. 2007;14(21):2278-87 [17896976.001]
  • [Cites] Pharmacol Rep. 2007 Jul-Aug;59(4):393-401 [17901567.001]
  • [Cites] Cancer Res. 2007 Oct 1;67(19):9018-23 [17909003.001]
  • [Cites] Antioxid Redox Signal. 2007 Oct;9(10):1659-75 [17867931.001]
  • [Cites] Cancer Sci. 2007 Dec;98(12):1949-58 [17900262.001]
  • [Cites] Neurol Clin. 2007 Nov;25(4):891-924, vii [17964020.001]
  • [Cites] Oncogene. 2007 Nov 1;26(50):7081-91 [17496928.001]
  • [Cites] Genes Dev. 2007 Nov 1;21(21):2775-87 [17974917.001]
  • [Cites] J Clin Invest. 2007 Nov;117(11):3211-23 [17965779.001]
  • [Cites] Virology. 2007 Nov 25;368(2):249-61 [17669459.001]
  • [Cites] Cancer Gene Ther. 2007 Dec;14(12):945-52 [17885675.001]
  • [Cites] Cardiology. 2007;108(4):228-36 [17106196.001]
  • [Cites] J Pharmacol Exp Ther. 2007 Dec;323(3):759-62 [17717190.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1859-67 [17828550.001]
  • [Cites] J Cell Physiol. 2008 Feb;214(2):491-503 [17960565.001]
  • [Cites] Mol Med. 2007 Nov-Dec;13(11-12):561-6 [17873969.001]
  • [Cites] Curr Neurovasc Res. 2007 Nov;4(4):295-302 [18045156.001]
  • [Cites] Nucleic Acids Res. 2007;35(20):6984-94 [17940099.001]
  • [Cites] Brain Res. 2007 Dec 14;1185:321-7 [17961521.001]
  • [Cites] Oncogene. 2007 Dec 6;26(55):7647-55 [17563745.001]
  • [Cites] Biochim Biophys Acta. 2008 Jan;1785(1):63-84 [17980712.001]
  • [Cites] World J Gastroenterol. 2007 Dec 14;13(46):6172-82 [18069756.001]
  • [Cites] J Pharmacol Exp Ther. 2008 Jan;324(1):160-9 [17928571.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20517-22 [18077353.001]
  • [Cites] Proteomics. 2008 Mar;8(6):1237-47 [18338825.001]
  • [Cites] Cytokine Growth Factor Rev. 2008 Apr;19(2):145-55 [18299246.001]
  • [Cites] Endocrinology. 2008 Apr;149(4):1942-50 [18096667.001]
  • [Cites] Cell Stem Cell. 2007 Jun 7;1(1):101-12 [18371339.001]
  • [Cites] Histol Histopathol. 2005 Jan;20(1):299-315 [15578447.001]
  • (PMID = 19802503.001).
  • [ISSN] 1537-744X
  • [Journal-full-title] TheScientificWorldJournal
  • [ISO-abbreviation] ScientificWorldJournal
  • [Language] ENG
  • [Grant] United States / NIEHS NIH HHS / ES / P30 ES06639; United States / NINDS NIH HHS / NS / R01 NS053946-01A2; United States / NINDS NIH HHS / NS / R01 NS053946-03S1; United States / NINDS NIH HHS / NS / R01 NS053946-03; United States / NIEHS NIH HHS / ES / P30 ES006639; United States / NINDS NIH HHS / NS / R01 NS053946-02; United States / NINDS NIH HHS / NS / R01 NS053946
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Forkhead Transcription Factors; 0 / Receptors, Erythropoietin; 11096-26-7 / Erythropoietin
  • [Number-of-references] 409
  • [Other-IDs] NLM/ NIHMS150105; NLM/ PMC2762199
  •  go-up   go-down


25. Ozekes S, Osman O, Ucan ON: Nodule detection in a lung region that's segmented with using genetic cellular neural networks and 3D template matching with fuzzy rule based thresholding. Korean J Radiol; 2008 Jan-Feb;9(1):1-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nodule detection in a lung region that's segmented with using genetic cellular neural networks and 3D template matching with fuzzy rule based thresholding.
  • First, to reduce the number of region of interests (ROIs) and the computation time, the lung regions of the CTs were segmented using Genetic Cellular Neural Networks (G-CNN).
  • RESULTS: The computer aided diagnosis (CAD) system achieved 100% sensitivity with 13.375 FPs per case when the nodule thickness was greater than or equal to 5.625 mm.
  • [MeSH-major] Diagnosis, Computer-Assisted. Lung Neoplasms / radiography. Neural Networks (Computer). Tomography, X-Ray Computed


31. Guck J, Schinkinger S, Lincoln B, Wottawah F, Ebert S, Romeyke M, Lenz D, Erickson HM, Ananthakrishnan R, Mitchell D, Käs J, Ulvick S, Bilby C: Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence. Biophys J; 2005 May;88(5):3689-98
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This cytoskeleton evolves during the normal differentiation of cells, is involved in many cellular functions, and is characteristically altered in many diseases, including cancer.
  • This suggests using optical deformability as an inherent cell marker for basic cell biological investigation and diagnosis of disease.
  • [MeSH-minor] 3T3 Cells. Actins / metabolism. Animals. Biomarkers. Breast Neoplasms / diagnosis. Breast Neoplasms / pathology. Cell Line. Cell Line, Tumor. Cell Shape. Cytoskeleton / metabolism. Disease Progression. Elasticity. Epithelial Cells / metabolism. Fibroblasts / metabolism. Humans. Lasers. Mice. Mice, Inbred BALB C. Microscopy, Confocal. Microscopy, Fluorescence. Neoplasm Metastasis

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Cell Physiol. 1968 Oct;72(2):141-8 [4301006.001]
  • [Cites] Science. 1968 Nov 29;162(3857):1024-6 [4301647.001]
  • [Cites] J Natl Cancer Inst. 1973 Nov;51(5):1409-16 [4357757.001]
  • [Cites] Cancer Res. 1982 Dec;42(12):5183-90 [7139623.001]
  • [Cites] Blood. 1985 Feb;65(2):283-8 [3967083.001]
  • [Cites] Biochim Biophys Acta. 1985;780(3):197-212 [3896312.001]
  • [Cites] Annu Rev Biophys Biophys Chem. 1988;17:397-430 [3293593.001]
  • [Cites] Science. 1989 Jul 14;245(4914):183-6 [2749255.001]
  • [Cites] Cancer Res. 1990 Sep 15;50(18):6087-94 [1697506.001]
  • [Cites] J Biomech Eng. 1990 Aug;112(3):283-94 [2214710.001]
  • [Cites] Science. 1990 Nov 30;250(4985):1266-9 [2173861.001]
  • [Cites] J Cell Biol. 1991 Apr;113(1):155-60 [2007620.001]
  • [Cites] Biorheology. 1991;28(3-4):301-13 [1932719.001]
  • [Cites] Mutat Res. 1991 Mar-Nov;256(2-6):139-48 [1722006.001]
  • [Cites] Science. 1992 Jan 17;255(5042):325-7 [1549777.001]
  • [Cites] Science. 1993 May 21;260(5111):1124-7 [7684161.001]
  • [Cites] Eur J Haematol. 1994 Jan;52(1):35-41 [8299768.001]
  • [Cites] Diagn Cytopathol. 1993 Dec;9(6):632-8 [8143535.001]
  • [Cites] Cell Biochem Funct. 1994 Dec;12(4):267-74 [7834816.001]
  • [Cites] Invasion Metastasis. 1994-1995;14(1-6):246-58 [7657517.001]
  • [Cites] Obstet Gynecol Clin North Am. 1996 Sep;23(3):641-55 [8869950.001]
  • [Cites] Science. 1998 Jan 23;279(5350):514-9 [9438837.001]
  • [Cites] Biorheology. 1997 Jul-Oct;34(4-5):309-26 [9578806.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Feb 2;96(3):921-6 [9927669.001]
  • [Cites] Exp Cell Res. 1999 Feb 25;247(1):105-13 [10047452.001]
  • [Cites] J Cell Sci. 1999 Apr;112 ( Pt 8):1169-79 [10085252.001]
  • [Cites] Eur Biophys J. 1999;28(4):312-6 [10394623.001]
  • [Cites] Phys Rev Lett. 2005 Mar 11;94(9):098103 [15784006.001]
  • [Cites] J Can Dent Assoc. 2002 Nov;68(10):617-21 [12410942.001]
  • [Cites] Biophys J. 1999 Dec;77(6):3085-95 [10585930.001]
  • [Cites] J Biomech. 2000 Jan;33(1):15-22 [10609514.001]
  • [Cites] Biophys J. 2000 Jan;78(1):520-35 [10620315.001]
  • [Cites] Exp Cell Res. 2000 Jan 10;254(1):130-42 [10623473.001]
  • [Cites] Science. 2000 Apr 7;288(5463):113-6 [10753110.001]
  • [Cites] Biophys J. 2000 May;78(5):2270-9 [10777725.001]
  • [Cites] Cancer Res. 2000 May 1;60(9):2504-11 [10811132.001]
  • [Cites] Am J Physiol Cell Physiol. 2000 Jul;279(1):C188-94 [10898730.001]
  • [Cites] Phys Rev Lett. 2000 Jun 5;84(23):5451-4 [10990966.001]
  • [Cites] Phys Rev Lett. 2000 Jul 24;85(4):880-3 [10991422.001]
  • [Cites] J Immunol Methods. 2000 Dec 1;246(1-2):175-85 [11121558.001]
  • [Cites] Biophys J. 2001 Aug;81(2):767-84 [11463624.001]
  • [Cites] Breast Cancer Res Treat. 2001 May;67(2):157-68 [11519864.001]
  • [Cites] Anal Chem. 2002 Jun 1;74(11):2451-7 [12069222.001]
  • [Cites] Cell Mol Life Sci. 2003 Jan;60(1):56-71 [12613658.001]
  • [Cites] Phys Rev Lett. 2003 Sep 5;91(10):108103 [14525511.001]
  • [Cites] Phys Rev Lett. 2003 Oct 10;91(15):158302 [14611506.001]
  • (PMID = 15722433.001).
  • [ISSN] 0006-3495
  • [Journal-full-title] Biophysical journal
  • [ISO-abbreviation] Biophys. J.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Biomarkers; 0 / Biomarkers, Tumor
  • [Other-IDs] NLM/ PMC1305515
  •  go-up   go-down


32. Yang X, Lazar IM: MRM screening/biomarker discovery with linear ion trap MS: a library of human cancer-specific peptides. BMC Cancer; 2009 Mar 27;9:96
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] MRM screening/biomarker discovery with linear ion trap MS: a library of human cancer-specific peptides.
  • BACKGROUND: The discovery of novel protein biomarkers is essential in the clinical setting to enable early disease diagnosis and increase survivability rates.
  • METHODS: MCF-7 breast cancer protein cellular extracts were analyzed by 2D-strong cation exchange (SCX)/reversed phase liquid chromatography (RPLC) separations interfaced to linear ion trap MS detection.
  • RESULTS: In this work, we report on the generation of a library of 9,677 peptides (p < 0.001), representing approximately 1,572 proteins from human breast cancer cells, that can be used for MRM/MS-based biomarker screening studies.
  • The highest-abundance proteins in the cellular extract had a molecular weight (MW)<50,000.

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proteomics. 2004 Apr;4(4):1175-86 [15048997.001]
  • [Cites] Proteomics. 2003 Nov;3(11):2208-20 [14595820.001]
  • [Cites] J Proteome Res. 2004 May-Jun;3(3):644-52 [15253448.001]
  • [Cites] Anal Chem. 2004 Jul 15;76(14):4193-201 [15253663.001]
  • [Cites] J Cell Biol. 1993 Nov;123(3):513-22 [8227122.001]
  • [Cites] Biochem J. 1995 Dec 15;312 ( Pt 3):863-70 [8554532.001]
  • [Cites] Nat Biotechnol. 1999 Oct;17(10):994-9 [10504701.001]
  • [Cites] J Proteome Res. 2004 Nov-Dec;3(6):1234-42 [15595733.001]
  • [Cites] Genome Biol. 2005;6(1):R9 [15642101.001]
  • [Cites] Drug Discov Today. 2005 Mar 1;10(5):353-63 [15749284.001]
  • [Cites] Mol Cell Proteomics. 2005 Apr;4(4):409-18 [15684407.001]
  • [Cites] J Proteome Res. 2005 Mar-Apr;4(2):377-86 [15822913.001]
  • [Cites] J Proteome Res. 2005 May-Jun;4(3):674-89 [15952714.001]
  • [Cites] Nat Rev Mol Cell Biol. 2005 Jul;6(7):577-83 [15957003.001]
  • [Cites] J Proteome Res. 2005 Jul-Aug;4(4):1427-33 [16083296.001]
  • [Cites] Mol Cell Proteomics. 2005 Aug;4(8):1134-44 [15923565.001]
  • [Cites] Proteomics. 2005 Aug;5(13):3537-45 [16041671.001]
  • [Cites] Mol Cell Proteomics. 2005 Sep;4(9):1265-72 [15958392.001]
  • [Cites] Expert Rev Proteomics. 2006 Feb;3(1):63-74 [16445351.001]
  • [Cites] Mol Cell Proteomics. 2006 Apr;5(4):573-88 [16332733.001]
  • [Cites] Electrophoresis. 2006 Apr;27(8):1609-16 [16550497.001]
  • [Cites] Mol Cell Proteomics. 2006 Jun;5(6):1146-57 [16546994.001]
  • [Cites] Curr Drug Metab. 2006 Jun;7(5):525-39 [16787160.001]
  • [Cites] Brief Funct Genomic Proteomic. 2006 Jun;5(2):112-20 [16772272.001]
  • [Cites] J Biotechnol. 2006 Aug 5;124(4):758-87 [16600411.001]
  • [Cites] Anal Chem. 2006 Aug 15;78(16):5762-7 [16906721.001]
  • [Cites] Rapid Commun Mass Spectrom. 2006;20(20):3039-55 [16986208.001]
  • [Cites] Pac Symp Biocomput. 2006;:219-30 [17094241.001]
  • [Cites] Thromb Haemost. 2007 Jan;97(1):67-80 [17200773.001]
  • [Cites] Nat Biotechnol. 2007 Jan;25(1):125-31 [17195840.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5860-5 [17389395.001]
  • [Cites] Assay Drug Dev Technol. 2007 Apr;5(2):247-64 [17477833.001]
  • [Cites] BMC Bioinformatics. 2007;8 Suppl 7:S23 [18047723.001]
  • [Cites] J Proteome Res. 2008 Apr;7(4):1529-41 [18311902.001]
  • [Cites] Rapid Commun Mass Spectrom. 2008 May;22(9):1359-66 [18381620.001]
  • [Cites] Brief Funct Genomic Proteomic. 2008 Sep;7(5):340-54 [18579614.001]
  • [Cites] Proteomics. 2001 Oct;1(10):1216-32 [11721634.001]
  • [Cites] Mol Cell Proteomics. 2002 May;1(5):376-86 [12118079.001]
  • [Cites] Genome Res. 2002 Aug;12(8):1231-45 [12176931.001]
  • [Cites] Trends Biotechnol. 2002 Dec;20(12 Suppl):S23-9 [12570156.001]
  • [Cites] J Proteome Res. 2003 Jan-Feb;2(1):43-50 [12643542.001]
  • [Cites] J Proteome Res. 2002 Sep-Oct;1(5):459-65 [12645918.001]
  • [Cites] Mass Spectrom Rev. 2003 May-Jun;22(3):182-94 [12838544.001]
  • [Cites] J Proteome Res. 2004 May-Jun;3(3):350-63 [15253416.001]
  • (PMID = 19327145.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA126669-01A1; United States / NCI NIH HHS / CA / R21 CA126669; United States / NCI NIH HHS / CA / R21 CA126669-01A1; United States / NCI NIH HHS / CA / R21CA126669
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Peptides
  • [Other-IDs] NLM/ PMC2670839
  •  go-up   go-down


33. Fang X, Tan W: Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. Acc Chem Res; 2010 Jan 19;43(1):48-57
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Molecular medicine is an emerging field focused on understanding the molecular basis of diseases and translating this information into strategies for diagnosis and therapy.
  • Currently, our ability to understand human diseases at the molecular level is limited by the lack of molecular tools to identify and characterize the distinct molecular features of the disease state, especially for diseases such as cancer.
  • In this Account, we will focus on the use of aptamers, generated from cell-based selections, as a novel molecular tool for cancer research.
  • However, this method does not always give an accurate diagnosis and does not allow clinicians to effectively assess the complex molecular alterations that are predictive of cancer progression.
  • One special feature of aptamers is that we can isolate them by selection against cancer cells without prior knowledge of the number and arrangement of proteins on the cellular surface.
  • This Account summarizes our recent efforts to develop aptamers through cell-SELEX for the study of cancer and apply those aptamers in cancer diagnosis and therapy.
  • We first discuss how we select aptamers against live cancer cells.
  • Aptamers can serve as agents for molecular profiling of specific cancer types.
  • They can also be used to modify therapeutic reagents to develop targeted cancer therapies.
  • Aptamers are also aiding the discovery of new cancer biomarkers through the recognition of membrane protein targets.
  • Importantly, we demonstrate how molecular assemblies can integrate the properties of aptamers and, for example, nanoparticles or microfluidic devices, to improve cancer cell enrichment, detection and therapy.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Anal Chem. 2007 Apr 15;79(8):3075-82 [17348633.001]
  • [Cites] Mol Cancer Ther. 2006 Dec;5(12):2957-62 [17172400.001]
  • [Cites] Anal Chem. 2007 Jul 1;79(13):4900-7 [17530817.001]
  • [Cites] Chem Rev. 2007 Sep;107(9):3715-43 [17715981.001]
  • [Cites] Mol Pharm. 2007 Sep-Oct;4(5):631-51 [17880166.001]
  • [Cites] Mol Cell Proteomics. 2007 Dec;6(12):2230-8 [17875608.001]
  • [Cites] Chembiochem. 2007 Dec 17;8(18):2223-6 [17990265.001]
  • [Cites] Nature. 2007 Dec 20;450(7173):1235-9 [18097410.001]
  • [Cites] Acc Chem Res. 2008 Jan;41(1):130-8 [18193823.001]
  • [Cites] Anal Chem. 2008 Feb 1;80(3):567-72 [18166023.001]
  • [Cites] Anal Chem. 2008 Feb 1;80(3):721-8 [18177018.001]
  • [Cites] Chemistry. 2008;14(6):1769-75 [18092308.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2586-91 [18272481.001]
  • [Cites] ChemMedChem. 2008 Mar;3(3):425-8 [18058891.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5664-9 [18398007.001]
  • [Cites] J Proteome Res. 2008 May;7(5):2133-9 [18363322.001]
  • [Cites] ChemMedChem. 2008 Jun;3(6):991-1001 [18338423.001]
  • [Cites] Angew Chem Int Ed Engl. 2008;47(28):5190-3 [18512861.001]
  • [Cites] J Am Chem Soc. 2008 Jul 16;130(28):9137-43 [18558676.001]
  • [Cites] Langmuir. 2008 Oct 21;24(20):11860-5 [18817428.001]
  • [Cites] Anal Chem. 2009 Feb 1;81(3):1033-9 [19115856.001]
  • [Cites] Leukemia. 2009 Feb;23(2):235-44 [19151784.001]
  • [Cites] Chembiochem. 2009 Mar 23;10(5):862-8 [19253922.001]
  • [Cites] Anal Chem. 2008 Feb 15;80(4):1067-72 [18198894.001]
  • [Cites] Int J Cancer. 2000 Jul 20;89(4):337-44 [10956407.001]
  • [Cites] J Biol Chem. 2001 May 11;276(19):16464-8 [11279054.001]
  • [Cites] Trends Mol Med. 2002 Jun;8(6):288-93 [12067615.001]
  • [Cites] Cancer Res. 2002 Jul 15;62(14):4029-33 [12124337.001]
  • [Cites] Nucleic Acids Res. 2002 Sep 15;30(18):4001-8 [12235384.001]
  • [Cites] Nat Biotechnol. 2003 Mar;21(3):262-7 [12610573.001]
  • [Cites] Anal Chem. 2003 May 1;75(9):2112-6 [12720349.001]
  • [Cites] Nat Rev Cancer. 2003 May;3(5):380-7 [12724736.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15416-21 [14676325.001]
  • [Cites] Clin Cancer Res. 2004 Feb 15;10(4):1241-9 [14977821.001]
  • [Cites] Proc Natl Acad Sci U S A. 1986 Nov;83(22):8744-8 [2877461.001]
  • [Cites] Science. 1990 Aug 3;249(4968):505-10 [2200121.001]
  • [Cites] Nature. 1990 Aug 30;346(6287):818-22 [1697402.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5855-9 [7597041.001]
  • [Cites] Curr Opin Chem Biol. 1997 Jun;1(1):5-9 [9667829.001]
  • [Cites] Cancer Res. 2004 Nov 1;64(21):7668-72 [15520166.001]
  • [Cites] PLoS Biol. 2005 Apr;3(4):e123 [15769183.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6315-20 [16606824.001]
  • [Cites] Anal Chem. 2006 May 1;78(9):2918-24 [16642976.001]
  • [Cites] Nucleic Acids Res. 2006;34(10):e73 [16740739.001]
  • [Cites] Curr Opin Chem Biol. 2006 Jun;10(3):272-81 [16678470.001]
  • [Cites] Cancer Res. 2006 Jun 15;66(12):5989-92 [16778167.001]
  • [Cites] Cell Immunol. 2006 Feb;239(2):92-102 [16797504.001]
  • [Cites] Nat Rev Microbiol. 2006 Aug;4(8):588-96 [16845429.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):11838-43 [16873550.001]
  • [Cites] Stem Cells. 2006 Oct;24(10):2220-31 [16794266.001]
  • [Cites] Clin Chem. 2007 Jun;53(6):1153-5 [17463173.001]
  • (PMID = 19751057.001).
  • [ISSN] 1520-4898
  • [Journal-full-title] Accounts of chemical research
  • [ISO-abbreviation] Acc. Chem. Res.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / R01 GM079359; United States / NIGMS NIH HHS / GM / R01 GM066137-03; United States / NIGMS NIH HHS / GM / R01 GM066137-04S1; United States / NIGMS NIH HHS / GM / R01 GM066137-06; United States / NIGMS NIH HHS / GM / R01 GM066137; United States / NIGMS NIH HHS / GM / R01 GM079359-01; None / None / / R01 GM079359-01; United States / NIGMS NIH HHS / GM / R01 GM079359-02; United States / NIGMS NIH HHS / GM / R01 GM066137-05A1; United States / NIGMS NIH HHS / GM / R01 GM079359-03; None / None / / R01 GM079359-02; None / None / / R01 GM079359-01S1; United States / NIGMS NIH HHS / GM / R01 GM066137-07; United States / NIGMS NIH HHS / GM / R01 GM066137-02; United States / NIGMS NIH HHS / GM / R01 GM066137-04; United States / NIGMS NIH HHS / GM / R01 GM066137-01; United States / NIGMS NIH HHS / GM / R01 GM079359-01S1
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Aptamers, Nucleotide
  • [Other-IDs] NLM/ NIHMS146250; NLM/ PMC2808443
  •  go-up   go-down


34. Sun C, Lee JS, Zhang M: Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev; 2008 Aug 17;60(11):1252-65
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Magnetic nanoparticles (MNPs) possess unique magnetic properties and the ability to function at the cellular and molecular level of biological interactions making them an attractive platform as contrast agents for magnetic resonance imaging (MRI) and as carriers for drug delivery.
  • To better address specific clinical needs, MNPs with higher magnetic moments, non-fouling surfaces, and increased functionalities are now being developed for applications in the detection, diagnosis, and treatment of malignant tumors, cardiovascular disease, and neurological disease.

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Bioconjug Chem. 1999 Mar-Apr;10(2):186-91 [10077466.001]
  • [Cites] Nat Biotechnol. 1999 Apr;17(4):375-8 [10207887.001]
  • [Cites] Pharm Res. 1999 Apr;16(4):494-502 [10227702.001]
  • [Cites] Cancer Res. 2004 Nov 1;64(21):7668-72 [15520166.001]
  • [Cites] NMR Biomed. 2004 Nov;17(7):484-99 [15526347.001]
  • [Cites] Gene Ther. 2005 Jan;12(1):5-11 [15496962.001]
  • [Cites] Biomaterials. 2005 Jun;26(18):3995-4021 [15626447.001]
  • [Cites] Nat Rev Drug Discov. 2005 Feb;4(2):145-60 [15688077.001]
  • [Cites] Biomacromolecules. 2006 Nov;7(11):3132-8 [17096542.001]
  • [Cites] Cell. 2006 Nov 17;127(4):679-95 [17110329.001]
  • [Cites] Clin Cancer Res. 2006 Nov 15;12(22):6677-86 [17121886.001]
  • [Cites] Nat Mater. 2006 Dec;5(12):971-6 [17115025.001]
  • [Cites] Adv Drug Deliv Rev. 2006 Dec 1;58(14):1532-55 [17092599.001]
  • [Cites] Adv Drug Deliv Rev. 2006 Dec 1;58(14):1556-77 [17107738.001]
  • [Cites] Adv Drug Deliv Rev. 2006 Dec 1;58(14):1471-504 [17116343.001]
  • [Cites] Angew Chem Int Ed Engl. 2006 Dec 11;45(48):8160-2 [17103471.001]
  • [Cites] J Am Chem Soc. 2006 Jun 7;128(22):7383-9 [16734494.001]
  • [Cites] J Microencapsul. 2006 Mar;23(2):203-12 [16754376.001]
  • [Cites] Neoplasia. 2006 Apr;8(4):302-11 [16756722.001]
  • [Cites] Mol Imaging Biol. 2006 Jul-Aug;8(4):201-7 [16791746.001]
  • [Cites] Biomaterials. 2006 Oct;27(30):5307-14 [16797691.001]
  • [Cites] Occup Med (Lond). 2006 Aug;56(5):307-11 [16868128.001]
  • [Cites] Langmuir. 2006 Dec 19;22(26):10989-93 [17154575.001]
  • [Cites] J Am Chem Soc. 2006 Dec 20;128(50):15982-3 [17165720.001]
  • [Cites] Small. 2005 May;1(5):482-501 [17193474.001]
  • [Cites] Small. 2006 Jun;2(6):785-92 [17193123.001]
  • [Cites] Nat Med. 2007 Jan;13(1):95-9 [17187073.001]
  • [Cites] Langmuir. 2007 Jan 30;23(3):1427-34 [17241069.001]
  • [Cites] J Am Chem Soc. 2007 Feb 7;129(5):1428-33 [17263428.001]
  • [Cites] Acta Biomater. 2007 Mar;3(2):233-42 [17224313.001]
  • [Cites] Curr Opin Biotechnol. 2007 Feb;18(1):4-10 [17126545.001]
  • [Cites] Cancer Res. 2007 Feb 15;67(4):1555-62 [17308094.001]
  • [Cites] Nat Med. 2007 Mar;13(3):372-7 [17322898.001]
  • [Cites] Angew Chem Int Ed Engl. 2007;46(8):1222-44 [17278160.001]
  • [Cites] Langmuir. 2007 Mar 27;23(7):4026-8 [17335257.001]
  • [Cites] J Magn Reson Imaging. 2007 Apr;25(4):667-80 [17347992.001]
  • [Cites] N Engl J Med. 2003 Jun 19;348(25):2491-9 [12815134.001]
  • [Cites] Mol Imaging. 2002 Apr-Jun;1(2):102-7 [12920851.001]
  • [Cites] Bioconjug Chem. 2003 Nov-Dec;14(6):1115-21 [14624624.001]
  • [Cites] Cancer Res. 2003 Dec 1;63(23):8122-5 [14678964.001]
  • [Cites] Cytometry A. 2004 Feb;57(2):86-93 [14750129.001]
  • [Cites] J Am Chem Soc. 2004 Jun 16;126(23):7206-11 [15186157.001]
  • [Cites] Microbes Infect. 2004 Jul;6(8):786-9 [15207826.001]
  • [Cites] Stroke. 2004 Jul;35(7):1631-5 [15166394.001]
  • [Cites] Med Res Rev. 2004 Sep;24(5):621-38 [15224383.001]
  • [Cites] Cancer Lett. 2004 Aug 30;212(2):167-75 [15279897.001]
  • [Cites] Biomed Microdevices. 2004 Mar;6(1):33-40 [15307442.001]
  • [Cites] Bioconjug Chem. 2004 Sep-Oct;15(5):1062-7 [15366960.001]
  • [Cites] Invest Radiol. 2004 Oct;39(10):619-25 [15377941.001]
  • [Cites] Neuropathol Appl Neurobiol. 2004 Oct;30(5):456-71 [15488022.001]
  • [Cites] N Engl J Med. 1971 Nov 18;285(21):1182-6 [4938153.001]
  • [Cites] Gene Ther. 2002 Jan;9(2):102-9 [11857068.001]
  • [Cites] Bioconjug Chem. 2002 Mar-Apr;13(2):264-8 [11906263.001]
  • [Cites] Biomaterials. 2002 Apr;23(7):1553-61 [11922461.001]
  • [Cites] AJNR Am J Neuroradiol. 2002 Apr;23(4):510-9 [11950637.001]
  • [Cites] Circulation. 2007 Apr 17;115(15):2076-86 [17438163.001]
  • [Cites] Acta Biomater. 2007 Jul;3(4):413-38 [17540628.001]
  • [Cites] Langmuir. 2007 Jul 17;23(15):8194-9 [17590032.001]
  • [Cites] Cancer Res. 2007 Jul 15;67(14):6882-8 [17638899.001]
  • [Cites] Cancer Res. 1989 Apr 1;49(7):1621-39 [2466558.001]
  • [Cites] Magn Reson Med. 1989 Nov;12(2):151-63 [2615625.001]
  • [Cites] Science. 1991 May 24;252(5009):1164-7 [2031186.001]
  • [Cites] Radiology. 1991 Sep;180(3):593-612 [1871268.001]
  • [Cites] Radiology. 1991 Oct;181(1):245-9 [1887040.001]
  • [Cites] Magn Reson Q. 1992 Mar;8(1):55-63 [1567758.001]
  • [Cites] Magn Reson Med. 1992 May;25(1):148-57 [1375703.001]
  • [Cites] Cancer Res. 1992 Jun 15;52(12):3396-401 [1596899.001]
  • [Cites] Magn Reson Med. 1993 May;29(5):599-604 [8505895.001]
  • [Cites] Bioconjug Chem. 1993 Sep-Oct;4(5):347-52 [8274518.001]
  • [Cites] Science. 1994 Mar 18;263(5153):1600-3 [8128245.001]
  • [Cites] Cancer. 1994 May 1;73(9):2432-43 [7513252.001]
  • [Cites] J Drug Target. 1994;2(2):157-65 [8069594.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7297-301 [7638184.001]
  • [Cites] Cancer Res. 1996 Oct 15;56(20):4686-93 [8840985.001]
  • [Cites] J Microencapsul. 1996 May-Jun;13(3):245-55 [8860681.001]
  • [Cites] Cancer Res. 1997 Jul 15;57(14):3063-5 [9230223.001]
  • [Cites] Magn Reson Med. 1998 Aug;40(2):236-42 [9702705.001]
  • [Cites] Biomed Pharmacother. 1998;52(2):51-8 [9755795.001]
  • [Cites] J Drug Target. 1998;6(3):167-74 [9888302.001]
  • [Cites] J Magn Reson Imaging. 1999 Feb;9(2):228-32 [10077018.001]
  • [Cites] Am J Physiol Cell Physiol. 2007 Aug;293(2):C597-605 [17428838.001]
  • [Cites] Nanomedicine (Lond). 2007 Feb;2(1):23-39 [17716188.001]
  • [Cites] Adv Drug Deliv Rev. 2007 Aug 10;59(8):748-58 [17659804.001]
  • [Cites] J Biol Inorg Chem. 2007 Sep;12(7):939-49 [17659368.001]
  • [Cites] Cancer Res. 2007 Sep 1;67(17):8156-63 [17804728.001]
  • [Cites] Nat Rev Cancer. 2007 Oct;7(10):737-49 [17891189.001]
  • [Cites] Nat Biotechnol. 2007 Oct;25(10):1165-70 [17891134.001]
  • [Cites] Chembiochem. 2007 Sep 24;8(14):1675-8 [17696177.001]
  • [Cites] Blood. 1973 Apr;41(4):529-37 [4688868.001]
  • [Cites] J Immunol Methods. 1982 Aug 13;52(3):353-67 [7130710.001]
  • [Cites] Cancer Res. 1987 Jun 15;47(12):3039-51 [3555767.001]
  • [Cites] Radiology. 1988 Aug;168(2):297-301 [3393649.001]
  • [Cites] AJR Am J Roentgenol. 1989 Jan;152(1):167-73 [2783272.001]
  • [Cites] Magn Reson Imaging. 1988 Nov-Dec;6(6):647-53 [2850434.001]
  • [Cites] Langmuir. 2005 Sep 13;21(19):8858-64 [16142971.001]
  • [Cites] Nat Mater. 2005 Oct;4(10):725-6 [16195762.001]
  • [Cites] Nat Biotechnol. 2005 Nov;23(11):1418-23 [16244656.001]
  • [Cites] AJR Am J Roentgenol. 2005 Dec;185(6):1477-86 [16304001.001]
  • [Cites] Gene Ther. 2006 Feb;13(4):283-7 [16462855.001]
  • [Cites] Neoplasia. 2006 Mar;8(3):214-22 [16611415.001]
  • [Cites] Anal Chem. 2006 May 1;78(9):2918-24 [16642976.001]
  • [Cites] Eur Biophys J. 2006 May;35(5):446-50 [16447039.001]
  • [Cites] Science. 2006 May 26;312(5777):1168-71 [16728630.001]
  • [Cites] J Control Release. 2000 Mar 1;65(1-2):271-84 [10699287.001]
  • [Cites] Nat Biotechnol. 2000 Apr;18(4):410-4 [10748521.001]
  • [Cites] Clin Exp Metastasis. 1999;17(7):555-66 [10845554.001]
  • [Cites] Cancer Res. 2000 Sep 1;60(17):4953-8 [10987312.001]
  • [Cites] Cancer Res. 2000 Dec 1;60(23):6641-8 [11118047.001]
  • [Cites] Radiology. 2001 Jan;218(1):27-38 [11152776.001]
  • [Cites] J Surg Res. 2001 Feb;95(2):200-6 [11162046.001]
  • [Cites] Radiology. 2001 May;219(2):316-33 [11323453.001]
  • [Cites] Pharmacol Rev. 2001 Jun;53(2):283-318 [11356986.001]
  • [Cites] Nature. 2001 May 24;411(6836):494-8 [11373684.001]
  • [Cites] Adv Enzyme Regul. 2001;41:189-207 [11384745.001]
  • [Cites] Eur Radiol. 2001;11(11):2319-31 [11702180.001]
  • [Cites] Adv Drug Deliv Rev. 2005 Feb 28;57(4):579-96 [15722165.001]
  • [Cites] Nat Rev Cancer. 2005 Mar;5(3):161-71 [15738981.001]
  • [Cites] J Am Chem Soc. 2005 Apr 27;127(16):5732-3 [15839639.001]
  • [Cites] Nat Rev Cancer. 2005 Jun;5(6):436-46 [15928674.001]
  • [Cites] Mol Pharm. 2005 May-Jun;2(3):194-205 [15934780.001]
  • [Cites] Nano Lett. 2005 Jun;5(6):1003-8 [15943433.001]
  • [Cites] PLoS Med. 2004 Dec;1(3):e66 [15630471.001]
  • [Cites] J Am Chem Soc. 2005 Aug 3;127(30):10676-85 [16045355.001]
  • [Cites] J Leukoc Biol. 2005 Sep;78(3):585-94 [15923216.001]
  • [Cites] J Am Chem Soc. 2005 Sep 7;127(35):12387-91 [16131220.001]
  • [Cites] Bioconjug Chem. 2002 May-Jun;13(3):554-60 [12009946.001]
  • [Cites] Glia. 2002 Aug;39(2):162-73 [12112367.001]
  • [Cites] Adv Drug Deliv Rev. 2002 Sep 13;54(5):631-51 [12204596.001]
  • [Cites] Pharm Res. 2002 Sep;19(9):1310-6 [12403067.001]
  • [Cites] Nat Med. 2003 Jan;9(1):123-8 [12514725.001]
  • [Cites] J Biol Chem. 2003 Feb 7;278(6):4135-44 [12454020.001]
  • [Cites] Magn Reson Med. 2003 Mar;49(3):403-8 [12594741.001]
  • [Cites] Nat Rev Cancer. 2002 Feb;2(2):83-90 [12635171.001]
  • [Cites] Mol Ther. 2003 May;7(5 Pt 1):700-10 [12718913.001]
  • [Cites] Circulation. 2003 May 20;107(19):2453-8 [12719280.001]
  • [Cites] Cancer Res. 2003 Jun 1;63(11):2723-7 [12782573.001]
  • [Cites] Nat Med. 2006 Aug;12(8):895-904 [16892035.001]
  • [Cites] Chemistry. 2006 Aug 16;12(24):6341-7 [16741906.001]
  • [Cites] J Biomed Mater Res A. 2006 Sep 1;78(3):550-7 [16736484.001]
  • [Cites] Mol Imaging. 2006 Apr-Jun;5(2):122-8 [16954026.001]
  • [Cites] Circulation. 2006 Oct 3;114(14):1504-11 [17000904.001]
  • [Cites] Nano Lett. 2006 Nov;6(11):2427-30 [17090068.001]
  • [Cites] Small. 2008 Mar;4(3):372-9 [18232053.001]
  • [Cites] Langmuir. 2006 Jun 6;22(12):5385-91 [16732667.001]
  • (PMID = 18558452.001).
  • [ISSN] 0169-409X
  • [Journal-full-title] Advanced drug delivery reviews
  • [ISO-abbreviation] Adv. Drug Deliv. Rev.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA119408-04; United States / NCI NIH HHS / CA / R01CA119408; United States / NCI NIH HHS / CA / R01 CA134213-02; United States / NIBIB NIH HHS / EB / R01EB006043; United States / NCI NIH HHS / CA / R01CA134213; United States / NIBIB NIH HHS / EB / R01 EB006043-02; United States / NIBIB NIH HHS / EB / R01 EB006043; United States / NCI NIH HHS / CA / R01 CA119408; United States / NCI NIH HHS / CA / R01 CA134213
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 202
  • [Other-IDs] NLM/ NIHMS62167; NLM/ PMC2702670
  •  go-up   go-down


35. Roosterman D, Kempkes C, Cottrell GS, Padilla BE, Bunnett NW, Turck CW, Steinhoff M: Endothelin-converting enzyme-1 degrades internalized somatostatin-14. Endocrinology; 2008 May;149(5):2200-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Agonist-induced internalization of somatostatin receptors (ssts) determines subsequent cellular responsiveness to peptide agonists and influences sst receptor scintigraphy.
  • Moreover, further investigation of endopeptidase-regulated trafficking of neuropeptides may result in novel concepts of neuropeptide receptor inactivation in cancer diagnosis.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Physiol Cell Physiol. 2003 May;284(5):C1319-29 [12540381.001]
  • [Cites] J Biol Chem. 2002 Jan 4;277(1):679-85 [11682489.001]
  • [Cites] J Biol Chem. 2004 May 14;279(20):21374-82 [15001578.001]
  • [Cites] J Neurochem. 2004 Jun;89(5):1057-91 [15147500.001]
  • [Cites] J Biol Chem. 2004 Jul 16;279(29):30670-9 [15128739.001]
  • [Cites] J Clin Endocrinol Metab. 1985 Jun;60(6):1161-5 [2860119.001]
  • [Cites] N Engl J Med. 1990 Nov 1;323(18):1246-9 [2170840.001]
  • [Cites] J Biol Chem. 1991 Oct 5;266(28):18907-13 [1680864.001]
  • [Cites] FEBS Lett. 1992 Oct 26;311(3):290-4 [1397330.001]
  • [Cites] J Neurochem. 1994 Jan;62(1):27-36 [7903352.001]
  • [Cites] J Biol Chem. 1994 Jul 15;269(28):18275-8 [8034569.001]
  • [Cites] FEBS Lett. 1995 Sep 4;371(2):140-4 [7672114.001]
  • [Cites] Endocrinology. 1997 Jan;138(1):296-306 [8977417.001]
  • [Cites] J Neuroendocrinol. 1997 Oct;9(10):741-51 [9355043.001]
  • [Cites] Biochem J. 1997 Dec 15;328 ( Pt 3):871-7 [9396733.001]
  • [Cites] Biochem J. 1998 Dec 1;336 ( Pt 2):291-8 [9820803.001]
  • [Cites] J Biol Chem. 1999 Jun 25;274(26):18524-35 [10373461.001]
  • [Cites] Protein Pept Lett. 2004 Oct;11(5):461-9 [15544567.001]
  • [Cites] FEBS Lett. 2005 Aug 15;579(20):4309-16 [16051222.001]
  • [Cites] Physiol Rev. 2006 Oct;86(4):1309-79 [17015491.001]
  • [Cites] FASEB J. 2006 Nov;20(13):2261-70 [17077303.001]
  • [Cites] Endocrinology. 2007 Mar;148(3):1050-8 [17170097.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11838-43 [17592116.001]
  • [Cites] Br J Pharmacol. 2007 Sep;152(1):132-40 [17603546.001]
  • [Cites] Curr Opin Allergy Clin Immunol. 2007 Oct;7(5):365-73 [17873574.001]
  • [Cites] J Cell Biol. 2007 Dec 3;179(5):981-97 [18039931.001]
  • [Cites] J Biol Chem. 1999 Nov 5;274(45):32248-57 [10542263.001]
  • [Cites] J Biol Chem. 2000 Jun 2;275(22):17201-10 [10748214.001]
  • [Cites] Anal Biochem. 2000 Nov 1;286(1):112-8 [11038281.001]
  • [Cites] J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S22-5 [11078325.001]
  • [Cites] Bioessays. 2001 Mar;23(3):261-9 [11223883.001]
  • [Cites] J Biol Chem. 2001 Jun 1;276(22):19452-60 [11279203.001]
  • [Cites] J Biol Chem. 2001 Jul 6;276(27):25427-37 [11306580.001]
  • [Cites] J Biol Chem. 2004 Mar 26;279(13):13110-8 [14711821.001]
  • (PMID = 18276747.001).
  • [ISSN] 0013-7227
  • [Journal-full-title] Endocrinology
  • [ISO-abbreviation] Endocrinology
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / R01 DK043207; United States / NIDDK NIH HHS / DK / R01 DK039957; United States / NIDDK NIH HHS / DK / R37 DK039957; United States / NIDDK NIH HHS / DK / DK39957; United States / NIDDK NIH HHS / DK / R56 DK043207; United States / NIDDK NIH HHS / DK / DK43207
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Arrestins; 0 / Iodine Radioisotopes; 0 / Receptors, Somatostatin; 0 / beta-arrestin; 0 / somatostatin receptor sst2A; 51110-01-1 / Somatostatin; EC 3.4.- / Endopeptidases; EC 3.4.23.- / Aspartic Acid Endopeptidases; EC 3.4.24.- / Metalloendopeptidases; EC 3.4.24.71 / endothelin-converting enzyme; RWM8CCW8GP / Octreotide
  • [Other-IDs] NLM/ PMC2329273
  •  go-up   go-down


36. Cuschieri K, Wentzensen N: Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiol Biomarkers Prev; 2008 Oct;17(10):2536-45
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia.
  • Human papillomavirus (HPV) infection of the genital tract is very common and normally follows a benign clinical course; however, in an unfortunate minority of infected individuals, it can cause disease that sometimes leads to cancer.
  • HPV oncogene expression and evidence of its deregulation can be monitored through direct detection of viral mRNA transcripts or through detection of the cellular protein p16.
  • Currently, there is promising data indicating that HPV mRNA and p16 might play an important role in future cervical cancer screening scenarios.
  • METHODS: PubMed and OVID were interrogated with search terms "HPV RNA;" "HPV mRNA;" "HPV transcript-detection, testing, and methods;" "p16" AND "cervical cancer;" "p16" AND "CIN;" "p16" AND "histology"; "p16" AND "cytology;" "p16;" and "screening. "
  • [MeSH-major] Biomarkers, Tumor / analysis. Neoplasm Proteins / genetics. Papillomaviridae / isolation & purification. Papillomavirus Infections / diagnosis. RNA, Messenger / analysis. Uterine Cervical Neoplasms / diagnosis
  • [MeSH-minor] Female. Humans. Mass Screening / methods. Precancerous Conditions / diagnosis. Precancerous Conditions / genetics. Precancerous Conditions / virology

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • International Agency for Research on Cancer - Screening Group. diagnostics - A practical manual on visual screening for cervical neoplasia .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 2006 Nov 1;107(9):2307-13 [17029280.001]
  • [Cites] Int J Cancer. 2007 Jan 15;120(2):351-6 [17066437.001]
  • [Cites] Cancer. 2006 Dec 25;108(6):494-500 [17063495.001]
  • [Cites] Cancer. 2007 Feb 25;111(1):58-66 [17186505.001]
  • [Cites] Cancer. 2007 Feb 25;111(1):1-14 [17219448.001]
  • [Cites] Int J Cancer. 2007 Jun 1;120(11):2435-8 [17294450.001]
  • [Cites] J Low Genit Tract Dis. 2007 Apr;11(2):98-104 [17415114.001]
  • [Cites] Cancer. 2007 Apr 25;111(2):83-92 [17334990.001]
  • [Cites] Br J Cancer. 2007 May 7;96(9):1419-24 [17342094.001]
  • [Cites] Clin Cancer Res. 2007 May 1;13(9):2599-605 [17473189.001]
  • [Cites] Int J Gynecol Pathol. 2007 Jul;26(3):223-8 [17581402.001]
  • [Cites] Dis Markers. 2007;23(4):213-27 [17627057.001]
  • [Cites] J Med Virol. 2000 Oct;62(2):251-8 [11002256.001]
  • [Cites] Int J Cancer. 2001 Apr 15;92(2):276-84 [11291057.001]
  • [Cites] Mol Diagn. 2001 Jun;6(2):125-30 [11468697.001]
  • [Cites] Oncogene. 2001 Nov 26;20(54):7874-87 [11753670.001]
  • [Cites] Oncogene. 2001 Nov 26;20(54):7888-98 [11753671.001]
  • [Cites] Acta Cytol. 2002 Jan-Feb;46(1):25-9 [11843554.001]
  • [Cites] Ophthalmology. 2002 Mar;109(3):542-7 [11874759.001]
  • [Cites] J Mol Diagn. 2002 May;4(2):97-102 [11986400.001]
  • [Cites] Cancer. 2002 Apr 15;94(8):2199-210 [12001118.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1948-52 [16103442.001]
  • [Cites] Gynecol Oncol. 2005 Apr;97(1):35-40 [15790434.001]
  • [Cites] Gynecol Oncol. 2005 Dec;99(3):578-84 [16139346.001]
  • [Cites] Cancer. 2005 Dec 25;105(6):461-7 [16116604.001]
  • [Cites] Int J Cancer. 2006 Mar 1;118(5):1254-60 [16161049.001]
  • [Cites] Dis Markers. 2007;23(4):273-81 [17627062.001]
  • [Cites] Dis Markers. 2007;23(4):315-30 [17627065.001]
  • [Cites] Int J Cancer. 2004 Mar 1;108(6):871-6 [14712490.001]
  • [Cites] Lancet. 2007 Sep 8;370(9590):890-907 [17826171.001]
  • [Cites] N Engl J Med. 2007 Oct 18;357(16):1579-88 [17942871.001]
  • [Cites] Int J Cancer. 2007 Dec 15;121(12):2787-93 [17722112.001]
  • [Cites] Lancet. 2007 Nov 24;370(9601):1764-72 [17919718.001]
  • [Cites] J Clin Pathol. 2008 Jan;61(1):132-7 [17468293.001]
  • [Cites] J Natl Compr Canc Netw. 2008 Jan;6(1):83-95 [18267061.001]
  • [Cites] Am J Surg Pathol. 2008 Apr;32(4):502-12 [18223479.001]
  • [Cites] Am J Surg Pathol. 2002 Nov;26(11):1389-99 [12409715.001]
  • [Cites] Diagn Cytopathol. 2002 Dec;27(6):365-70 [12451568.001]
  • [Cites] J Clin Pathol. 2003 Jan;56(1):56-63 [12499437.001]
  • [Cites] Am J Surg Pathol. 2003 Feb;27(2):187-93 [12548164.001]
  • [Cites] Anal Quant Cytol Histol. 2003 Feb;25(1):8-11 [12630076.001]
  • [Cites] Cancer. 2003 Apr 25;99(2):89-96 [12704688.001]
  • [Cites] Mod Pathol. 2003 Jul;16(7):665-73 [12861062.001]
  • [Cites] EMBO J. 2003 Aug 15;22(16):4212-22 [12912919.001]
  • [Cites] Acta Cytol. 2003 Jul-Aug;47(4):616-23 [12920756.001]
  • [Cites] Gynecol Oncol. 2003 Oct;91(1):201-8 [14529682.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):492-6 [15006929.001]
  • [Cites] J Med Virol. 2004 May;73(1):65-70 [15042650.001]
  • [Cites] Acta Cytol. 2004 Mar-Apr;48(2):173-80 [15098536.001]
  • [Cites] Cancer. 2004 Apr 25;102(2):100-8 [15098254.001]
  • [Cites] Cancer. 2004 Jun 25;102(3):142-9 [15211472.001]
  • [Cites] J Clin Microbiol. 2004 Jul;42(7):3176-84 [15243079.001]
  • [Cites] J Med Virol. 2004 Sep;74(1):107-16 [15258976.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1355-60 [15298958.001]
  • [Cites] Diagn Cytopathol. 2004 Oct;31(4):235-42 [15452898.001]
  • [Cites] Hum Pathol. 1992 Feb;23(2):117-28 [1310950.001]
  • [Cites] J Virol Methods. 1991 Dec;35(3):305-13 [1667790.001]
  • [Cites] Int J Cancer. 1992 Jul 9;51(5):831-4 [1319412.001]
  • [Cites] Gynecol Oncol. 1995 Feb;56(2):239-44 [7896192.001]
  • [Cites] J Virol Methods. 1995 Jul;54(1):75-81 [7559859.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4350-4 [8633069.001]
  • [Cites] Am J Pathol. 1998 Dec;153(6):1741-8 [9846965.001]
  • [Cites] Virchows Arch. 2004 Dec;445(6):610-5 [15378361.001]
  • [Cites] Virchows Arch. 2004 Dec;445(6):616-20 [15480761.001]
  • [Cites] Acta Cytol. 2004 Nov-Dec;48(6):771-82 [15581161.001]
  • [Cites] Diagn Cytopathol. 2005 Jan;32(1):21-4 [15584047.001]
  • [Cites] J Virol Methods. 2005 Mar;124(1-2):211-5 [15664071.001]
  • [Cites] Mod Pathol. 2005 Feb;18(2):267-73 [15492761.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):367-72 [15734959.001]
  • [Cites] Int J Cancer. 2005 May 10;114(6):973-6 [15645423.001]
  • [Cites] J Clin Pathol. 2005 May;58(5):525-34 [15858126.001]
  • [Cites] Zentralbl Gynakol. 2005 Jun;127(3):140-5 [15915391.001]
  • [Cites] Gynecol Oncol. 2005 Jun;97(3):908-15 [15943992.001]
  • [Cites] J Natl Cancer Inst. 2005 Jul 20;97(14):1072-9 [16030305.001]
  • [Cites] Int J Gynecol Cancer. 2006 Jan-Feb;16(1):347-53 [16445657.001]
  • [Cites] Int J Cancer. 2006 Feb 15;118(4):791-6 [16287075.001]
  • [Cites] Mod Pathol. 2006 Mar;19(3):384-91 [16415792.001]
  • [Cites] Clin Sci (Lond). 2006 May;110(5):525-41 [16597322.001]
  • [Cites] J Clin Microbiol. 2006 Apr;44(4):1310-7 [16597856.001]
  • [Cites] Cancer. 2006 Apr 25;108(2):119-23 [16411180.001]
  • [Cites] Int J Cancer. 2006 Sep 1;119(5):1102-7 [16570279.001]
  • [Cites] Br J Dermatol. 2006 Jul;155(1):129-36 [16792764.001]
  • [Cites] J Clin Pathol. 2006 Aug;59(8):827-30 [16467166.001]
  • [Cites] J Virol Methods. 2006 Oct;137(1):58-62 [16828171.001]
  • [Cites] Gynecol Oncol. 2006 Oct;103(1):62-6 [16494930.001]
  • [Cites] Gynecol Oncol. 2006 Oct;103(1):18-20 [16919709.001]
  • [Cites] J Clin Pathol. 2006 Oct;59(10):1017-28 [16679355.001]
  • (PMID = 18842994.001).
  • [ISSN] 1055-9965
  • [Journal-full-title] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • [ISO-abbreviation] Cancer Epidemiol. Biomarkers Prev.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / ZIA CP010124-14
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins; 0 / P16 protein, human; 0 / RNA, Messenger
  • [Number-of-references] 89
  • [Other-IDs] NLM/ NIHMS212843; NLM/ PMC2900792
  •  go-up   go-down


37. Poulsen ML, Bisgaard ML: MUTYH Associated Polyposis (MAP). Curr Genomics; 2008 Sep;9(6):420-35
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MUTYH Associated Polyposis (MAP), a Polyposis predisposition caused by biallelic mutations in the Base Excision Repair (BER) gene MUTYH, confers a marked risk of colorectal cancer (CRC).
  • Most thoroughly investigated are the two most common MUTYH variants, Y179C and G396D, both generating dysfunctional gene products.PHENOTYPIC FEATURES OF MAP INCLUDE: development of 10-100 colorectal adenomas, debuting at 46-47 years, often CRC at time of clinical diagnosis, and in some, development of extracolonic manifestations.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Carcinogenesis. 2004 Oct;25(10):1859-66 [15180946.001]
  • [Cites] J Cell Sci. 2004 Oct 1;117(Pt 21):4873-5 [15456841.001]
  • [Cites] Hum Mutat. 2004 Oct;24(4):353-4 [15366000.001]
  • [Cites] Oncogene. 2004 Sep 2;23(40):6820-2 [15273732.001]
  • [Cites] Nucleic Acids Res. 2004;32(14):4332-9 [15310837.001]
  • [Cites] Clin Gastroenterol Hepatol. 2004 Aug;2(8):633-8 [15290654.001]
  • [Cites] Gastroenterology. 2004 Jul;127(1):9-16 [15236166.001]
  • [Cites] Gastroenterology. 2004 Jun;126(7):1681-5 [15188161.001]
  • [Cites] Br J Cancer. 2004 Apr 19;90(8):1591-3 [15083190.001]
  • [Cites] Genes Chromosomes Cancer. 2004 May;40(1):1-9 [15034862.001]
  • [Cites] Int J Cancer. 2004 May 1;109(5):680-4 [14999774.001]
  • [Cites] Int J Cancer. 2004 Apr 20;109(4):554-8 [14991577.001]
  • [Cites] J Natl Cancer Inst. 2004 Feb 18;96(4):261-8 [14970275.001]
  • [Cites] Nature. 2004 Feb 12;427(6975):652-6 [14961129.001]
  • [Cites] Cancer Res. 2003 Nov 15;63(22):7595-9 [14633673.001]
  • [Cites] Clin Genet. 2007 Dec;72(6):551-5 [17956577.001]
  • [Cites] Genet Test. 2007 Fall;11(3):315-20 [17949294.001]
  • [Cites] Dis Colon Rectum. 2007 Oct;50(10):1612-7 [17674103.001]
  • [Cites] Int J Colorectal Dis. 2007 Oct;22(10):1173-8 [17703316.001]
  • [Cites] Fam Cancer. 2007;6(1):43-51 [17039270.001]
  • [Cites] Nature. 2007 Jun 21;447(7147):941-50 [17581577.001]
  • [Cites] Eur J Cancer. 2007 Jul;43(10):1617-21 [17524638.001]
  • [Cites] J Med Genet. 2007 Jun;44(6):353-62 [17327285.001]
  • [Cites] Clin Genet. 2007 May;71(5):427-33 [17489848.001]
  • [Cites] J Surg Oncol. 2007 May 1;95(6):499-506 [17219385.001]
  • [Cites] Gut. 2007 Apr;56(4):593 [17369389.001]
  • [Cites] Virchows Arch. 2007 Mar;450(3):311-9 [17252231.001]
  • [Cites] DNA Repair (Amst). 2007 Mar 1;6(3):274-9 [17161978.001]
  • [Cites] Crit Rev Oncol Hematol. 2007 Feb;61(2):153-61 [17064931.001]
  • [Cites] Am J Pathol. 2003 Sep;163(3):827-32 [12937124.001]
  • [Cites] Lancet. 2003 Jul 5;362(9377):39-41 [12853198.001]
  • [Cites] Am J Pathol. 2003 May;162(5):1545-8 [12707038.001]
  • [Cites] Gut. 2003 May;52(5):742-6 [12692062.001]
  • [Cites] J Mol Biol. 2003 Mar 21;327(2):431-43 [12628248.001]
  • [Cites] N Engl J Med. 2003 Feb 27;348(9):791-9 [12606733.001]
  • [Cites] Hum Mol Genet. 2002 Nov 1;11(23):2961-7 [12393807.001]
  • [Cites] Genes Cells. 2002 May;7(5):461-74 [12056405.001]
  • [Cites] J Biol Chem. 2002 Mar 29;277(13):11135-42 [11801590.001]
  • [Cites] Nat Genet. 2002 Feb;30(2):227-32 [11818965.001]
  • [Cites] Cancer Lett. 2001 May 10;166(1):65-9 [11295288.001]
  • [Cites] Hum Mol Genet. 2001 Apr;10(7):721-33 [11257105.001]
  • [Cites] Nucleic Acids Res. 2001 Jan 15;29(2):553-64 [11139626.001]
  • [Cites] Hum Mol Genet. 2000 Sep 22;9(15):2215-21 [11001924.001]
  • [Cites] J Clin Oncol. 2000 Nov 1;18(21 Suppl):19S-31S [11060321.001]
  • [Cites] Biochemistry. 2000 Jun 27;39(25):7331-6 [10858279.001]
  • [Cites] N Engl J Med. 2000 Jul 13;343(2):78-85 [10891514.001]
  • [Cites] Am J Gastroenterol. 2006 Dec;101(12):2810-7 [17026565.001]
  • [Cites] J Clin Pathol. 2006 Nov;59(11):1212-5 [16943222.001]
  • [Cites] Carcinogenesis. 2006 Nov;27(11):2243-9 [16774938.001]
  • [Cites] Fam Cancer. 2006;5(3):221-6 [16998667.001]
  • [Cites] Hum Mutat. 2006 Oct;27(10):1064 [16941501.001]
  • [Cites] Am J Hum Genet. 2006 Oct;79(4):768-71; author reply 771-2 [16960817.001]
  • [Cites] Br J Cancer. 2006 Jul 17;95(2):239-42 [16804517.001]
  • [Cites] Int J Cancer. 2006 Aug 15;119(4):807-14 [16557584.001]
  • [Cites] Crit Rev Oncol Hematol. 2006 Jun;58(3):208-20 [16434208.001]
  • [Cites] Front Biosci. 2006;11:3062-80 [16720376.001]
  • [Cites] Clin Gastroenterol Hepatol. 2006 Apr;4(4):499-506 [16616356.001]
  • [Cites] Clin Chem. 2006 Apr;52(4):739-43 [16455870.001]
  • [Cites] World J Gastroenterol. 2006 Feb 14;12(6):951-5 [16521226.001]
  • [Cites] Hum Genet. 2006 Mar;119(1-2):206-11 [16408224.001]
  • [Cites] Int J Cancer. 2006 Apr 15;118(8):1937-40 [16287072.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):312-4 [16492921.001]
  • [Cites] Am J Gastroenterol. 2006 Feb;101(2):385-98 [16454848.001]
  • [Cites] Mutat Res. 2005 Dec 11;591(1-2):60-73 [16081110.001]
  • [Cites] Carcinogenesis. 2005 Nov;26(11):2010-8 [15987719.001]
  • [Cites] Clin Genet. 2005 Nov;68(5):442-7 [16207212.001]
  • [Cites] Mutat Res. 2005 Oct 15;578(1-2):430-3 [15890374.001]
  • [Cites] J Med Genet. 2005 Oct;42(10):756-62 [15788729.001]
  • [Cites] Hum Mutat. 2005 Oct;26(4):394 [16134147.001]
  • [Cites] Hum Mutat. 2005 Oct;26(4):393 [16134146.001]
  • [Cites] J Med Genet. 2005 Sep;42(9):e54 [16140997.001]
  • [Cites] Fam Cancer. 2005;4(3):267-71 [16136388.001]
  • [Cites] Fam Cancer. 2005;4(3):219-25 [16136381.001]
  • [Cites] Am J Med Genet A. 2005 Apr 15;134A(2):212-4 [15690400.001]
  • [Cites] CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 [15761078.001]
  • [Cites] J Natl Cancer Inst. 2005 Feb 16;97(4):320-1; author reply 321-2 [15713969.001]
  • [Cites] Int J Cancer. 2005 Apr 10;114(3):505-7 [15578699.001]
  • [Cites] Nucleic Acids Res. 2005;33(2):597-604 [15673720.001]
  • [Cites] DNA Repair (Amst). 2005 Mar 2;4(3):315-25 [15661655.001]
  • [Cites] Tech Coloproctol. 2004 Dec;8 Suppl 2:s305-8 [15666112.001]
  • [Cites] J Med Genet. 2005 Jan;42(1):95-6 [15635083.001]
  • [Cites] Hum Genet. 2004 Nov;115(6):498-503 [15449173.001]
  • [Cites] J Natl Cancer Inst. 2004 Nov 3;96(21):1631-4 [15523092.001]
  • [Cites] Gastroenterology. 1999 Jun;116(6):1453-6 [10348829.001]
  • [Cites] Nat Struct Biol. 1998 Dec;5(12):1058-64 [9846876.001]
  • [Cites] Lancet Oncol. 2004 Oct;5(10):600-6 [15465463.001]
  • [Cites] Ann Med. 2004;36(5):379-88 [15478312.001]
  • [Cites] Cell Mol Life Sci. 2003 Oct;60(10):2064-83 [14618256.001]
  • [Cites] Hum Mol Genet. 2003 Oct 15;12 Spec No 2:R159-65 [12915454.001]
  • [Cites] Gut. 2008 May;57(5):704-13 [18194984.001]
  • [Cites] Genet Test. 2007 Winter;11(4):373-9 [17931073.001]
  • [Cites] Clin Cancer Res. 2008 Jan 1;14(1):139-42 [18172263.001]
  • [Cites] J Clin Lab Anal. 2007;21(6):372-4 [18022921.001]
  • [Cites] Biochem Soc Trans. 2005 Aug;33(Pt 4):679-83 [16042573.001]
  • [Cites] Hum Mutat. 2005 Aug;26(2):63-8 [15977173.001]
  • [Cites] Genet Test. 2005 Summer;9(2):147-51 [15943555.001]
  • [Cites] Colorectal Dis. 2005 Jul;7(4):327-31 [15932553.001]
  • [Cites] Am J Hum Genet. 2005 Jul;77(1):112-9 [15931596.001]
  • [Cites] Int J Cancer. 2005 Aug 10;116(1):73-7 [15761860.001]
  • (PMID = 19506731.001).
  • [ISSN] 1389-2029
  • [Journal-full-title] Current genomics
  • [ISO-abbreviation] Curr. Genomics
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Other-IDs] NLM/ PMC2691665
  • [Keywords] NOTNLM ; (Attenuated) familial adenomatous polyposis / Colorectal cancer / MUTYH associated polyposis / The MUTYH gene / base excision repair / lynch syndrome.
  •  go-up   go-down


38. Qian W, Zhukov T, Song D, Tockman MS: Computerized analysis of cellular features and biomarkers for cytologic diagnosis of early lung cancer. Anal Quant Cytol Histol; 2007 Apr;29(2):103-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Computerized analysis of cellular features and biomarkers for cytologic diagnosis of early lung cancer.
  • OBJECTIVE: To present a set of novel computerized analysis algorithms to construct a computer-aided cytologic diagnosis (CACD) system to differentiate lung cancer biomarkers and identify cancer cells in the tissue-based specimen images.
  • STUDY DESIGN: Molecular methods, including application of cancer-specific markers, may prove to be complementary to cytology diagnosis, especially when they are combined with CACD system for biomarker assessment.
  • We trained a novel CACD system to recognize expression of the cancer biomarkers histone H2AX in lung cancer cells and then tested the accuracy of this system to distinguish resected lung cancer from preneoplastic and normal tissues.
  • The major characteristics of CACD algorithms is to adapt detection parameters according to cellular image contents.
  • CONCLUSION: The presented algorithms and CACD system for cellular feature enhancement, segmentation and classification are very important in distinguishing benign and malignant lesions.

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17484274.001).
  • [ISSN] 0884-6812
  • [Journal-full-title] Analytical and quantitative cytology and histology
  • [ISO-abbreviation] Anal. Quant. Cytol. Histol.
  • [Language] ENG
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


39. Seibel MJ: Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev; 2005 Nov;26(4):97-122
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Consequently, the interest in, and the need for effective measures to be used in the screening, diagnosis and follow-up of such pathologies has markedly grown.
  • Together with clinical and imaging techniques, biochemical tests play an important role in the assessment and differential diagnosis of metabolic bone disease.
  • In recent years, the isolation and characterisation of cellular and extracellular components of the skeletal matrix have resulted in the development of molecular markers that are considered to reflect either bone formation or bone resorption.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13453-8 [9811821.001]
  • [Cites] J Clin Endocrinol Metab. 1998 Nov;83(11):3930-5 [9814471.001]
  • [Cites] J Biol Chem. 2000 Jun 2;275(22):16666-72 [10747989.001]
  • [Cites] J Bone Miner Res. 2000 Jul;15(7):1337-45 [10893682.001]
  • [Cites] Osteoporos Int. 2000;11 Suppl 6:S66-76 [11193241.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Jan;86(1):192-9 [11232000.001]
  • [Cites] Clin Chem. 2001 Aug;47(8):1443-50 [11468235.001]
  • [Cites] J Bone Miner Res. 2001 Aug;16(8):1408-15 [11499863.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Aug;86(8):3801-4 [11502814.001]
  • [Cites] J Bone Miner Res. 2001 Sep;16(9):1642-50 [11547833.001]
  • [Cites] Med J Aust. 2001 Sep 3;175(5):242-5 [11587253.001]
  • [Cites] Osteoporos Int. 2001;12(10):835-43 [11716186.001]
  • [Cites] Clin Chem. 1985 Oct;31(10):1720-3 [3876176.001]
  • [Cites] Bone. 1985;6(5):339-41 [3879453.001]
  • [Cites] Metabolism. 1985 Oct;34(10):955-61 [3930916.001]
  • [Cites] J Clin Invest. 1977 May;59(5):819-27 [404321.001]
  • [Cites] Biochem J. 1985 Dec 15;232(3):715-24 [4091817.001]
  • [Cites] Science. 1974 Dec 20;186(4169):1115-7 [4478921.001]
  • [Cites] N Engl J Med. 1979 Jul 5;301(1):13-23 [449904.001]
  • [Cites] Am J Clin Nutr. 1972 Jul;25(7):652-4 [5035051.001]
  • [Cites] Enzymologia. 1971 Jul 31;41(1):9-26 [5116110.001]
  • [Cites] J Lab Clin Med. 1970 Jan;75(1):11-8 [5410492.001]
  • [Cites] J Clin Invest. 1970 Aug;49(8):1497-509 [5431661.001]
  • [Cites] Int Rev Connect Tissue Res. 1970;5:93-163 [5533228.001]
  • [Cites] J Biol Chem. 1967 May 25;242(10):2570-1 [6026249.001]
  • [Cites] Lancet. 1984 Feb 11;1(8372):307-10 [6141381.001]
  • [Cites] Lancet. 1984 May 19;1(8386):1091-3 [6144827.001]
  • [Cites] J Biol Chem. 1983 Oct 25;258(20):12723-7 [6355090.001]
  • [Cites] N Engl J Med. 1981 Oct 22;305(17):988-91 [7278923.001]
  • [Cites] Biochem Biophys Res Commun. 1978 Sep 14;84(1):52-7 [728134.001]
  • [Cites] J Bone Miner Res. 2004 Aug;19(8):1250-8 [15231011.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Nov;89(11):5477-81 [15531500.001]
  • [Cites] Clin Chem. 1992 May;38(5):663-70 [1582017.001]
  • [Cites] J Clin Endocrinol Metab. 1992 Mar;74(3):476-80 [1740479.001]
  • [Cites] J Clin Endocrinol Metab. 1992 Mar;74(3):487-94 [1740481.001]
  • [Cites] Clin Chim Acta. 1991 Sep 14;201(1-2):27-33 [1790624.001]
  • [Cites] Calcif Tissue Int. 1991 Dec;49(6):421-6 [1818768.001]
  • [Cites] Biochem Biophys Res Commun. 1976 Jul 12;71(1):83-90 [183768.001]
  • [Cites] J Bone Miner Res. 1991 Jun;6(6):639-44 [1887826.001]
  • [Cites] Metabolism. 1991 Feb;40(2):205-8 [1988778.001]
  • [Cites] Clin Chem. 1981 Dec;27(12):2002-7 [7307252.001]
  • [Cites] Biochem J. 1981 Sep 1;197(3):759-62 [7325985.001]
  • [Cites] Clin Chem. 1995 Nov;41(11):1560-6 [7586543.001]
  • [Cites] Clin Chem. 1995 Aug;41(8 Pt 1):1195-7 [7628100.001]
  • [Cites] Acta Endocrinol (Copenh). 1993 Nov;129(5):388-92 [8279219.001]
  • [Cites] Eur J Clin Invest. 1993 Jun;23(6):341-9 [8344334.001]
  • [Cites] J Bone Miner Res. 1993 Feb;8(2):127-32 [8442431.001]
  • [Cites] Biochim Biophys Acta. 1993 Mar 21;1156(3):288-90 [8461318.001]
  • [Cites] Br J Rheumatol. 1993 Apr;32(4):307-12 [8461924.001]
  • [Cites] Int J Biochem. 1993 Apr;25(4):545-50 [8467955.001]
  • [Cites] J Biol Chem. 1993 May 5;268(13):9901-7 [8486670.001]
  • [Cites] Clin Chem. 1993 Jun;39(6):942-7 [8504561.001]
  • [Cites] J Bone Miner Res. 1993 May;8(5):635-41 [8511991.001]
  • [Cites] J Bone Miner Res. 1993 May;8(5):643-8 [8511992.001]
  • [Cites] Acta Orthop Scand Suppl. 1995 Oct;266:171-5 [8553847.001]
  • [Cites] Bone. 1995 Oct;17(4):335-9 [8573404.001]
  • [Cites] Nature. 1996 Aug 1;382(6590):448-52 [8684484.001]
  • [Cites] Science. 1996 Aug 30;273(5279):1236-8 [8703060.001]
  • [Cites] J Clin Endocrinol Metab. 1996 Sep;81(9):3289-94 [8784085.001]
  • [Cites] Biochemistry. 1977 Jun 28;16(13):3030-6 [880293.001]
  • [Cites] Eur J Endocrinol. 1996 Aug;135(2):231-7 [8810739.001]
  • [Cites] J Bone Miner Res. 1999 May;14(5):792-801 [10320528.001]
  • [Cites] J Bone Miner Res. 1999 Jul;14(7):1203-10 [10404022.001]
  • [Cites] Clin Chem. 1999 Sep;45(9):1501-9 [10471653.001]
  • [Cites] J Bone Miner Res. 1999 Oct;14(10):1654-63 [10491212.001]
  • [Cites] Clin Chem. 1999 Oct;45(10):1858-60 [10508135.001]
  • [Cites] J Bone Miner Res. 1999 Nov;14(11):1926-33 [10571693.001]
  • [Cites] Proc Natl Acad Sci U S A. 1975 Dec;72(12):4905-9 [1061079.001]
  • [Cites] Exp Clin Endocrinol Diabetes. 1996;104(3):289-92 [8817249.001]
  • [Cites] Ann Clin Biochem. 1996 Jul;33 ( Pt 4):347-8 [8836394.001]
  • [Cites] J Bone Miner Res. 1996 Mar;11(3):337-49 [8852944.001]
  • [Cites] Clin Chem. 1996 Oct;42(10):1639-44 [8855148.001]
  • [Cites] Clin Chem. 1996 Nov;42(11):1796-804 [8906079.001]
  • [Cites] J Bone Miner Res. 1996 Nov;11(11):1784-92 [8915787.001]
  • [Cites] Calcif Tissue Int. 1996 Dec;59(6):454-60 [8939771.001]
  • [Cites] J Clin Endocrinol Metab. 1996 Jun;81(6):2264-70 [8964862.001]
  • [Cites] Eur J Clin Invest. 1996 Dec;26(12):1107-14 [9013086.001]
  • [Cites] Proc Assoc Am Physicians. 1997 Mar;109(2):174-80 [9069586.001]
  • [Cites] J Bone Miner Res. 1997 Mar;12(3):447-55 [9076588.001]
  • [Cites] J Biol Chem. 1997 Apr 11;272(15):9755-63 [9092508.001]
  • [Cites] Calcif Tissue Int. 1997 May;60(5):419-23 [9115158.001]
  • [Cites] Bull Cancer. 1997 Jan;84(1):17-24 [9180854.001]
  • [Cites] J Bone Miner Res. 1997 Jul;12(7):1028-34 [9200001.001]
  • [Cites] J Bone Miner Res. 1997 Jan;12(1):59-65 [9240726.001]
  • [Cites] J Bone Miner Res. 1997 Sep;12(9):1407-15 [9286756.001]
  • [Cites] Clin Chem. 1997 Sep;43(9):1570-6 [9299935.001]
  • [Cites] Anticancer Res. 1997 Jul-Aug;17(4B):3167-70 [9329628.001]
  • [Cites] Clin Chem. 1997 Nov;43(11):2076-82 [9365391.001]
  • [Cites] J Clin Endocrinol Metab. 1998 Jan;83(1):68-75 [9435418.001]
  • [Cites] J Bone Miner Res. 1998 Mar;13(3):475-82 [9525348.001]
  • [Cites] Biochem J. 1998 May 1;331 ( Pt 3):727-32 [9560298.001]
  • [Cites] J Clin Endocrinol Metab. 1998 Jul;83(7):2266-74 [9661593.001]
  • [Cites] Acta Endocrinol (Copenh). 1991 Apr;124(4):391-8 [2031437.001]
  • [Cites] Matrix. 1991 Apr;11(2):133-43 [2072878.001]
  • [Cites] Clin Biochem. 1977 Oct;10(5):171-4 [21038.001]
  • [Cites] J Clin Endocrinol Metab. 1990 May;70(5):1431-7 [2110577.001]
  • [Cites] J Bone Miner Res. 1990 Jul;5(7):671-6 [2118710.001]
  • [Cites] Clin Chim Acta. 1990 Jan 15;186(2):133-50 [2178806.001]
  • [Cites] Biochem J. 1990 Oct 15;271(2):345-50 [2241919.001]
  • [Cites] J Clin Endocrinol Metab. 1990 Feb;70(2):467-72 [2298858.001]
  • [Cites] Osteoporos Int. 1994 Nov;4(6):349-52 [7696831.001]
  • [Cites] Clin Endocrinol (Oxf). 1995 Feb;42(2):141-6 [7704958.001]
  • [Cites] Clin Chem. 1995 May;41(5):679-86 [7729045.001]
  • [Cites] J Bone Miner Res. 1994 Oct;9(10):1643-9 [7817812.001]
  • [Cites] J Bone Miner Res. 1994 Sep;9(9):1433-40 [7817828.001]
  • [Cites] Arthritis Rheum. 1995 Jan;38(1):82-90 [7818577.001]
  • [Cites] Eur J Clin Chem Clin Biochem. 1994 Sep;32(9):675-80 [7865622.001]
  • [Cites] J Bone Miner Res. 1994 Dec;9(12):1883-8 [7872053.001]
  • [Cites] Biochem J. 1994 Aug 15;302 ( Pt 1):175-9 [7915111.001]
  • [Cites] Clin Chem. 1994 Nov;40(11 Pt 1):2022-5 [7955372.001]
  • [Cites] Clin Chem. 1994 Nov;40(11 Pt 1):2071-7 [7955381.001]
  • [Cites] Gynecol Obstet Invest. 1994;38(1):60-4 [7959331.001]
  • [Cites] J Clin Endocrinol Metab. 1994 Aug;79(2):366-71 [8045949.001]
  • [Cites] J Clin Endocrinol Metab. 1993 Oct;77(4):1046-53 [8104954.001]
  • [Cites] Clin Chem. 1994 Mar;40(3):358-63 [8131267.001]
  • [Cites] J Bone Miner Res. 1994 Mar;9(3):347-54 [8191928.001]
  • [Cites] Bone Miner. 1994 Feb;24(2):81-94 [8199535.001]
  • [Cites] Clin Biochem. 1994 Feb;27(1):49-55 [8200115.001]
  • [Cites] J Bone Miner Res. 1999 Mar;14(3):464-9 [10027912.001]
  • [Cites] Eur J Endocrinol. 1999 Apr;140(4):332-7 [10097253.001]
  • [Cites] Calcif Tissue Int. 2001 Oct;69(4):209-13 [11730252.001]
  • [Cites] Calcif Tissue Int. 2001 Oct;69(4):229-34 [11730257.001]
  • [Cites] Maturitas. 2002 Jan 30;41(1):23-33 [11809340.001]
  • [Cites] Clin Chem. 1976 Dec;22(12):2025-8 [11900.001]
  • [Cites] Calcif Tissue Int. 2002 Mar;70(3):137-45 [11907709.001]
  • [Cites] Clin Sci (Lond). 1992 Sep;83(3):375-82 [1327658.001]
  • [Cites] Clin Chem. 1992 Oct;38(10):2055-60 [1394989.001]
  • [Cites] Clin Chem. 1992 Nov;38(11):2313-8 [1424129.001]
  • [Cites] J Biol Chem. 2004 Feb 13;279(7):5470-9 [14645229.001]
  • [Cites] J Bone Miner Res. 1992 Nov;7(11):1243-50 [1466250.001]
  • [Cites] J Bone Miner Res. 1992 Nov;7(11):1251-8 [1466251.001]
  • [Cites] Anal Biochem. 1992 Nov 15;207(1):168-75 [1489091.001]
  • [Cites] J Bone Miner Res. 1990 Jan;5(1):5-11 [2309579.001]
  • [Cites] Clin Chem. 1990 Jun;36(6):875-8 [2357825.001]
  • [Cites] Clin Chem. 1990 Jul;36(7):1328-32 [2372946.001]
  • [Cites] J Clin Endocrinol Metab. 1990 Aug;71(2):442-51 [2380339.001]
  • [Cites] Metabolism. 1988 Sep;37(9):872-7 [2458519.001]
  • [Cites] J Clin Endocrinol Metab. 1989 Dec;69(6):1160-5 [2511220.001]
  • [Cites] Physiol Rev. 1989 Jul;69(3):990-1047 [2664828.001]
  • [Cites] Clin Chim Acta. 1989 Jun 30;182(2):173-81 [2776350.001]
  • [Cites] Lancet. 1985 Oct 12;2(8459):800-1 [2864532.001]
  • [Cites] J Clin Endocrinol Metab. 1988 Oct;67(4):741-8 [3262119.001]
  • [Cites] Panminerva Med. 1988 Jan-Mar;30(1):23-5 [3262212.001]
  • [Cites] Anal Biochem. 1988 Feb 15;169(1):197-203 [3369682.001]
  • [Cites] Biochem J. 1988 Jun 1;252(2):495-500 [3415669.001]
  • [Cites] Pediatr Res. 1987 Mar;21(3):296-300 [3494227.001]
  • [Cites] J Chromatogr. 1987 Jan 23;413:65-78 [3558696.001]
  • [Cites] Bone. 1985;6(1):9-13 [3873250.001]
  • [Cites] Anal Biochem. 1984 Jul;140(1):129-37 [6486400.001]
  • [Cites] Analyst. 1984 Dec;109(12):1621-2 [6532253.001]
  • [Cites] Clin Chem. 1984 Jul;30(7):1182-6 [6547374.001]
  • [Cites] Calcif Tissue Int. 1982 May;34(3):285-90 [6809291.001]
  • [Cites] Am J Clin Nutr. 1983 Mar;37(3):478-94 [6829490.001]
  • [Cites] N Engl J Med. 1980 Jun 26;302(26):1460-6 [6990261.001]
  • [Cites] Clin Sci (Lond). 1980 Oct;59(4):215-23 [7000418.001]
  • [Cites] Crit Rev Clin Lab Sci. 1982;16(3):161-94 [7047076.001]
  • (PMID = 16648882.001).
  • [ISSN] 0159-8090
  • [Journal-full-title] The Clinical biochemist. Reviews
  • [ISO-abbreviation] Clin Biochem Rev
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  • [Other-IDs] NLM/ PMC1320175
  •  go-up   go-down


40. Bock O, Büsche G, Koop C, Schröter S, Buhr T, Kreipe H: Detection of the single hotspot mutation in the JH2 pseudokinase domain of Janus kinase 2 in bone marrow trephine biopsies derived from chronic myeloproliferative disorders. J Mol Diagn; 2006 May;8(2):170-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In a series of proven Ph- CMPDs classified according to World Health Organization criteria (n = 79), we detected the JAK2 mutation in 90% of polycythemia vera, 22% of cellular prefibrotic chronic idiopathic myelofibrosis, 60% of advanced chronic idiopathic myelofibrosis, and 27% of essential thrombocythemia.
  • Besides providing support in the differential diagnosis of reactive versus neoplastic myeloproliferations, this newly developed assay reveals considerable overlaps between histologically different disease entities, indicating that additional genetic alterations might be responsible for the established differences of CMPD subentities.

  • Genetic Alliance. consumer health - Chronic Myeloproliferative Disorders.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Mol Diagn. 2003 Feb;5(1):54-60 [12552081.001]
  • [Cites] Am J Clin Pathol. 2003 Jan;119(1):152-8 [12520711.001]
  • [Cites] Diagn Mol Pathol. 2003 Sep;12(3):119-23 [12960692.001]
  • [Cites] Lancet. 2005 Mar 19-25;365(9464):1054-61 [15781101.001]
  • [Cites] Cancer Cell. 2005 Apr;7(4):387-97 [15837627.001]
  • [Cites] N Engl J Med. 2005 Apr 28;352(17):1779-90 [15858187.001]
  • [Cites] Nature. 2005 Apr 28;434(7037):1144-8 [15793561.001]
  • [Cites] Blood. 2005 Jun 1;105(11):4187-90 [15817681.001]
  • [Cites] Blood. 2005 Aug 15;106(4):1207-9 [15860661.001]
  • [Cites] N Engl J Med. 2000 Apr 27;342(17):1255-65 [10781623.001]
  • [Cites] Mol Cell Biol. 2000 May;20(10):3387-95 [10779328.001]
  • [Cites] Int J Hematol. 2001 Feb;73(2):170-6 [11372728.001]
  • [Cites] Anal Biochem. 2001 Aug 1;295(1):116-7 [11476553.001]
  • [Cites] Oncogene. 2002 May 13;21(21):3334-58 [12032773.001]
  • [Cites] Int J Hematol. 2002 Aug;76(2):133-45 [12215011.001]
  • [Cites] Int J Hematol. 2002 Aug;76 Suppl 2:6-8 [12430892.001]
  • [Cites] Blood. 2003 Sep 1;102(5):1869-71 [12730106.001]
  • (PMID = 16645202.001).
  • [ISSN] 1525-1578
  • [Journal-full-title] The Journal of molecular diagnostics : JMD
  • [ISO-abbreviation] J Mol Diagn
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Proto-Oncogene Proteins; 0 / RNA, Messenger; EC 2.7.10.1 / Protein-Tyrosine Kinases; EC 2.7.10.2 / Fusion Proteins, bcr-abl; EC 2.7.10.2 / JAK2 protein, human; EC 2.7.10.2 / Janus Kinase 2
  • [Other-IDs] NLM/ PMC1867581
  •  go-up   go-down


41. Alhamdani MS, Schröder C, Hoheisel JD: Oncoproteomic profiling with antibody microarrays. Genome Med; 2009;1(7):68
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The incidence of cancer and its associated mortality are increasing globally, indicating an urgent need to develop even more effective and sensitive sets of biomarkers that could help in early diagnosis and consequent intervention.
  • Given that many cellular processes are carried out by proteins, cancer research has recently shifted toward an exploration of the full proteome for such discovery.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Cancer. 2004 Apr 20;109(4):507-15 [14991571.001]
  • [Cites] Proteomics. 2003 Nov;3(11):2116-22 [14595810.001]
  • [Cites] Mol Cell Proteomics. 2003 Oct;2(10):1096-103 [12917320.001]
  • [Cites] J Mol Recognit. 2003 Jul-Aug;16(4):165-76 [12898667.001]
  • [Cites] Nature. 2003 Mar 13;422(6928):198-207 [12634793.001]
  • [Cites] Proteomics. 2003 Jan;3(1):56-63 [12548634.001]
  • [Cites] Biotechniques. 2002 Dec;Suppl:14-23 [12514925.001]
  • [Cites] Nat Genet. 2002 Dec;32 Suppl:526-32 [12454649.001]
  • [Cites] N Engl J Med. 2002 Nov 14;347(20):1593-603 [12432047.001]
  • [Cites] Anal Biochem. 2002 Oct 15;309(2):253-60 [12413459.001]
  • [Cites] Cancer Res. 2001 Oct 15;61(20):7585-93 [11606398.001]
  • [Cites] Trends Cell Biol. 2001 Nov;11(11):S60-5 [11684444.001]
  • [Cites] Mol Cell Proteomics. 2007 Dec;6(12):2150-64 [17848589.001]
  • [Cites] Int J Oncol. 2007 Dec;31(6):1325-32 [17982658.001]
  • [Cites] Proteomics. 2007 Sep;7(17):3055-65 [17787036.001]
  • [Cites] Biotechniques. 2008 Apr;44(5):649-54 [18474040.001]
  • [Cites] Prostate. 2008 Jun 1;68(8):872-82 [18361406.001]
  • [Cites] Eur J Cancer. 2008 Feb;44(3):472-80 [18171612.001]
  • [Cites] Cell Prolif. 2008 Feb;41(1):59-85 [18211286.001]
  • [Cites] J Proteome Res. 2008 Jan;7(1):319-27 [18047267.001]
  • [Cites] Mol Cell Proteomics. 2008 Jan;7(1):163-9 [17934210.001]
  • [Cites] Mol Cancer Ther. 2006 Aug;5(8):2115-20 [16928833.001]
  • [Cites] J Proteome Res. 2006 Aug;5(8):1866-78 [16889408.001]
  • [Cites] Genome Res. 2006 Aug;16(8):1041-5 [16809670.001]
  • [Cites] Proteomics. 2006 Mar;6(6):1791-802 [16485257.001]
  • [Cites] Nat Rev Genet. 2006 Mar;7(3):200-10 [16485019.001]
  • [Cites] Proteomics. 2006 Feb;6(4):1104-9 [16404717.001]
  • [Cites] Am J Pathol. 2006 Jan;168(1):93-103 [16400012.001]
  • [Cites] Cancer Res. 2005 Dec 1;65(23):11193-202 [16322270.001]
  • [Cites] Proteomics. 2005 Nov;5(17):4327-37 [16237735.001]
  • [Cites] Nat Methods. 2005 Sep;2(9):642-3 [16184665.001]
  • [Cites] BMC Cancer. 2005;5:110 [16117833.001]
  • [Cites] Lung Cancer. 2005 Aug;49(2):145-54 [16022908.001]
  • [Cites] Expert Rev Proteomics. 2004 Oct;1(3):355-64 [15966831.001]
  • [Cites] J Proteome Res. 2005 May-Jun;4(3):758-67 [15952723.001]
  • [Cites] Mol Cell Proteomics. 2005 Jun;4(6):773-84 [15793073.001]
  • [Cites] Mol Cell Proteomics. 2005 Apr;4(4):492-522 [15695426.001]
  • [Cites] Oncogene. 2007 Jun 21;26(29):4216-25 [17297476.001]
  • [Cites] Proteomics. 2007 Jun;7(11):1786-99 [17474144.001]
  • [Cites] Nat Methods. 2007 May;4(5):437-44 [17417647.001]
  • [Cites] Eur J Cancer. 2007 May;43(7):1117-24 [17379503.001]
  • [Cites] Proteomics. 2007 Feb;7(4):540-7 [17309099.001]
  • [Cites] Mol Syst Biol. 2007;3:79 [17299416.001]
  • [Cites] Prostate. 2007 Feb 15;67(3):255-67 [17192876.001]
  • [Cites] Nat Methods. 2007 Jan;4(1):13-7 [17195019.001]
  • [Cites] Int J Oncol. 2007 Jan;30(1):105-11 [17143518.001]
  • [Cites] OMICS. 2006 Fall;10(3):411-27 [17069517.001]
  • [Cites] Cancer Res. 2006 Oct 15;66(20):9886-94 [17047050.001]
  • [Cites] Br J Haematol. 2006 Oct;135(2):184-97 [16939496.001]
  • [Cites] Mol Cell Proteomics. 2006 Sep;5(9):1681-96 [16735300.001]
  • [Cites] Proteomics. 2006 Sep;6(17):4688-703 [16933336.001]
  • [Cites] Clin Chem. 2006 Sep;52(9):1651-9 [16809399.001]
  • [Cites] BMC Cancer. 2009;9:142 [19432987.001]
  • [Cites] Biotechniques. 2009 Apr;46(4):297-304 [19450236.001]
  • [Cites] N Biotechnol. 2009 Apr;25(4):195-203 [19429539.001]
  • [Cites] Mol Oncol. 2007 Dec;1(3):313-20 [19383305.001]
  • [Cites] Int J Oncol. 2009 May;34(5):1291-301 [19360341.001]
  • [Cites] Anal Chem. 2009 Mar 15;81(6):2168-75 [19281260.001]
  • [Cites] Methods Mol Biol. 2009;509:57-84 [19212715.001]
  • [Cites] Curr Opin Chem Biol. 2008 Oct;12(5):483-90 [18718552.001]
  • [Cites] J Mol Recognit. 2009 Mar-Apr;22(2):57-64 [18546091.001]
  • [Cites] J Proteome Res. 2009 Feb;8(2):483-92 [19072160.001]
  • [Cites] Pathol Oncol Res. 2008 Dec;14(4):481-3 [18415708.001]
  • [Cites] Methods Mol Biol. 2009;504:51-71 [19159090.001]
  • [Cites] Anal Biochem. 2009 Feb 15;385(2):234-41 [19027707.001]
  • [Cites] Methods Mol Biol. 2009;528:259-67 [19153698.001]
  • [Cites] BMC Bioinformatics. 2008;9:443 [18937839.001]
  • [Cites] Folia Biol (Praha). 2008;54(4):134-40 [18808740.001]
  • [Cites] J Proteome Res. 2008 Sep;7(9):3668-77 [18680356.001]
  • [Cites] J Transl Med. 2008;6:41 [18652693.001]
  • [Cites] Proteomics. 2008 Jun;8(11):2211-9 [18528842.001]
  • [Cites] Expert Rev Proteomics. 2008 Jun;5(3):425-33 [18532910.001]
  • [Cites] Exp Biol Med (Maywood). 2008 Jun;233(6):708-20 [18408141.001]
  • [Cites] Biosens Bioelectron. 2008 Jul 15;23(12):1759-68 [18343101.001]
  • [Cites] Proteomics. 2005 Feb;5(2):420-5 [15700241.001]
  • [Cites] Breast Cancer Res Treat. 2004 Aug;86(3):281-91 [15567944.001]
  • [Cites] J Pharm Biomed Anal. 1989;7(2):155-68 [2488616.001]
  • [Cites] Ann Biol Clin (Paris). 1992;50(5):337-53 [1485691.001]
  • [Cites] Mol Cell Proteomics. 2004 Apr;3(4):327-44 [14754989.001]
  • (PMID = 19591665.001).
  • [ISSN] 1756-994X
  • [Journal-full-title] Genome medicine
  • [ISO-abbreviation] Genome Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2717394
  •  go-up   go-down


42. Maletić-Savatić M, Vingara LK, Manganas LN, Li Y, Zhang S, Sierra A, Hazel R, Smith D, Wagshul ME, Henn F, Krupp L, Enikolopov G, Benveniste H, Djurić PM, Pelczer I: Metabolomics of neural progenitor cells: a novel approach to biomarker discovery. Cold Spring Harb Symp Quant Biol; 2008;73:389-401
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Late diagnosis leads to late therapy and poor prognosis.
  • Recently, we have adopted metabolomics techniques to develop an approach that combines both in vitro analysis of cellular samples and in vivo analysis of the mammalian brain.
  • Herein, we present our strategy for both cellular and systems metabolomics, based on an integrative processing of the spectroscopy data that uses analytical tools from both metabolomic and spectroscopy fields.
  • Our studies link systems and cellular neuroscience through the functions of specific metabolites.

  • MedlinePlus Health Information. consumer health - Stem Cells.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Plant Mol Biol. 2002 Jan;48(1-2):155-71 [11860207.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3030-5 [11867752.001]
  • [Cites] Nat Rev Drug Discov. 2002 Feb;1(2):153-61 [12120097.001]
  • [Cites] J Cereb Blood Flow Metab. 2002 Aug;22(8):899-907 [12172375.001]
  • [Cites] Nat Med. 2002 Dec;8(12):1439-44 [12447357.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16267-72 [12444255.001]
  • [Cites] Biochim Biophys Acta. 2003 Jan 20;1619(2):151-8 [12527111.001]
  • [Cites] Analyst. 2003 Jan;128(1):32-6 [12572799.001]
  • [Cites] Anal Chem. 2005 Mar 1;77(5):1282-9 [15732908.001]
  • [Cites] Curr Opin Biotechnol. 2005 Apr;16(2):174-9 [15831383.001]
  • [Cites] Analyst. 2005 May;130(5):606-25 [15852128.001]
  • [Cites] Nat Rev Microbiol. 2005 Jul;3(7):557-65 [15953932.001]
  • [Cites] NeuroRx. 2005 Apr;2(2):197-214 [15897945.001]
  • [Cites] Mol Imaging. 2005 Jul-Sep;4(3):143-64 [16194447.001]
  • [Cites] Drug Discov Today. 2005 Nov 15;10(22):1551-8 [16257378.001]
  • [Cites] Ann Clin Biochem. 2003 Jan;40(Pt 1):16-24 [12542907.001]
  • [Cites] Hum Genet. 2003 May;112(5-6):581-92 [12607117.001]
  • [Cites] Nat Rev Drug Discov. 2003 Aug;2(8):668-76 [12904817.001]
  • [Cites] Nucl Med Commun. 2003 Nov;24(11):1149-54 [14569169.001]
  • [Cites] MAGMA. 2003 Nov;16(3):135-43 [14564645.001]
  • [Cites] Radiology. 2003 Dec;229(3):838-46 [14657318.001]
  • [Cites] Neuroimage. 2004 Jan;21(1):311-7 [14741669.001]
  • [Cites] Chem Res Toxicol. 2004 Feb;17(2):165-73 [14967004.001]
  • [Cites] Drug Discov Today. 2004 Mar 15;9(6):260-1 [15003243.001]
  • [Cites] Trends Biotechnol. 2004 May;22(5):245-52 [15109811.001]
  • [Cites] Magn Reson Med. 2004 May;51(5):904-12 [15122672.001]
  • [Cites] Mol Psychiatry. 2004 Jul;9(7):684-97, 643 [15098003.001]
  • [Cites] Nat Rev Cancer. 2004 Jul;4(7):551-61 [15229480.001]
  • [Cites] Philos Trans R Soc Lond B Biol Sci. 2004 Jun 29;359(1446):857-71 [15306403.001]
  • [Cites] Annu Rev Biophys Bioeng. 1979;8:1-25 [382999.001]
  • [Cites] Pharmacogenomics. 2006 Oct;7(7):1095-107 [17054419.001]
  • [Cites] Magn Reson Med. 2007 Jan;57(1):164-71 [17191231.001]
  • [Cites] J Proteome Res. 2007 Feb;6(2):443-58 [17269702.001]
  • [Cites] Eur Radiol. 2007 Jul;17(7):1651-62 [17235536.001]
  • [Cites] Neurotherapeutics. 2007 Jul;4(3):330-45 [17599700.001]
  • [Cites] NMR Biomed. 2007 Aug;20(5):493-504 [17167819.001]
  • [Cites] J Proteome Res. 2007 Nov;6(11):4469-77 [17929959.001]
  • [Cites] Science. 2007 Nov 9;318(5852):980-5 [17991865.001]
  • [Cites] Nat Protoc. 2007;2(11):2692-703 [18007604.001]
  • [Cites] Chem Res Toxicol. 2008 Jan;21(1):9-27 [18171018.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2117-22 [18252821.001]
  • [Cites] Nat Biotechnol. 2000 Nov;18(11):1142-3 [11062428.001]
  • [Cites] Nat Biotechnol. 2000 Nov;18(11):1157-61 [11062433.001]
  • [Cites] FEBS Lett. 2000 Nov 10;484(3):169-74 [11078872.001]
  • [Cites] Nat Biotechnol. 2001 Jan;19(1):45-50 [11135551.001]
  • [Cites] Curr Opin Biotechnol. 2001 Feb;12(1):82-6 [11167078.001]
  • [Cites] Plant Cell. 2001 Jan;13(1):11-29 [11158526.001]
  • [Cites] Anat Rec. 2001 Apr15;265(2):54-84 [11323770.001]
  • [Cites] NMR Biomed. 2001 Jun;14(4):224-32 [11410940.001]
  • [Cites] NMR Biomed. 2001 Jun;14(4):233-46 [11410941.001]
  • [Cites] NMR Biomed. 2001 Jun;14(4):247-59 [11410942.001]
  • [Cites] NMR Biomed. 2001 Jun;14(4):260-4 [11410943.001]
  • [Cites] Proc Natl Acad Sci U S A. 1983 Aug;80(16):4945-8 [6576367.001]
  • [Cites] Biochimie. 1983 Aug-Sep;65(8-9):449-70 [6416302.001]
  • [Cites] Proc Natl Acad Sci U S A. 1985 Apr;82(7):2148-52 [3856889.001]
  • [Cites] Magn Reson Med. 1985 Feb;2(1):86-9 [3831681.001]
  • [Cites] Magn Reson Med. 1988 Jan;6(1):92-8 [3352510.001]
  • [Cites] Magn Reson Med. 1989 Jan;9(1):79-93 [2540396.001]
  • [Cites] Med Phys. 1989 May-Jun;16(3):388-97 [2739620.001]
  • [Cites] NMR Biomed. 1988 Jun;1(3):131-5 [3275124.001]
  • [Cites] Magn Reson Med. 1998 Jun;39(6):899-911 [9621913.001]
  • [Cites] Nat Med. 1998 Nov;4(11):1313-7 [9809557.001]
  • [Cites] Magn Reson Med. 1999 Jun;41(6):1108-18 [10371442.001]
  • [Cites] Eur J Radiol. 1999 May;30(2):125-31 [10401593.001]
  • [Cites] NMR Biomed. 1999 Jun;12(4):205-16 [10421912.001]
  • [Cites] J Magn Reson. 1999 Sep;140(1):120-30 [10479554.001]
  • [Cites] NMR Biomed. 2004 Nov;17(7):484-99 [15526347.001]
  • [Cites] Curr Drug Metab. 2004 Oct;5(5):389-98 [15544433.001]
  • [Cites] Blood. 2005 Jan 1;105(1):420-5 [15331444.001]
  • [Cites] Genome Biol. 2005;6(11):354 [16277757.001]
  • [Cites] Methods Mol Med. 2006;124:419-39 [16506433.001]
  • [Cites] Phys Med Biol. 2006 Aug 21;51(16):R579-636 [16885612.001]
  • [Cites] Proteomics. 2006 Sep;6(17):4716-23 [16888765.001]
  • [Cites] Am J Transplant. 2008 Mar;8(3):701-6 [18294167.001]
  • [Cites] Nature. 2008 May 15;453(7193):396-400 [18425110.001]
  • [Cites] Nat Med. 2000 Mar;6(3):271-7 [10700228.001]
  • [Cites] NMR Biomed. 2000 May;13(3):129-53 [10861994.001]
  • [Cites] Chem Res Toxicol. 2001 Oct;14(10):1401-12 [11599932.001]
  • [Cites] Curr Opin Biotechnol. 2002 Feb;13(1):20-4 [11849953.001]
  • (PMID = 19022759.001).
  • [ISSN] 1943-4456
  • [Journal-full-title] Cold Spring Harbor symposia on quantitative biology
  • [ISO-abbreviation] Cold Spring Harb. Symp. Quant. Biol.
  • [Language] ENG
  • [Grant] United States / NINDS NIH HHS / NS / R01-NS32764; United States / NINDS NIH HHS / NS / K08 NS044276-05; United States / NINDS NIH HHS / NS / 5K08 NS044276; United States / NINDS NIH HHS / NS / R01 NS032764; United States / NIDDK NIH HHS / DK / T32 DK007521; United States / NINDS NIH HHS / NS / R21 NS053875; United States / NINDS NIH HHS / NS / R21 NS053875-02; United States / NINDS NIH HHS / NS / K08 NS044276; United States / NINDS NIH HHS / NS / R21NS05875-1; United States / NIDDK NIH HHS / DK / T32DK07521-16
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers
  • [Number-of-references] 82
  • [Other-IDs] NLM/ NIHMS369204; NLM/ PMC4037147
  •  go-up   go-down


43. Jokerst JV, McDevitt JT: Programmable nano-bio-chips: multifunctional clinical tools for use at the point-of-care. Nanomedicine (Lond); 2010 Jan;5(1):143-55
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Applications such as disease diagnosis and prognosis for areas including cancer, heart disease and HIV are described.
  • This report describes the construction and use of two major classes of nano-bio-chip designs that serve as cellular and chemical processing units, and provides perspective on future growth in this newly emerging field of programmable nano-bio-chip sensor systems.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 2008 Jan 10;358(2):105-7 [18184955.001]
  • [Cites] Lab Chip. 2007 Oct;7(10):1238-55 [17896006.001]
  • [Cites] Nature. 2008 Apr 3;452(7187):571-9 [18385731.001]
  • [Cites] N Engl J Med. 2008 Jul 24;359(4):366-77 [18596266.001]
  • [Cites] Nat Nanotechnol. 2008 May;3(5):242-4 [18654511.001]
  • [Cites] Lab Chip. 2008 Dec;8(12):1982-3 [19023459.001]
  • [Cites] Lab Chip. 2008 Dec;8(12):2015-31 [19023464.001]
  • [Cites] Lab Chip. 2008 Dec;8(12):2079-90 [19023471.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20173-8 [19075237.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20637-40 [